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Abstract 
 
Salmonella is responsible for millions of infections worldwide, with varied disease 
outcomes, ranging from localised gastroenteritis to a fatal systemic infection. As a 
facultative anaerobe, Salmonella is able to respire using nitrate as an alternative 
electron acceptor. This study highlights the role of two gaseous intermediates 
produced during nitrate respiration, nitric oxide (NO) and nitrous oxide (N2O), during 
Salmonella pathogenesis.  
Building from previous studies, a link is drawn between the high level of production of 
N2O by Salmonella, and the metabolically expensive, and seemingly unimportant 
synthesis of vitamin B12. We demonstrate the importance of the vitamin B12 
independent methionine synthase, MetE, both during nitrate respiration and for 
survival within macrophages. We hypothesise that when respiring on nitrate in the 
intestine Salmonella releases N2O which is detrimental to vitamin B12 availability and 
commensal survival in the intestine. Salmonella however is protected two-fold from 
the toxicity of N2O, by the presence of MetE, and by the ability to synthesise vitamin 
B12 de novo. This phenomenon is further investigated across multiple Salmonella 
serovars, with the indication that enteric strains produce both higher levels of vitamin 
B12 and N2O.  
As well as during nitrate respiration, Salmonella also encounters NO exogenously 
when challenged by the host defense inside macrophages. Since NO is a highly toxic 
compound effective detoxification systems are essential for survival. A relationship 
between NO and tellurite resistance in Salmonella is shown. Three putative tellurite 
resistance proteins, TehB, STM1808 and YeaR were confirmed to provide resistance 
against tellurite in Salmonella and share functional redundancy in the anaerobic 
detoxification of NO and infection of macrophages. Using a suite of NO sensitive 
mutants, we also demonstrate a clear correlation between tellurite and NO sensitivity. 
Collectively this study highlights two important aspects of the nitrogen cycle which 
contribute to pathogenesis in Salmonella.  
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1.1 General  
Salmonella is a genus of Gram negative bacteria which contains just two species: 
Salmonella bongori and Salmonella enterica. Within enterica there are over 2500 
different Salmonella serovars, a sub-species categorisation system based on outer 
membrane antigens, and includes all of those which cause disease in humans 
(Ochman and Groisman 1994).  
Only about 50 of these serovars have been isolated as known pathogens (Coburn, 
Grassl and Finlay 2007). Different serovars of Salmonella can infect different hosts, 
some are host specific, and restricted to a single host, whilst others are generalists 
and have the ability to infect a wide range of mammalian and avian hosts. There are 
two main disease types associated with Salmonella. A systemic typhoidal infection 
caused by S. Typhi in humans and more common non-typhoidal strains which cause 
localised gastrointestinal/enteric infections (enteritis), such as S. Typhimurium in 
humans and S. Dublin in calves (Coburn et al. 2007)  
Salmonella Typhi and Paratyphi (see 1.4.2 Enteric fever) almost exclusively cause a 
systemic infection in humans and therefore are referred to as host restricted strains. 
Similarly, Salmonella Gallinarum is only known to cause a systemic infection in 
chickens/fowl. Salmonella Cholerasuis and Salmonella Dublin are most commonly 
known to cause a systemic infection in pigs and cattle respectively, but also have the 
ability to infect other hosts, including humans, these serovars are referred to as host 
adapted strains, since they most commonly infect a single host but it is not a strict 
restriction. There are then further strains such as Salmonella Typhimurium and 
Salmonella Enteritidis which cause an enteric infection in a wide range of hosts, and 
as such are un-restricted serovars (Uzzau et al. 2000). The most common non-
typhoidal serovar used as a model laboratory strain is Salmonella enterica subs. 
enterica serovar Typhimurium (S. Typhimurium), so called because as well as causing 
a self-limiting gastroenteritis in humans resulting in fever and diarrhoea, it causes, as 
the name suggests Typhoid like symptoms in mice. S. Typhimurium SL1344 is used 
throughout this thesis and referred to as Salmonella, unless otherwise stated.  
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1.2 Sources of contamination 
A natural Salmonella infection progresses post oral infection. The origin of infection 
can be from numerous sources. Approximately 95% of infections are associated with 
the eating of contaminated foodstuffs, this can include raw or undercooked meat either 
from an infected animal or one that has become contaminated post slaughter, eggs 
from infected chickens, and unpasteurised milk (Mead et al. 1999). There are also 
non-animal foods which can be sources of contamination, often due to the plants 
having been fertilized with contaminated water. Salad crops and other foods which are 
eaten raw are therefore common sources, this is due to the fact that they are poorly 
washed and not cooked before eating, so any bacteria which have adhered to the 
leaves will remain (L Plym and Wierup 2006, Lynch, Tauxe and Hedberg 2009, Islam 
et al. 2004, Henao-Herreño et al. 2016, Ibenyassine et al. 2007).  
Salmonella is frequently found in environmental water samples, soil, and sediment. A 
review on water-borne Salmonella infections highlighted that the majority of papers 
looking at infections from this source were from Asia, and very few were from the other 
endemic regions of Africa and Central/Southern America (Threlfall 2002). These 
studies have highlighted the effect that lack of chlorination, equipment failures and 
back-siphonage in the water obtained from well-water, unboiled spring water and 
piped water of these areas have on infection numbers.  
 
1.3 Route of infection  
Once an individual has consumed the bacteria, since it has the ability to withstand high 
pH (Foster and Hall 1991, Garcia-del Portillo, Foster and Finlay 1993), it travels 
through the stomach and to the small intestine. Here it preferentially invades the 
epithelial cells of the small intestine (terminal ileum) or enters into the immune system 
by passing through M-cells which filter the gut lumen and transport foreign bodies to 
the Peyer’s patches where they can be taken up by macrophages (Jones, Ghori and 
Falkow 1994, Galán and Curtiss 1989). Internalisation into macrophages occurs via 
the process of phagocytosis, dependent on the recognition of specific molecules by 
receptors on the surface of the macrophage. Inside the macrophage, Salmonella can 
replicate and in the case of typhodal strains disseminate and cause systemic infection 
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of other organs such as the spleen and liver (Alvarez-Ordóñez et al. 2011, Dougan et 
al. 2011, Mastroeni and Grant 2013, Carter and Collins 1974).  
 
1.4 Disease Types  
1.4.1 Gastroenteritis 
The most common Salmonella infection in humans is Salmonellosis, which causes a 
gastrointestinal infection. A number of different S. enterica subspecies can lead to 
Salmonellosis in humans with around 20 serovars causing approximately 70% of 
cases, with the top three, S. enterica Typhimurium, Enteritidis and Newport causing 
40% of infections. Symptoms of the infection usually occur 8-72 hours after ingestion 
of contaminated material and include inflammation of the intestine, abdominal 
cramping, vomiting and, diarrhea or constipation. In the large majority of cases the 
infection will be self-limiting and will be eradicated by the host immune system in 2-5 
days with no requirement for treatment (Hohmann 2001). However, those under 5 or 
over 65 and immunocompromised patients may require treatment, which could either 
include hospitalisation in order to replace lost fluids or, antibiotics (Gordon 2008, Wen, 
Best and Nourse 2017, Musil et al. 2016). While Salmonellosis is a worldwide disease, 
the rates of infections vary between countries based on levels of contaminated food 
and water. A 2010 study estimates that there are 93.8 million cases of Salmonella 
induced gastroenteritis globally each year, with 155,000 (0.17%) of these resulting in 
death (Majowicz et al. 2010). While the cost to life of Salmonellosis is therefore quite 
low there is a large economic cost due to loss of productivity.  
 
1.4.2 Enteric fever  
In humans a systemic Salmonella infection is known as enteric fever and includes both 
typhoid fever and paratyphoid fever caused by S. Typhi and S. Paratyphi serovars. 
Symptoms of typhoid fever start similarly to Salmonellosis, with abdominal cramps, 
vomiting and diarrhea/constipation but combined with a high fever. Progression of the 
infection includes dissemination and subsequent inflammation of the liver and spleen, 
coupled with weight loss and severe confusion. If left untreated the infection can cause 
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either internal bleeding in the digestive tract or peroration of the digestive tract, this 
can result in sepsis and lead to multi organ failure which can be fatal. 
Accurate data for the numbers of typhoid fever cases are unavailable, however 
estimates put the global total instances of typhoid between 11.9-20 million with about 
1% of these, 129-200,000, resulting in death. In addition to this there are an estimated 
5 million paratyphoid cases annually. (Crump, Luby and Mintz 2004, Crump 2014, 
Mogasale et al. 2014)  
Typhoid fever must be treated with antibiotics in order to stop the infection spreading 
and becoming fatal. Therefore, in addition to the large number of deaths caused by 
the infection there is a large economic cost. Current vaccines and antibiotics and the 
issues faced in these areas are discussed in 1.5 Current Treatment.  
 
1.4.3 Chronic carrier stage  
Chronic carriers of typhoid fever are those who are infected with S. Typhi, appear to 
recover and are then symptomless and appear healthy. In these patients, the bacteria 
colonise the gall bladder, where they are protected from the host immune defense. 
From here the bacteria can be periodically released into the bile and excreted and 
hence a chronic carrier can go on to infect other patients without being aware they are 
doing so or that they are even infected. This is of particular concern in regions where 
there is poor sanitation and drinking water can become contaminated with human 
waste  (Gonzalez-Escobedo, Marshall and Gunn 2011).  
 
1.4.4 Invasive Non-typhoidal Salmonella  
Invasive non-typhoidal Salmonella (iNTS) are non typhoidal strains, commonly the two 
serovars primarily responsible for gastroenteritis, S. Typhimurium or S. Enteritidis, 
which can cause a more typhoid-like infection. These strains are more resistant to the 
host-mediated killing by macrophages and hence are able to enter the bloodstream 
causing a systemic spread of the bacteria (Feasey et al. 2012). This disease has 
emerged in Africa, commonly developing into invasive diseases in individuals already 
suffering from malaria or HIV (Okoro et al. 2012).  Between 22-25% of African patients 
succumb to a iNTS infection, much higher percentages than the global deaths from 
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typhoid fever, approximately 1% (Gordon et al. 2008). The link between HIV positive 
patients and those suffering from a iNTS disease is extremely high, with 95% of adults 
presenting with iNTS being HIV positive – this is not a link seen for Typhoid fever 
(Kankwatira, Mwafulirwa and Gordon 2004). The development of this disease in HIV 
positive individuals is due to abnormalities in the host not mutations of the bacteria. 
Three key defects have been described: a weakened gut mucosal layer which leads 
to increased dissemination from the gut; dysregulation of cytokines within immune 
cells; and impaired serum killing of the bacteria (Feasey, 2012).   
 
1.5 Current Treatment 
1.5.1 Antibiotic use and resistance 
Typhoid fever is seen more in the developing world, partly due to poorer sanitation in 
these areas leading to acquisition of the infection through contaminated food or water, 
and partly due to the emergence of multi-drug resistant (MDR) strains in these areas.  
To avoid fatality, patients with typhoid fever require treatment with antibiotics. The 
most common, ‘first-line’ antibiotics used to treat typhoid fever are chloramphenicol, 
amplicillin and trimethoprim; however, since 1989, strains of both Salmonella Typhi 
and Paratyphi are becoming increasingly resistant to these drugs, and these multi-
drug-resistant (MDR) strains have been the cause of large outbreaks (Glynn et al. 
1998, Rahman et al. 2014, Wong et al. 2015, Wirth 2015).  
It is thought that in the Global North these MDR strains developed in the animal 
agriculture sector, where antibiotics are frequently and inappropriately used, before 
spreading to humans through contaminated foodstuffs (Marshall and Levy 2011, 
Holmberg et al. 1984, Helke et al. 2017).  
The current antibiotic of choice is ciprofloxacin, however strains have been isolated 
which also show resistance to this drug (Threlfall 2002, Rowe, Ward and Threlfall 
1997). This is becoming a rapidly increasing problem in the commonly endemic 
regions of the Global South but also due to individuals travelling more frequently to 
these regions, there are increasing reports of patients in the Global North with MDR 
Salmonella infections.  
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Along with methods aimed at reducing contamination and therefore cases of typhoid 
fever, new antibiotics are required to target the pressing issue of severe MDR 
Salmonella.  
 
1.5.2 Vaccines 
Due to the severity and increasingly hard to treat strains of Salmonella there is an 
increase in pressure on the availability of a long lasting vaccine.  
A vaccine for typhoid fever was first developed in 1916 and relied on heat-killed 
Salmonella Typhi cells to produce a parenteral whole cell vaccine. This vaccine was 
reasonably effective, protecting 51 to 88% of those treated for up to 7 years. However, 
there were side effects that came with vaccination, including fever in up to 30% of 
cases, and headaches and severe localised pain in up to 35% (Guzman et al. 2006). 
A modern vaccine was generated using purified, non-denatured, Vi capsular 
polysaccharide of S. Typhi. The Vi capsular antigen is encoded on the Salmonella 
pathogenicity island 7 (SPI-7), which is absent in the non-typhoid Salmonella 
typhimurium, and is known to be acutely important for virulence (Tran et al. 2010). The 
Vi vaccine is produced in multiple forms, Typhim Vi® (Sanofi Pasteur), 
Typherix® (GSK) and Typbar Vi® (Bharat Biotech) and has a reported efficiency of 
between 64 and 72% (Klugman et al. 1987, Acharya et al. 1987) with minimal side 
effects, the vaccine must be boosted every 2 years. In addition, there is a conjugated 
form of the vaccine which provides vaccination against tetanus in addition to typhoid, 
Typbar TCV®.   
The other current vaccine is a live attenuated vaccine; this offers multiple benefits.  It 
can be orally administered which both means no hazardous materials such as needles 
are produced and it can be easily administered not just by medical professionals. 
Importantly they can induce mucosal, cellular and humoral immune responses. Since 
live attenuated vaccines have the theoretical ability to revert to a fully virulent strain it 
is important that the attenuation is produced via multiple well defined mutations.  
The Ty21a vaccine is an attenuated strain of S. Typhi Ty2 and contains a mutation in 
GalE and lacks the Vi antigen (Formal et al. 1981). The GalE mutation results in the 
strain being unable to produce the enzyme responsible for the reversible conversion 
of UDP-glucose to UDP-galactose, the accumulation of UDP-galactose in the 
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cytoplasm results in cell lysis (Germanier and Füer 1975). This strain also has 
numerous other mutations including in the gene encoding RpoS which is important for 
stress responses. This vaccine is currently in use as Vivotif® (PaxVax Corporation), 
which is administered as three or four capsule pills on alternate days, with protection 
being achieved 7 days after the final dose. High rates of efficiency and tolerability are 
seen with this vaccine, with up to 87% efficiency for up to 7 years and suggested re-
immunisation after 5 years (Jin et al. 2017, Levine et al. 2007). Additionally, Ty21a has 
been shown to provide a level of protection against S. Paratyphoid B, which doesn’t 
possess the Vi-antigen and therefore Vi polysaccharide based vaccines are 
ineffective, however use of both vaccines together has been heralded as a way to 
increase the immune response (Pakkanen et al. 2015).  
One potential target for vaccine development is the recently discovered Salmonella 
Typhi toxin. This toxin is only found in S. Typhi and S. Paratyphi – two human host-
restricted strains which cause enteric fever. Since the toxin is only present in these 
strains human studies will need to be carried out in order to know exactly what role the 
toxin plays in virulence and whether it can therefore be targeted as a preventative 
strategy; however the presence of the toxin has been linked to the progression of the 
disease and therefore it is expected that an antitoxin immune response should be able 
to be utlised to protect against Typhoid fever (Galán 2016). 
There are many aspects to an ideal typhoid vaccine and each presents its own 
problems. Ideally a vaccine would protect against the range of Salmonella serovars 
which are responsible for invasive infections worldwide, these have been highlighted 
as Salmonella Typhi, Salmonella Paratyphi A, Salmonella Paratyphi B, Salmonella 
Typhimurium, Salmonella Enteritidis and Salmonella Choleraesuis (Tennant and 
Levine 2015). In addition, the current vaccines cannot be administered to the very 
young and this would be highly beneficial as the infection is more dangerous in these 
individuals (Crump and Mintz 2010). The live attenuated vaccines offer the best 
immune response but come with a risk of reversion to a virulent state, while this can 
be avoided with careful combinations of mutations, this requires extensive research 
(Spreng, Dietrich and Weidinger 2006).  
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1.6 Immune defenses and responses, and infection methods  
Initial Salmonella infection results in the inflammation of local tissue via the presence 
of cell membrane components including lipopolysaccharide (LPS). This inflammation 
results in the recruitment of cytokines such as interferon-γ (IFN-γ) or tumor necrosis 
factor-α (TNF-α) which are required to activate macrophages (Arango Duque and 
Descoteaux 2014, Hu and Ivashkiv 2009, Duluc et al. 2009). As highlighted in the 1.3 
Routes of infection section, it is important for the progression of Salmonella disease 
that the bacteria can survive within phagocytic cells including macrophages, as these 
phagocytes are central to the control of infection, being critical for survival in mice 
infected with Salmonella. Macrophages employ multiple antibacterial mechanisms in 
order to attempt to kill any bacteria that they have engulfs. This includes the release 
of reactive oxygen species (ROS) and the release of nitric oxide (NO) (Lowenstein et 
al. 1993). The inducible nitric oxide synthase, iNOS, is specific to macrophages and 
is responsible for their nitric oxide production (Aktan 2004).  
 
1.6.1 Salmonella Pathogenicity Islands  
The pathogenicity of Salmonella is largely down to regions of the genome referred to 
as Salmonella pathogenicity islands (Lostroh and Lee 2001). These islands contain 
the proteins required, and regulatory elements, for a specific virulence phenotype. 
These islands are highly conserved between the numerous Salmonella serovars and 
due to their lower GC content than the rest of the genome are thought to have been 
acquired via horizontal gene transfer (Li et al. 1995).  
Salmonella pathogenicity islands 1 and 2 (SPI-1 and SPI-2) are found in all serovars 
in the Salmonella enterica species (Ochman and Groisman 1996). These SPIs encode 
type III secretion systems (TTSS), which allow for the transfer of bacterial proteins into 
the host cell. TTSSs are needle-like structures which span the bacterial envelope 
(Waterman and Holden 2003).  The proteins injected by SPI-1 interfere with 
macrophage biochemistry and physiology and therefore vital processes, having 
effects including initiating the uptake of the bacteria. SPI-2 then promotes survival 
within the cell and causes apoptosis of macrophages.  
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1.6.1.1 Salmonella Pathogenicity Island 1 
SPI-1 is 40kb in length, contains 29 genes, and is primarily known to be vital for the 
uptake by intestinal epithelial cells, which are not usually phagocytic (Zhou and Galán 
2001). SPI-1 is important for the survival of all Salmonella within the intestine whether 
the particular serovar causes an enteric or a systemic infection (Lostroh and Lee 
2001). Indeed while SPI-1 has been shown to be required for an orally-progressed 
infection it is non-essential for a systemic infection (Marcus et al. 2000, Jones et al. 
1994). There are at least 13 proteins delivered by the SPI-1 machinery. Three 
important members of this group are SopB, SipA and SipC which are required for the 
rearrangement of actin in the host cell which results in the uptake of the bacteria 
(Raffatellu et al. 2005). The main regulatory trigger for SPI-1 is a change in pH that 
occur between the stomach and small intestine. HilA, HilC, HilD and InvF are the main 
regulators of SPI-1 (Eichelberg and Galán 1999). HilA is a member of the OmpR family 
of regulators and is known to be of particular importance for the regulation of SPI-1 
(Bajaj, Hwang and Lee 1995).  
 
1.6.1.2 Salmonella Pathogenicity Island 2 
Once engulfed within a cell the large phagosome quickly reduces, within hours, to the 
Salmonella containing vacuole (SCV). SPI-2 behaves similarly to SPI-1 and inserts 
effector proteins across the SCV membrane into the cell cytosol via the translocon 
pore  (Guignot and Tran Van Nhieu 2016). SPI-2 has four main functions, the 
acquisition of proteins from the host cell, the movement towards the nucleus and golgi 
apparatus, bacterial replication within the SCV and prevention of the binding of iNOS 
to the SCV reducing RNS exposure (Haraga, Ohlson and Miller 2008, Figueira and 
Holden 2012).  
The positioning of the SCV near to the Golgi apparatus has been shown to be 
associated with an increase in bacterial growth. The effectors SseG, SseF and SifA 
are particularly important for this association of the SCV with the golgi (Ramsden et 
al. 2007). Myosin II, an actin-based motor, has also been shown to be important for 
this movement (Wasylnka et al. 2008, Steele-Mortimer 2008). A large number of 
effectors function to maintain the SCV, including SifA, PipB2, SseJ and SopD2, this 
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maintainance is vital for the ability of Salmonella to replicate within the host cell 
(Haraga et al. 2008, Waterman and Holden 2003, Cirillo et al. 1998). 
Alteration of iNOS locality by the SCV is considered to be another SPI-2 dependent 
process, which in turn reduces the amount of RNS which target the bacteria; with 
peroxynitirite being excluded from the SCV via SPI-2 effectors. The significance of this 
role of SPI-2 has been demonstrated with the reduction in a virulence defect in iNOS-
/- mice (Chakravortty, Hansen-Wester and Hensel 2002, Waterman and Holden 2003).  
NRAMP1 is a macrophage transmembrane protein which is key to the killing of 
Salmonella by the macrophage and controls bacterial growth in the reticuloendothelial 
system. This has been well studied in the mouse model but a role for NRAMPp1 in 
human infections has been harder to confirm (Dunstan et al. 2001, Mastroeni and 
Sheppard 2004).  
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1.7 Global microbial N-cycle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The nitrogen cycle is one of the key nutrient cycles in the environment; and microbes 
play a large role in this. All organisms rely on nitrogen for the synthesis of nucleic acids 
and proteins as well as many other essential compounds. The nitrogen cycle exists in 
6 main parts, demonstrated in Figure 1. 
In the atmosphere nitrogen exists as dinitrogen gas (N2), an inert form of nitrogen. This 
therefore cannot be taken up by plants and so the nitrogen must be ‘fixed’ into 
ammonia (NH4+). This process is primarily undertaken by bacteria along with archaea. 
Nitrogen can also be fixed by lightning, but at an insignificant level (Ferguson and 
Libby 1971).  
Figure 1 The microbial Nitrogen Cycle. Nitrogen Fixation (1), Aerobic Ammonia 
Oxidation/Nitrification (2), Nitrite Oxidation (3), Denitrification (4), Annamox (5), 
Dissimilatory Nitrate Reduction Pathway (6) 
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Nitrogen fixation is carried out by Diazotrophs, bacteria and archaea which are able to 
grow without the presence of fixed nitrogen. Some plants have symbiotic relationships 
with nitrogen fixing bacteria, commonly in the root nodules of legumes where Rhizobia 
are the most abundant. Some Cyanobacteria also form symbiotic relationships with 
plants such as ferns and fungi including lichens, these bacteria produce oxygen as a 
by-product of the process (Berman-Frank, Lundgren and Falkowski 2003). In 
traditional farming, fields would be cycled through rotations of food crops and legumes, 
often clover, these legumes then are left to rot on the fields and the captured nitrogen 
is released into the soil (Wang et al. 2014, Zhang et al. 2015).  However, in modern 
farming practices this takes too long and is therefore not an efficient way to ensure the 
food crops are getting enough nitrogen and therefore nitrogen fertilisers are added. 
The Haber Bosch process requires very high pressures and temperatures to fix 
nitrogen from air mixed with natural gas (Sutton et al. 2011).   
The next stage of the cycle is nitrification, where ammonium is oxidized via 
hydroxylamine, NH2OH, to nitrite (NO2-), and subsequently to nitrate (NO3-). The first 
step is performed by ammonia-oxidising bacteria (AOB), primarily Nitrosomonas and 
Nitrosococcus and the ammonia-oxidising archaea (AOA), Nitrosopumilus 
maritimus and Nitrososphaera viennensis (Martens-Habbena et al. 2009). Nitrification 
can lead to issues with nitrogen run off and associated eutrophication, as nitrite is 
more soluble than ammonium (Conley et al. 2009).  
Nitrite can then be returned to ammonia, via the dissimilatory nitrate reduction to 
ammonium (DNRA) pathway, to N2 via N2H4 by the anammox pathway, or to N2 via 
denitrification (Jetten 2008, Jetten et al. 2009). Traditionally little consideration has 
been given to the impact of the dissimilatory nitrate reduction to ammonium pathway 
to global nitrogen cycling; however, many soil bacteria have the ability to perform 
DNRA and is it thought to be the dominant pathway for nitrite cycling in some 
environments (Giblin et al, 2013).  
Denitrification is the anaerobic reduction of nitrate (NO3-) via nitrite (NO2-) nitric oxide 
(NO) and nitrous oxide (N2O) to dinitrogen (N2). This process has been well studied in 
numerous bacteria, with the best understanding in the soil dwelling bacteria 
Paracoccus denitrificans. Research in this field has focused on the truncation of the 
pathway and subsequent release of the potent greenhouse gas N2O into the 
atmosphere, and ways this could be reduced (Sullivan et al. 2013).  
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The nitrous oxide reductase, NosZ, is responsible for the conversion of nitrous oxide 
to dinitrogen gas and the completion of the nitrogen cycle. There are multiple factors 
known to affect the function of NosZ in agricultural soil dwelling bacteria, and hence 
the levels of N2O which are successfully reduced. These include the amount of 
nitrogen fertilizer added to soils, water content, oxygen levels, nutrient availability, 
temperature and pH (Sahrawat, 1986(Sullivan et al. 2013).  
 
1.8 Denitrification in Salmonella 
Salmonella, along with other Enterobacteriaceae also undertake denitrification. 
However, unlike classical denitrifiers, the final step in the pathway, the reduction of 
N2O to N2 is missing, we therefore refer to denitrification in Salmonella as truncated 
denitrification (Rowley et al. 2012). This process is important for Salmonella in 
anaerobic or microoxic conditions because as facultative anaerobes they can use 
alternative electron acceptors, including nitrate, in order to respire.  
The first step in this process, the reduction of NO3 to NO2 either uses the membrane-
bound dissimilatory nitrate reducatase, Nar in the cytoplasm, or the periplasmic 
dissimilatory nitrate reductase, Nap. There are two membrane bound systems, that 
encoded by narGHJI, which functions anaerobically, and that by narZYWV, which is 
active aerobically, and a single periplasmic system, encoded by napFDAGHBC. 
(Rowley et al. 2012) NarG accounts for about 98% of nitrate reduction. In addition to 
nitrate reduction, NarG is able to catalyse the reduction of nitrite if no nitrate is present. 
The other enzyme responsible for this step is Nir, either NirK, the cytochrome cd1, cu-
containing nitrite reductase (Gilberthorpe and Poole 2008) or a siroheme-containing 
nitrite reductase (NirB), Salmonella only possesses NirB.Ideally, to prevent NO 
accumulation, the NO-generating and NO-consuming processes should function in a 
concerted fashion to form N2O, which until recently was considered to be less cytotoxic 
(discussed in 1.11 Nitrous Oxide).   
The reduction of nitric oxide will be further discussed in 1.10 NO detoxification, and 
can take three forms, oxidation to nitrate, or reduction to ammonium or N2O. There is 
no enzyme present in the entire Enterobacteriaceae family which reduces N2O and 
hence in Salmonella denitrification is truncated at this stage.  
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Exposure to nitrate and nitrite in low oxygen conditions may occur outside the host but 
also in the mammalian intestine, as part of the host-generated inflammatory response 
(Lopez et al, 2012). Inflammation is generally thought to be a way that the host fights 
a pathogen, however this host generated nitrate has been shown to provide a growth 
advantage to members of the Enterobacteriaceae family including E. coli and 
Salmonella. The gut microbiota, which play many important roles including providing 
pathogen colonization resistance, is primarily made up of fermenting microbes which 
would be unable to use the nitrate as an electron source for respiration (Guarner and 
Malagelada 2003, Guarner 2006, Tremaroli and Bäckhed 2012). This phenomenon 
has been demonstrated multiple times, suggesting the ability of Salmonella to respire 
on nitrate and to trigger the host to produce this nitrate, is of key importance to its 
survival and virulence (Winter et al. 2013).  
SopE, a type III effector protein, has been shown to increase the severity of 
inflammation in the intestine via Rho GTPase mediated caspase-1 activation and 
consequent release of the cytokine IL-1β (Müller et al. 2009). SipA is also delivered 
by a type III secretion system and plays a role in pathogen-mediated inflammation 
(Higashide et al. 2002, Stecher et al. 2007) 
 
1.9 Toxicity of Nitric Oxide  
Nitric oxide plays many roles in the human body including as a neuronal signaling 
molecule and as a regulator of vasodilation of blood vessels and hence blood pressure 
(Irshad and Chaudhuri 2002). Indeed, the latter of these functions has led to the 
increased use of nitric oxide as an athletic supplement, although studies on the 
benefits of these are inconclusive (Bescós et al. 2012). Conversely at the same time 
there is growing industry based around antioxidants designed to reduce RNS and ROS 
(Devasagayam et al. 2004).  
 
As a free radical, nitric oxide (NO) has cytostatic and cytotoxic antibacterial activity in 
both aerobic and anaerobic environments, causing widespread damage to numerous 
cellular targets. Targets of this damage include DNA, proteins (both fully formed 
proteins  and via amino acid targeting) and transcriptional regulators (Fang 2004). NO 
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is highly reactive, and can form other toxic reactive nitrogen species (RNS), such as 
peroxynitrite (Brunelli, Crow and Beckman 1995).  
 
Salmonella is exposed to RNS at different locations during its infectious cycle in 
vertebrate hosts (Prior et al. 2009). Nitrogen species are found distributed throughout 
the length of the gastrointestinal tract, representing a serious problem for enteric 
pathogens. The acidity of the stomach converts dietary and salivary nitrite to nitrous 
acid, and subsequently by disproportionation to other nitrogen species, including NO. 
The endogenous production of nitric oxide via the denitrification pathway has already 
been mentioned in 1.8 Denitrification in Salmonella.  
 
Numerous cell types including leukocytes and hepatocytes can produce NO via the 
conversion of L-arginine to L-citrulline. Macrophages form a crucial part of the early 
response of the immune system to attack by pathogens, and production of NO is a 
vital part of the macrophage armory. Activated macrophages produce micromolar 
concentrations of NO through expression of inducible nitrous oxide synthase (iNOS), 
in response to inflammatory cytokines (IL-1, TNF-α, IFN-γ) and bacterial 
lipopolysaccharide (LPS) (De Groote and Fang 1995). The release of nitric oxide by 
macrophages has been seen to occur within two hours of phagocytosis and been 
shown to clear 99% of S. Typhimurium within six hours (Vazquez-Torres et al. 2000).  
 
The iNOS mediated production of NO is an important defense mechanism against S. 
Typhimurium infection, with mice lacking functional alleles of iNOS significantly more 
susceptible to Salmonella infection (Alam et al. 2002, Mastroeni et al. 2000). 
Paradoxically, host derived NO and the ensuing pro-inflammatory cascade during 
enteritis has also been shown to be of benefit to Salmonella, in outcompeting the 
commensal flora of the intestine (Stecher et al. 2007).  
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1.10 NO detoxification 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enzymes 
Hmp flavohaemoglobin  
Nar membrane-bound dissimilatory nitrate reductase 
Nap periplasmic dissimilatory nitrate reductase 
NirB siroheme containing nitrite reductase 
NrfA cytochrome c nitrite reductase 
Nif nitrogenase 
NorVW anaerobic nitric oxide reductase 
flavorubredoxin 
Regulators 
Fur ferric uptake regulator 
FNR fumarate and nitrate reductase 
regulator 
MetR methionine repressor 
NsrR nitric oxide sensitive repressor 
NorR nitric oxide reductase regulator 
Figure 2  Nitrogen cycle in Salmonella. Enzymes and regulators involved are shown in red, positive 
regulators are indicated by arrows and repressors by perpendicular lines. Adapted from (Arkenberg et 
al. 2011) 
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Two key enzymes in detoxification of NO are flavohemoglobin (HmpA) and 
flavorubredoxin (NorVW) (Mills et al, 2008), which convert nitric oxide to nitrous oxide 
under anoxic conditions. This represents the conversion of a potent cytotoxin to a 
potent greenhouse gas.  In order to better understand the underlying metabolic driving 
force for intracellular nitric oxide production under nitrate-sufficient / glycerol limited 
and nitrate-limited / glycerol sufficient conditions in continuous cultures of Salmonella 
Typhimurium have been studied (Rowley et al 2013) and transcription of genes of the 
nitric oxide responsive NsrR regulon were used as a qualitative reporter of intracellular 
NO generation. Since nitric oxide is detoxified by conversion to nitrous oxide in the 
cytoplasm, direct measurement of nitric oxide released by bacteria will grossly 
underestimate the actual level produced intracellularly by nitrate metabolism. S. 
Typhimurium cannot reduce nitrous oxide and so nitrous oxide production has been 
measured as a more quantitative measure of the fraction of nitrate metabolized that 
forms nitric oxide. Under nitrate-sufficient / nitrite-sufficient / glycerol-limited conditions 
this can be a remarkable ~15% and 100% ~of the total nitrate and nitrite consumed in 
the bioreactor, respectively. This decreases to <0.1% under nitrate-limited / nitrite-
limited / glycerol-sufficient conditions. 
 
1.10.1 Mechanisms for NO detoxification 
As a critical component of intracellular survival much more focus has been given to 
the detoxification of exogenous, rather than endogenous NO, with several systems 
implicated in the enzymatic detoxification of NO. Well-characterized enzymes with the 
ability to metabolize NO include the soluble flavohaemoglobin HmpA, the di-iron 
centred flavorubredoxin NorV with its NADH- dependant oxidoreductase NorW 
(NorVW) and the cytochrome c nitrite reductase NrfA. NorVW and NrfA are only active 
under anaerobic or micro-oxic conditions. NorVW reduces NO to N2O, whereas NrfA 
uses either NO or nitrite to form ammonia. Flavorubredoxin (NorV) is an oxygen-
sensitive nitric oxide reductase which reduces NO to N2O (Hutchings, Mandhana and 
Spiro 2002). Neither, NorV or NrfA are required for Salmonella survival in mice (Bang 
et al., 2006).  
 
HmpA has only a minor role in NO detoxification under anoxic conditions, where it 
converts NO to N2O, but is the crucial enzyme when oxygen is present, reducing NO 
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to NO3-. Expression of hmpA in Salmonella has been shown to be induced by NO, and 
repressed by intracellular iron, an important mechanism by which detoxification of NO 
is accomplished without causing oxidative stress (Bang et al. 2006). Such NO 
detoxification is vital for survival in the presence of both oxidative and nitrosative 
stresses. hmpA is highly induced in S. Typhimurium inside macrophages (Eriksson et 
al. 2003), suggesting that HmpA is involved in the bacterial defence against the 
nitrosative burst.  However, this is not the case in HeLa epithelial cells where 
Salmonella is not exposed to either oxidative or nitrosative stress (Hautefort et al. 
2007). hmpA mutants are moderately attenuated in a C3H/HeN mouse virulence 
model (ityR), but not in C57/BL6 mice (ityS) (Bang et al. 2006). C57/BL6 mice succumb 
to S. Typhimurium infection before they produce a nitrosative burst. A key regulator of 
HmpA expression is the nitric oxide-sensitive repressor NsrR. NsrR belongs to the 
Rrf2 family of transcriptional repressors and senses NO specifically by a [2Fe-2S] 
cluster. This assumption results from great similarities between NsrR and other [2Fe-
2S] cluster containing members of the Rrf2 family like IscR or RirA (Schwartz et al., 
2001). The presence of the [Fe-S] clusters makes the protein structure and binding 
prone to damage by NO so that genes repressed by NsrR, are de-repressed after 
exposure to NO. The NsrR regulon of Salmonella consists of at least hmpA, ytfE, ygbA, 
hcp-hcr, yeaR-yoaG, nrfA, tehB and STM1808 (Karlinsey et al. 2012). ytfE (nipC), is 
highly induced in E. coli under conditions of nitrosative stress, contains a di-iron centre 
of the histidine-carboxylate family and is involved in the repair of damaged [Fe-S] 
clusters. Mutation of ytfE in E. coli results in a strain that grows poorly under anaerobic 
respiratory conditions and that has an increased sensitivity to iron starvation (Justino 
et al., 2006). In S. Typhimurium, yftE expression is induced by nitrite and during 
RAW264.7 macrophage infection, although the ytfE mutant constructed did not display 
a growth defect under these and other inducing conditions. Most surprisingly given the 
NO sensitivity, a ytfE mutant has a lower LD50 post low dose oral infection of C57BL/6J 
mice than the isogenic parent. STM1808 is annotated on the S. Typhimurium genome 
as a putative cytoplasmic protein, but the conserved domain database identifies a 
DUF1971 superfamily domain within the protein sequence, possibly involved in 
tellurite resistance. During a bioinformatic screen for NsrR binding sites, an NsrR 
promoter box (ggtgtatattaaatacatc) was first predicted upstream of STM1808 
(Rhodionov et al 2005). TehB and YeaR are other putative tellurite resistance proteins 
identified as NsrR regulated in E. coli, indicating a role for tellurite resistance proteins, 
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either directly or indirectly, in NO detoxification. In S. Typhimurium STM1808 was the 
most up-regulated gene during RNS stress at pH4.4. More recently deletion mutants 
of NsrR regulated genes were exposed to the NO-releasing compound Spermidine-
NONOate in LB cultures in the presence of oxygen (Karlinsey et al 2012). Confirmation 
of hmpA sensitivity was demonstrated along with impaired growth of ∆STM1808. No 
sensitivity of other NsrR regulated genes was observed. In M9 minimal medium the 
sensitivity of strains increases. A contribution of HmpA, Hcp, YgbA and STM1808 is 
proposed to help with the aerobic resistance of S. Typhimurium against nitrosative 
stress (Karlinsey et al. 2012).  
 
1.11 Nitrous Oxide  
The end protect of Salmonella’s truncated denitrification is nitrous oxide (N2O). N2O is 
most commonly thought of a potent greenhouse gas, with atmospheric concentrations 
rising and a radiation potential over 300 fold higher than carbon dioxide and a high 
stability meaning it can last for 120 years (Ravishankara, Daniel and Portmann 2009, 
Canfield, Glazer and Falkowski 2010). A large amount, over 60%, of the nitrous oxide 
released into the atmosphere comes from agricultural soils where nitrogen fertilisers 
are added to increase crop yield but simultaneously triggers denitrification in microbes, 
some of which under certain conditions do not undergo complete denitrification and 
release nitrous oxide.   
There is therefore a focus on the part microbes have to play in the production of N2O 
and potential mitigation strategies which could be employed to halt the increase of the 
gas in our atmosphere (Richardson et al. 2009). In some bactria, nitrous oxide 
reductase (NosZ) is responsible for the conversion of N2O to inert N2 gas and therefore 
the correct functioning of this enzyme is vital to the reduction of this gas in the 
atmosphere. One study unveiled the importance of extracellular copper concentration 
for the expression of nosZ as well as being important as a cofactor (Sullivan et al. 
2013). A link was also made between N2O release and vitamin B12-dependent 
pathways, showing a cytotoxic effect of N2O in the important denitrifier Paracoccus 
denitrificans, this will be further expanded upon in this thesis and discussed in 1.13.2 
Methionine synthases and nitrous oxide.  
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A combination of studies by (Stremińska et al. 2012, Rowley et al. 2012) and Runkel 
et al (personal communication) has identified that nitrous oxide production by 
Salmonella Typhimurium cultured in nitrate sufficient/glycerol limited chemostats is an 
order of magnitude higher than that produced by related non-pathogenic E. coli strains 
(Figure 3). E. coli possesses the same denitrification mechanisms as Salmonella, or 
more importantly, lacks the same gene, nitrous oxide reductase and therefore similarly 
has a net release of nitrous oxide.  
Based on these studies, in a recent review on the biological role of nitrite (Maia and 
Moura 2014) the authors queried why Salmonella produce a large level of both NO 
and N2O. The question was raised that given the cytotoxic effects of NO why is it the 
case that is it being produced – is it to be reduced in order to produce N2O and if so 
for what reason? This is discussed further in 1.13.2 Methionine synthases and nitrous 
oxide.  
 
Figure 3 Levels of N2O produced by S. Typhimurium SL1344 and E. coli 
MG1655. Strains grown in nitrate sufficient, glycerol limited minimal media in 
chemostats. (Runkel, personal communication). 
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1.12 Vitamin B12 and Salmonella 
1.12.1 Vitamin B12 synthesis  
Vitamin B12, or cobalamin, is one of the most complex molecules in the natural world, 
it consists of a central corrin ring containing a cobalt ion. The synthesis of this vitamin 
is limited to bacteria and archaea; even though it is also required by animals. Due to 
the molecules complexity, over 30 genes are required for its complete synthesis, in 
Salmonella these genes are clustered together in the cob operon, which accounts for 
1% of the genome (Martens et al. 2002, Jeter and Roth 1987). It is important to note 
that it has been reported that the cob operon is only activated under anaerobic 
conditions, and therefore the synthesis of vitamin B12 by Salmonella only occurs 
anaerobically (Jeter, 1984).  
The synthesis of vitamin B12 is split into three parts. Part I is the conversion of 
uroporphyrinogen III (Uro III) to cobinamide. This involves the methylation of the 
porphyrin ring, amidation of carboxyl groups, removal of ring carbon, insertion and 
reduction of the cobalt and addition of the edenosyll moiety and aminopropanol side 
chain. Part II produces the lower axial ligand of the cobalt atom, by synthesizing 
dimethylbenzimisdazole (DMB). Part III covalently links the products of parts I and II, 
the combinamide and DMB with a phosphoribosyl moiety to complete the production 
of cobalamin (Roth et al. 1993). 
Vitamin B12, produced by bacteria, including Lactobacillus reuteri is present in the 
human gut, but bacterial uptake is often limited due to the presence of an efficient host 
uptake system (LeBlanc et al. 2013). The absorption of Vitamin B12 in the human 
intestine has been studied since the 1950’s (Booth and Mollin 1959, Cooper and 
Castle 1960). Absorption of B12 is reliant on a glycoprotein called intrinsic factor which 
is produced by the parietal cells of the stomach (Fedosov 2012, Fyfe et al. 2004, 
Moestrup 2006).   
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1.12.2 Vitamin B12 requirements  
Vitamin B12 is required for a wide range of processes in both bacteria and animals. 
One common process is in the production of acetyl-CoA, an important molecule in the 
Krebs cycle; another is in ribonucleotide reduction which is important for DNA 
synthesis in bacteria; most enteric bacteria also rely on vitamin B12 in order to ferment 
1,2-propandiol, ethanolamine and glycerol, which is important in anaerobic 
environments (Martens et al. 2002). 
In humans there are two processes which rely on vitamin B12, the folate dependent 
methylation of homocysteine to methionine and the production of succinyl-coenzyme 
A from methylmalonyl-coenzyme A (Fenech 2001). B12 deficiency in humans leads to 
an increase in homocysteine levels which can have serious implications in the risk of 
stroke and heart disease (Martens et al. 2002).   
In Salmonella there are four vitamin B12 dependent enzymes: vitamin B12-dependent 
methionine synthase, MetH; ethanolamine ammonia lyase, which degrades 
ethanolamine (Roof and Roth 1989); propanediol dehydratase which allows 
Salmonella to use propanediol as a carbon source; and queuosine synthase, which 
produces queuosine, a nucleoside found in four tRNAs which is not essential for 
growth under laboratory conditions (Frey et al. 1988). 
Until 2001 (Price-Carter et al. 2001) it was thought that these processes were all non-
essential, that is, that the deletion of vitamin B12 synthesis from Salmonella had no 
detrimental effect on Salmonella under any conditions tested. This therefore resulted 
in a B12 paradox – why would Salmonella have retained this large and energetically 
expensive operon if there is no physiological requirement for the end product? This 
paradox has been researched in recent years and some insights have been reported.  
Tetrathionate is an alternative electron acceptor which is produced in the inflamed 
intestine via the reaction between reactive oxygen species and luminal sulphur 
compounds. Salmonella has the ability to respire on tetrathionate, an ability that 
enables it to outcompete the host microbiota (Winter et al. 2010). Tetrathionate allows 
Salmonella to grow on both ethanolamine and propanediol, both of which are vitamin 
B12 dependent processes (Price-Carter et al. 2001, Thiennimitr et al. 2011). Of note, 
Price Carter et al state that the utilisation of ethanolamine in order for Salmonella to 
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grow using tetrathionate are the only conditions they know of where Salmonella 
requires vitamin B12.  
 
1.13 Methionine synthesis 
Methionine is an essential amino acid that can be produced by Salmonella via two 
enzymes, a vitamin B12 dependent (MetH) or vitamin B12 independent (MetE) 
methionine synthase. This is the only process in Salmonella that has both a vitamin 
B12 dependent and independent system. Both enzymes catalyse the transfer of a 
methyl group from methyltetrahydrofolate to homocysteine which leads to the 
production of H4Folate and methionine (Banerjee and Matthews 1990, Drennan, 
Matthews and Ludwig 1994, Kräutler 2005). MetH uses methylcobalamin as the 
intermediate by which this methyl transfer occurs, whilst MetE requires folate  (Schulte, 
Stauffer and Stauffer 1984). It has been reported that the vitamin B12 dependent 
enzyme, MetH, is 60 times more active than the alternative vitamin B12 independent 
enzyme, MetE (Smith and Neidhardt 1983). MetE is divergently transcribed to the 
MetR transitional regulator, whilst MetH is located in a completely different genomic 
loci (Figure 4).  
 
 
It should therefore be the case that since Salmonella can only produce vitamin B12 
under anaerobic conditions that metE mutants are methionine auxotrophs in the 
presence of oxygen and in the absence of exogenous vitamin B12 (Escalante-
Semerena, Suh and Roth 1990). Jeter et al., showed that while metE mutants cannot 
Figure 4 Genomic location of metH and metE, metR. Numbers indicate 
nucleotide position on the S. Typhimurium LT2 genome. Constructed in 
colibase. 
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grow aerobically they can grow anaerobically even without exogenous vitamin B12 or 
methionine, due to their ability to synthesis the required vitamin B12 (Jeter, Olivera and 
Roth 1984). A double metE cob mutant, which relies on the vitamin B12 dependent 
MetH to synthesis methionine, and is lacking the proteins required to produce vitamin 
B12, cannot grow aerobically or anaerobically. 
In a study by Smith and Neidhardt in 1983 which looked at proteins in E. coli that are 
induced by oxygen, metE was identified as oxygen inducible and also stated that metH 
is inhibited by the presence of oxygen. This confirms the findings by Jeter et al., that 
a metE mutant cannot grow aerobically, since the remaining methionine synthase, 
metH, would be repressed (Jeter et al. 1984). Expression data produced by (Kröger 
et al. 2012), supports this report, with the caveat that this is nutrient rich media, which 
contains methionine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Methionine synthesis in Salmonella. The final stage converts 
homocysteine to methionine and can either be vitamin B12 dependent 
(metH) or independent (metE).  
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1.13.1 Regulation of methionine synthesis 
Both metE and metH are regulated by MetR (Urbanowski et al. 1987, Urbanowski and 
Stauffer 1989). MetR belongs to the LysR family of helix-turn-helix transcriptional 
regulators, and binds as a dimer to a dyad sequence. Homocysteine, an intermediate 
in the biosynthesis of methionine, binds to MetR and enhances the activity of some 
MetR-activated promoters (metE and glyA (a serine hydroxymethyltransferase). The 
exception is metH, which is activated by MetR in the absence of homocysteine. There 
is some inconsistency in the literature as to how well MetR induces expression of 
metH, however in E. coli, (Cai et al. 1989) showed that MetR stimulated metE 
expression ~16-fold and metH expression ~8-fold. MetR also acts as a negative 
regulator of its own expression.  
Expression of metE, as well as the other methionine biosynthetic genes, with the 
exception of metH, are repressed by the addition of high levels of methionine to the 
growth medium. This repression is mediated by a repressor protein, MetJ, and a co-
repressor, S-adenosylmethionine (SAM or AdoMet). Vitamin B12 can repress the 
synthesis of MetE, mediated by the MetH holoenzyme, which contains a cobamide 
prosthetic group.  
There have been reported differences between the regulation of methionine 
biosynthesis in Salmonella and E. coli. For example there is no MetJ binding site 
upstream of metH in Salmonella, and we should consider this when relying on the E. 
coli literature (Cai et al. 1989).  
 
1.13.2 Methionine synthases and nitrous oxide 
It was first reported in 1968 that nitrous oxide (N2O) can bind to, and inactivate vitamin 
B12. Since then this has been confirmed many times over due to the use of N2O as an 
anaesthetic (Nunn 1987, Sanders, Weimann and Maze 2008, LASSEN et al. 1954). 
Vitamin B12 deficiency (hyperhomocysteinemia) is most commonly seen due to a lack 
of the vitamin in the diet (Stabler and Allen 2004). However, there are also many 
reports of the deficiency due to prolonged exposure to nitrous oxide, for instance in 
anesthesiologists or those that recreationally abuse the gas (Chiang et al. 2013).  
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In mice, rats and in humans (where there is only a MetH type vitamin B12 dependent 
methionine synthase) it has been shown that methionine levels drop after exposure to 
N2O (Nunn 1987). This is due to N2O binding to and depleting the vitamin B12 pool and 
thus MetH cannot function (Deacon et al. 1980).  
In a similar scenario to that reported in mammalian cells, when nitrous oxide is present 
in high levels in the bacteria Paracoccus denitrificans, the production of methionine by 
MetH is inhibited due its requirement for vitamin B12. However, due to the presence of 
a secondary methionine synthase, which does not require vitamin B12, production of 
methionine can continue. It has been shown that under these conditions metE is 
upregulated in order to compensate for the functional loss of metH (Sullivan et al. 
2013). It has also been previously shown in Paracoccus denitrificans that in conditions 
when N2O accumulate (a nosZ mutant), a metE deletion strain (where MetH is the only 
enzyme available to produce methionine) has hampered growth.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Outline of the inhibition of N2O on the production of methionine by MetH  
in Paracoccus denitrificans A) In the absence of N2O methionine is produced by MetH. 
B) In the presence of N2O, vitamin B12 is targeted by N2O and so methionine is produced 
by MetE not MetH.  
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There has been controversy in the past regarding whether or not nitric oxide as well 
as nitrous oxide can react with vitamin B12 but there are some studies, which 
demonstrate that nitric oxide has a similar inhibitory effect. It has been shown that NO 
can inhibit the synthesis of methionine by MetH, in rat hepatocytes (Nicolaou et al. 
1996) and demonstrated spectroscopically that NO is able to interact directly with 
vitamin B12 and stop the methionine synthase activity in cultured rat muscle cells 
(Danishpajooh et al. 2001). Biochemical analysis has revealed that nitric oxide has a 
high affinity for cobalamin II, and interacts with cobalamin III at low pHs (Sharma et al. 
2003).  
 
1.4 Research Gap:  
Salmonella is a pathogen which causes disease worldwide, with both a huge 
economical burden and cost to human life. The ever growing concerns of MDR strains 
are putting pressure on the discovery of new antibiotics to treat those infected and 
new vaccines to prevent disease. A new potential vaccine strain has many desired 
characteristics but to start with must have a range of mutations which allow it to survive 
within the host without being virulent. It is therefore required to build on the 
fundamental knowledge of processes Salmonella employs to contribute to its 
pathogenesis. One area where there are gaps in the research is in the nitrogen cycle. 
Nitric oxide is a highly toxic compound produced both by macrophages as part of the 
host response and by Salmonella’s own metabolism when growing on nitrate. Since 
Salmonella must be able to survive within macrophages in order for disease to 
progress effective detoxification of nitric oxide is therefore vital. While this topic is fairly 
well understood, particularly aerobically, there are potentially as yet undiscovered 
proteins which are involved in the anaerobic detoxification of nitric oxide.  
 
One route for detoxification of nitric oxide is to nitrous oxide. It has been observed that 
Salmonella produces high levels of this gas, much higher levels than its close relative 
E. coli; it is however not clear why this is the case. Understanding why Salmonella 
releases this toxic gas in such large quantities is important to the overall understanding 
of the nitrogen cycle in Salmonella.  
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2 Materials and Methods  
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2.1 Strains & plasmids 
The isogenic parent strain from which all other mutants used in this study are derived 
is Salmonella enterica serovar Typhimurium SL1344 (Hoiseth & Stocker, 1981). A list 
of all strains and plasmids used in this study can be found in Table 1 and 2 
respectively. 
 
Table 1 A list of all strains used in this study, their genotypes and origins.  
Strain Genotype Source 
SL1344 S. enterica serovar Typhimurium 
4/74 hisG rpsL 
(Hoiseth and Stocker 
1981) 
S. Cholerasuis Salmonella enterica serovar 
Choleraesuis 
Mark Roberts, personal 
communication  
S. Dublin Salmonella enterica serovar Dublin Mark Roberts, personal 
communication 
S. Gallinarum Salmonella enterica serovar 
Gallinarum 
Mark Roberts, personal 
communication 
S. Pullorum Salmonella enterica serovar Pullorum Mark Roberts, personal 
communication 
S. Enteritidis Salmonella enterica serovar 
Enteritidis 
Mark Roberts, personal 
communication 
C. rodentium Citrobacter rodentium  Gad Frankel, personal 
communication 
GR0301 SL1344 ΔcstA::cmR This Study 
GR0303 SL1344 ΔytfE::kanR This Study 
 SL1344 ΔnorV::kanR Mills et al, 2008 
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 SL1344 ΔnrfA::kanR Mills et al, 2008  
GR0306 SL1344 ΔnsrR This Study 
GR0308 SL1344 ΔtehB This Study 
GR0309 SL1344 ΔhmpA::cmR This Study 
GR0310 SL1344 ΔSTM1808 This Study 
GR0311 SL1344 ΔyeaR This Study 
GR0312 SL1344 ΔSTM1808  ΔtehB::cmR 
ΔyeaR::kanR 
This Study 
GR0320 SL1344 ΔmetE::cmR This Study 
GR0321 SL1344 ΔmetH::kanR This Study 
GR0322 SL1344 ΔmetR::kanR This Study 
GR0323 SL1344 ΔmetE::cmR ΔmetH::kanR This Study 
GR0324 SL1344 ΔpocR::kanR This Study 
GR0325 SL1344 ΔmetE::cmR ΔpocR This Study 
GR0326 SL1344 ΔmetE::cmR ΔcobS This Study 
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Table 2 A list of all plasmids used in this study, their genotypes and origins.  
Plasmid Genotype Source 
pCP20 Temperature sensitive replication and 
thermal induction of FLP synthesis, 
AmpR, CmR 
(Cherepanov and 
Wackernagel 1995) 
pkD3 AmpR, pANT-Sγ derivative containing a 
FRT-flanked CmR cassette  
(Datsenko and Wanner 
2000) 
pkD4 AmpR, pANT-Sγ derivative containing a 
FRT-flanked KanR cassette 
(Datsenko and Wanner 
2000) 
pkD46 AmpR, pINT-ts derivative containing a 
araC-ParaB and γ, β, exo genes 
(Datsenko and Wanner 
2000) 
 
2.2 Media 
2.2.1 Rich media 
The following rich media are used in this study: 
• Luria-Bertani (LB) broth: 
10 g Tryptone, 5 g Yeast Extract, 10 g NaCl per 1 L distilled H2O (dH2O) 
• Green plates for selection of non-lysogenic P22 transductants: 
8 g Tryptone, 1g Yeast Extract, 5 g NaCl, 1.5% (w/v) agar per 1 L dH2O; addition of 
21 mL of 40% (w/v) glucose (F/S), 25 mL of 2.5% (w/v) alizarin yellow G and 3.3 mL 
of 2% (w/v) aniline blue (F/S) after autoclaving. 
 
2.2.2 Minimal media 
M9 minimal media was used for all minimal media experiments composing of 
Na2HPO4 6 g/l, KH2PO4 3 g/l, NaCl 0.5 g/l, NH4Cl 0.1 g/l to be autoclaved, and then 
additionally MgSO4 1mM, CaCl2 0.1mM. Either glucose, 55mM, or NaNO3 20mM and 
glycerol 5mM were added as indicated. When indicated methionine (30 µg/ml) or 
vitamin B12 (concentrations as indicated) were added.  
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Sterilization of media is achieved by autoclaving at 121°C for 15 min. Media was 
supplemented with Kanamycin (75 µg/mL), Chloramphenicol (10 µg/mL), Ampicillin 
(100 µg/mL), when appropriate. 
 
2.2.3 Overnight cultures  
Aerobic overnight cultures are prepared using 10 ml of the same media as to be used 
in the main experiment in a 25 ml universal, supplemented with appropriate antibiotics. 
The bacterial cultures are incubated overnight at 37°C with shaking at 200 rpm.  
Anaerobic overnight cultures are prepared using the same media as to be used in 
main experiment, supplemented with appropriate antibiotics. A 50 ml falcon was filled 
to the top with media and sealed with parafilm. The bacterial cultures are incubated 
overnight at 37°C statically. When strains were grown in M9 minimal media, 
methionine (30 mg/ml) was added to ensure equal growth of all strains (including 
methionine auxotrophs); cultures were then washed twice with PBS prior to use.  
 
2.4 Aerobic growth 
Aerobic growth was conducted in 50 ml media in 250 ml conical flasks at 37°C with 
agitation or in 24 well plates in 1 ml media at 37°C with 10 seconds agitation every 15 
minutes as indicated.  
 
2.5 Anaerobic growth  
Anaerobic growth was primarily conducted in 200 ml media in 250 ml Durans. After 
inoculation media was sparged with N2 gas for 10 minutes to create anaerobic 
conditions. Cultures were incubated statically at 37°C. When the cultures were 
saturated with N2O, first they underwent N2 saturation and then 5 minutes of sparging 
with 99% N2O.  
Where indicated growth was conducted in 1 ml media in 24 well plates, 400 µl of 
mineral oil was gently pipetted on top of the media and the plates were sealed with a 
silicon sealant and parafilm.  Cultures were incubated statically at 37°C in a 
SpectraMax Plus 384 Microplate Reader.  
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2.6 Mutant Construction 
Deletion of genes was carried out using lambda red recombination as previously 
described (Datsenko and Wanner 2000), briefly this relies on amplifying an antibiotic 
gene cassette, either from plasmid pKD3 (CmR) or pKD4 (KanR), with homologous 
flanking regions to the gene of interest and transforming this into S. Typhimurium 
containing pKD46. This plasmid encodes the lambda red recombinase system which 
recognises the homologous region and exchanges the gene of interest with the 
antibiotic resistance cassette. Mutations were then moved to a clean SL1344 
background via P22 bacteriophage transductions, and Green plates used to select for 
non-lysogenic colonies.  
Primers used for construction and verification of mutants are listed in Table 3 and 4, 
PCR components and protocols are listed in Table 5 and 6. The four reactions carried 
out to confirm correct mutant construction were, forward and reverse externals for the 
gene of interest both on the ‘mutant’ and the WT, and forward external for the gene of 
interest and reverse internal for the relevant cassette, both on the ‘mutant’ and the 
WT. The former creates different size bands based on the difference between the 
length of the gene and the size of the cassette, and the later cannot form a product for 
the WT and confirms the cassette is inserted in the correct location for the mutant. 
Expected sizes for each reaction are given throughout this thesis for each gel image.  
DNA for PCR was either obtained via QIAprep Spin Miniprep Kit (QIAGEN) according 
to manufacturer’s instructions and eluted in 50 µl dH2O, or alternatively via a colony 
boilate whereby a colony was suspended in 100 µl dH2O, placed at 100 °C for 10 
minutes, centrifuged at 13,000 rpm for 1 min and the supernatant used.  
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Table 3 Primers used for mutant construction 
 Forward Primer Reverse Primer 
cobS 
ATGAGTAAGCTGTTTTGGGCCATG
CTCGCTTTTATTAGCCGTGTAGGC
TGGAGCTGCTTC 
TCATAACAGAGCCAGCAGAAAGAT
CAATTCACCAAGTTCGCATATGAA
TATCCTCCTAG 
cstA 
AATGTAACATCTCTCTGGAACACC
CAAACGGACAACAACTGTGTAGG
CTGGAGCTGCTTC 
CCCTCTCCTTATTCTGGAGAGGGC
TATTGATGTAAAAAGACATATGAAT
ATCCTCCTTAG 
hcr 
AAGAAGACATGAAGCAATTG 
CTGAGCGCGTAAGGAGGTCA 
GTGTAGGCTGGAGCTGCTTC 
GCGCTGACGCTTACCGGGCC 
TACGATGGAACGTTTACCGA 
CATATGAATATCCTCCTTAG 
hmpA 
ATGCTTGACGCACAAACCATCGCT
ACAGTAAAGGCCACCAGTGTAGG
CTGGAGCTGCTTC 
TTACAGCACTTTATGCGGGCCGAA
GCATTCGTAATGAATGCATATGAA
TATCCTCCTTAG 
metE 
TCGAAACGCGTCTGGATACGGAA
GTTAAAAGCTGGTTTGCGTGTAGG
CTGGAGCTGCTTC 
TATTTCGCCTGACGCAGATTGTGC
GCCGCTTTGACCATGCATATGAAT
ATCCTCCTTAG 
metH 
GTGAGCAGCAAAGTTGAACAACTG
CGTGCGCAGTTAAATGGTGTAGG
CTGGAGCTGCTTC 
TCAGTCCGCATCGTAACCCAGGTT
CGGCGCGAGCCACCGCCATATGA
ATATCCTCCTTAG 
metR 
ATGATCGAAATTAAACATCTGAAA
ACACTCCAGGCATTGCGTGTAGG
CTGGAGCTGCTTC 
TTACAGGCGCGGCTGTGATCCTG
GCTTCGCTGTGGGTGCACATATGA
ATATCCTCCTTAG 
nsrR 
GTGCAGTTAACGAGTTTCACCGAT
TACGGCTTACGTGCGCGTGTAGG
CTGGAGCTGCTTC 
TCACTCCACCAGTAATAATTTATAA
AGCGGTTGATTCTCTCATATGAAT
ATCCTCCTTAG 
pocR 
AATATCTGAGCTATTCAATTTCACG
CCGTTTTGTCAGTTGGTGTAGGCT
GGAGCTGCTTC 
AAAAGACTATCAAAAATCGGCAAT
AGCAAAATATTGCTATCATATGAAT
ATCCTCCTTAG 
STM1273 
CTTATGATTGGGTATTAAAAA 
CCAGAAGAGTCTTATAATCGT 
GTAGGCTGGAGCTGCTTC 
ATCTATCCCATGTCGAATTCA 
TGGTCTTTTTTCAGCCGCGCA 
TATGAATATCCTCCTTAG 
STM1808 
TTAAATACATCTTTTAATCACCACA
TCAGGGAGATGTCTTGTGTAGGCT
GGAGCTGCTTC 
CTGGGCGGGACGCCGCCCAGTG
GTGACTGGTTTACCGATGCATATG
AATATCCTCCTTAG 
yeaR 
TGAGATTATCGCTGAGTAACCTGC
GTGAAGAGGGAAGCAAGTGTAGG
CTGGAGCTGCTTC 
TTATTCGTGACCGTGACGGTATAA
GTAGCTTTTCCCATTACATATGAAT
ATCCTCCTTAG 
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Table 4 Primers used for mutant confirmation 
 Forward Primer Reverse Primer 
pkD3 
- 
TTATACGCAAGGCGACAAGG 
pkD4 
- CAGTCATAGCCGAATAGCCT 
cobS 
ACTGGTGACAAATGAGGTGG CGTGCGCAGCAACATATTGA 
cstA 
CACCCAAACGGACAACAACT GGGCTATTGATGTAAAAAGA 
 
hcr 
CACCGGGCCGACCGCGCCGG AAGTTTAGTTGAAGATGACG 
hmpA 
TTAATGCTATCGCGGCCTAC ATACTGCCCGGGACGGTATT 
metE 
CGGAACTGCATCAACGTCTG CCCGTCAAAGGGTAGCGCCG 
metH 
GAAAGAGATGGAGCGTCAGG GGACCGCTGTAGTTCTGCTC 
metR 
ACTCTAAATAGTTCGGCTT TCATGAATAACATGCATGTT 
nsrR 
GTGTCGGGTAAGCCATTACG 
 
TTTCTGCTTCGCGTTCCTGG 
 
pocR 
GTCAATATTCATGGTGATGA ACTATCAAAAATCGGCAATA 
 
STM1273 
GCGCTGTTTATTTACATCAG 
  
CGAGTGGTTGAGTTTATAACC 
STM1808 
GATACACACGCTCCTTCGGG 
 
AACGATGAAAGGGCTTGAGG 
 
yeaR AAAATACTGTTTTTGGAGCG GGTACCAGCAACGTCATCGG 
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Table 5 PCR components.  
 Volume for 25 µl total 
reaction (µl) 
Volume for 50 µl total 
reaction 
BIOMIX (Bioline) 2x 12.5 25 
Forward Primer (1 µM) 1 1 
Reverse Primer (1 µM) 1 1 
DNA 5 5 
dH2O (Sigma) 5.5 18 
 
Table 6 PCR program  
 Knockout construction Mutant confirmation 
Temperature (°C) Time (Minutes) Temperature (°C) Time (Minutes) 
1: Initial denaturation 95 2 95 2 
2: Denaturation 95 2 95 2 
3: Annealing 45-60 1 50 1 
4: Elongation 72 2 72 2 
5: Repeats (Steps 2-
4) 
35x   25x   
6: Final elongation 72 10 72 10 
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2.7 Gel electrophoresis 
Gel electrophoresis was used both to check quantity and quality of DNA during cloning 
and to confirm correct mutant construction. Either 5 µL of PCR product or 5 µL purified 
DNA product or plasmid mixed with 1 µL loading dye was used. Gels were 1% (w/v) 
agarose gel containing 0.004% (v/v) Ethidium Bromide, made and run in TBE buffer 
(Thermo Fisher). The gel is run at 100 V for 45 minutes. For size comparison, a 1 
kilobase (kb) Hyperladder (Bioline) is run as a marker. Imaging of the gel is done under 
exposure to UV light. 
 
2.8 B12 bioassay  
The method for measuring vitamin B12 was optimised from (Lawrence and Roth 1996). 
Strains were grown anaerobically in M9 minimal media for 24 hours, without 
methionine and with the addition of nicotinic acid (2 ng/ml), aspartic acid (50 ng/ml), 
thiamine (100 µM), leucine (5 µg/ml), cysteine (50 ng/ml), cobalt (II) chloride (5 µM) 
and 0.2% (v/v) 1,2-propanediol. Cells were harvested by centrifugation for 10 mins 
(4000 rpm) and pellet was resuspended in lysis buffer (45 mM Tris, 90 mM NaCl, 1% 
(v/v) SDS) and boiled for 15 minutes. A ΔmetE LB O/N was washed 3X in PBS. 
Minimal M9 agar (3g agar, 160 mL dH2O, 40 mL 5xM9 minimal media) with a ΔmetE 
top agar was prepared. Discs were placed on-top of agar with 10 µL of each strain to 
be tested. Plates were incubated O/N at 37 °C and the size of bacterial growth 
measured the following day. A standard curve was generated using samples of known 
concentration of vitamin B12.  
 
2.9 Measurement of nitrogen cycle intermediates  
Headspace gas samples (3 mL) were taken using a 5 mL gas-tight syringe (Hamilton) 
and stored in 3 mL pre-evacuated screw cap EXETAINER® vials (Labco). N2O gas 
samples were analysed by GC through injection of a 50 μL sample into a Clarus 500 
gas chromatographer (PerkinElmer) with an electron capture detector and Elite-PLOT 
Q [DVB Plot column, 30 m × 0.53 mm ID, carrier: N2, make-up: 95% (v/V) argon/5% 
(v/v) methane]. Standards of N2O [5, 100, 1,000, 5,000, and 10,000 ppm (Scientific 
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and Technical Gases)] were used to quantify N2O levels. Total N2O amounts were 
calculated by applying Henry’s Law constant for N2O at 30°C, KH cc of 0.5392.  
NO levels in whole Duran bottles (200ml) were measured using the Nitric Oxide 
Analyser (NOA 280i, General Electric). This method relies on calibration of the NOA 
with 90 ppm NO gas, and provides a read-out in ppm. For NO measurements, the 
entire headspace of the bottle was measured, this is required for the analyser to reach 
a steady level for accurate measurement of the NO concentration. Separate bottles 
were therefore set up and sacrificed at each timepoint.  
1 mL liquid aliquots were sampled for each culture using a needle and syringe. The 
optical density (λ600 nm) was measured using a SpectraMax M5 spectrophotometer. 
The sample was centrifuged at 16,000 g for 5 minutes to pellet residual cells and the 
supernatant stored at -20°C. NO3- and NO2- concentration was measured using NOA, 
with 20 µL of thawed liquid sample being injected into a purge vessel. The purge 
vessel contained 3 mL of either (NaI, 1% w/v in acetic acid) for analysis of NO2- or 
(VCl3, 1% HCl) for NO3-, and was connected to a chemiluminescence detector. The 
reducing agent continuously experienced agitation by N2 in order to transport NO 
through the NO analyser and to maintain an anaerobic environment. 
 
2.10 Western Blot 
WT, ΔmetE and ΔmetEΔpocR bacteria were grown as anaerobic cultures in 200 mL 
1X M9 as described above for 17h and 48h and an aerobic WT culture was grown for 
24h in 50 mL 1X M9. A 6 mL aliquot was taken from each culture and centrifuged for 
10 mins (4000 rpm). Pellets were resuspended in a mixture of 50 µL B-
mercaptoethanol and 950 µL Laemmli sample buffer. Solution was boiled for 5 mins 
and centrifuged (20,000 x g) for 2 mins. Proteins were separated on 12% (v/v) 
denaturing gels (SDS-PAGE) at 180 V for 90 mins. One gel was stained with instant 
blue protein stain (Expedeon), incubated for 1h and de-stained in H2O O/N. 
For MetE detection, a nitrocellulose membrane was soaked in methanol for 1 min and 
then soaked with blotting paper in transfer buffer (48 mM Tris, 39 mM glycine, 0.04% 
(v/v) SDS) for 5 mins. Electro-transfer occurred for 1 h at 10 V onto membrane. 
Membrane was blocked with 5% (w/v) milk powder in 1X Tris-buffered saline with 
Tween 20 (TBST) buffer (20 mM Tris, 150 mM NaCl and 0.1% (v/v) Tween 20) and 
56 
 
incubated O/N at 4 °C. The membrane was incubated for 1h in 1:10,000 anti-MetE 
rabbit polyclonal antibody (44,45) diluted in 1% (w/v) milk powder in 1X TBST. The 
membrane was washed twice with 1X TBST for 1 min with agitation then incubated for 
1h in 1:10,000 horseradish peroxidase-conjugated anti-rabbit IgG (Pierce, Rockford, 
IL) diluted in 1% (w/v) milk powder in 1X TBST. The membrane was washed 3X in 1X 
TBST and then incubated in 1X TBST for 2h both with agitation. Blot was visualised 
and protein detected using a lumino-based chemiluminescent detection system 
(Qiagen). 
 
2.11 Gentamicin protection assay 
RAW 264.7 cells were maintained in DMEM with 10% foetal bovine serum (FBS) and 
2mM L-glutamine in a 37°C, 5% CO2 incubator. Bacterial strains were freshly cultured 
on agar plates and the dose added at a multiplicity of infection of 10 to 1 cells which 
were seeded 48hrs prior to infection.  IFN-λ  (1000U) was added 24hrs prior to 
infection, L-NAME (1 mM) was added with the dose and at the same concentration in 
maintenance media. Strains were left to infect for 1 hr prior to treatment with 
gentamycin (100 μg ml-1) for a further hour and either lysed or incubated for a further 
22hrs with 10 μg ml-1 gentamycin. Prior to lysis with 1% Triton X-100 in H2O, cells were 
washed twice with PBS and then plated on LB agar and cfu ml-1 counts taken.  
 
2.12 MIC assay 
Growth was conducted in 96 well plates in SpectraMax M5 plate reader, with culture 
volumes of 100 uL. Starter cultures were grown overnight in relevant media/conditions, 
the inoculum was added at a final concentration of 1/300 McFarland standard (Moore 
and Kaplan 1992).  Starting concentrations were as follows, potassium tellurite (20 
mM), potassium selenite (4.87 mM) and hydrogen peroxide (5 μM); subsequent 
concentrations were achieved by serial dilution.  
 
2.13 Statistics 
Results for multiple groups were analysed using GraphPad prism v.6 software by 
ANOVA or student t-test as stated. Significance for all tests taken as p≤0.05. 
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3.  A link between tellurite, nitric oxide and virulence in 
Salmonella Typhimurium: the role of TehB, STM1808 and 
YeaR. 
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3.1 Introduction 
 
As described in the introduction, nitric oxide detoxification is of key importance to the 
survival of Salmonella inside macrophages. This chapter will focus on the 
characterisation of three proteins, TehB, STM1808 and YeaR, all annotated as tellurite 
resistance proteins, namely in their roles in both tellurite and nitric oxide protection.   
In a prior study in the Rowley group, a microarray was conducted in order to identify 
proteins involved in anaerobic nitric oxide protection using RNA extracted from S. 
Typhimurium strain SL1344 cultured anaerobically on glucose medium and exposed 
to 40 μm NO (Anke Arkenberg, personal communication). Three genes, STM1808, 
yeaR and tehB, all annotated as tellurite resistance genes, were amongst the genes 
significantly up-regulated, (37, 11 and 15 fold respectively) post NO addition (Figure 
7). The fact that all three genes were up-regulated and share the same predicted 
function warranted further inquiry into their individual and combined role in NO 
detoxification and forms the basis of this study. 
The three proteins, STM1808, TehB and yeaR have numerous similarities which will 
be discussed, but most importantly, they are all regulated by the nitric oxide-sensitive 
repressor NsrR (Karlinsey et al. 2012). NsrR belongs to the Rrf2 family of 
transcriptional repressors and senses NO specifically at a [2Fe-2S] site (Tucker et al. 
2008). The presence of the [Fe-S] clusters makes NsrR highly sensitive to damage by 
NO so that genes repressed by NsrR, are de-repressed following NO exposure. In 
addition to the three proteins studied here, the NsrR regulon of Salmonella consists of 
other proteins known to be involved in NO protection, including at least hmpA, ytfE, 
ygbA and hcp-hcr (Gilberthorpe et al. 2007, Bang et al. 2006, Karlinsey et al. 2012).  
Tellurite is an oxyanion of tellurium which is highly toxic to a large range of bacteria 
(Taylor 1999). The cause of tellurite toxicity is not fully understood, however it is 
thought that tellurite interacts with both cellular thiols and glutathione which leads to 
its reduction to elemental tellurium (Te0) and the release of superoxide, the elimination 
of which results in oxidation of cellular thiols and in turn the shutdown of multiple 
essential processes (Taylor 1999, Turner et al. 2001, Turner, Weiner and Taylor 
1995b) 
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Across bacteria there are at least five known tellurite resistance (TeR) determinants, 
located both on the chromosome and on plasmids, all of which are unrelated at the 
level of DNA/protein structure and includes tehAB, klaABC, terZABCDEF, tmp, trgAB 
and cysK (Taylor 1999). Studies looking at these different systems suggest they work 
in very different ways. Rhodobacter sphaeroides, which is resistant to approximately 
4 mM tellurite (1000 fold higher than Salmonella) contains two of the known tellurite 
resistance determinants, trgAB and immediately downstream, cysK (the latter also 
found in E. coli and Salmonella). TrgAB encodes a membrane-associated protein 
while CysK is required for cysteine synthesis (Moore and Kaplan 1992, O'Gara, 
Gomelsky and Kaplan 1997). The KlaABC system does not require a cysteine 
metabolic pathway or glutathione whereas TehAB does (Turner et al. 1995b). The TeR 
determinant, Tmp, identified in the pea blight pathogen Pseudomonas syringae, 
appears to be a thiapurine methytransferase. Similarly, TehAB, which is also found in 
E. coli and Salmonella, contains motifs associated with SAM-dependent N-
methyltransferases (Turner, Weiner and Taylor 1995a). Additionally, TehA has been 
shown to provide resistance against disinfectants and antiseptics as well as protecting 
the cells from uncoupling (Turner, Taylor and Weiner 1997, Lohmeier-Vogel, Ung and 
Turner 2004). Furthermore it is known that TehAB requires a functional electron 
transport chain and a functional quinone pool in order to provide resistance against 
tellurite (Turner et al. 1995b). 
 
The fact that a number of these systems require either strong up-regulation or 
mutations in the genes before TeR is observed, combined with the knowledge that 
most bacteria will not encounter tellurite at significant levels, suggests that TeR may 
not be the primary function of these proteins (Taylor 1999). However, the existence of 
several separately evolved proteins with overlapping functions suggests a level of 
physiological importance. This is even more noticeable in Salmonella. Of the three 
tellurite resistance proteins studied here, TehB, STM1808 and YeaR, there is 46% 
amino acid identity between STM1808 and YeaR but no clear homology between 
TehB. One of these genes, STM1808, is not present in the close relative E. coli 
suggesting an increased requirement for the function of TeR systems in Salmonella.  
Of the three TeR proteins in this study, TehB has been the best characterised in E. coli 
studies. It has, however, been reported that TehB in Salmonella, which is homologous 
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to TehB from Haemophilus influenzae does not have homology in the domain that 
functions as an S-adenosyl-L-methionine (SAM)-dependent methyltransferase that is 
considered to be required for tellurite resistance (Karlinsey et al. 2012).  
  
Figure 7 Tellurite resistance genes are up-regulated by exogenous nitric oxide. RNA was 
extracted from anaerobic cultures of Salmonella Typhimurium. Fold change in expression 
between 0 and 10 mins post 40μm NO addition, as determined by microarray analysis, is plotted. 
Data shown is the mean of 4 biological replicates. Error bars represent standard error. (Data 
provided by Anke Arkenberg, personal communication)  
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3.1.1 Aims  
This chapter aims to characterise TehB, TehB and STM1808 in relation to their roles 
in nitric oxide protection by:  
 
• Creating knockout mutants of the three genes, including a triple knockout strain 
• Monitoring the survival of the strain in the presence of tellurite, aerobically and 
anaerobically  
• Determining the role the proteins play in NO protection and detoxification, both 
by monitoring growth and measuring NO levels produced by denitrifying strains  
• Investigate the tellurite resistance properties of known nitric oxide detoxification 
systems 
• Assess the survival of the mutant strains in macrophages  
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3.2 Results 
3.2.2 Mutant construction  
Knockout mutant constructs have been created for STM1808, yeaR and tehB using 
the λ-red method in SL1344 (Datsenko and Wanner 2000) and described in detail in 
the materials and methods. The single mutants have the pkD3 or pkD4 antibiotic 
resistance cassette remaining whereas the ΔtehB ΔSTM1808 ΔyeaR triple mutant has 
the cassette flipped out for the tehB and yeaR mutations but remaining for STM1808. 
The cassettes were removed using pCP20. Constructs were confirmed using colony 
PCR using both external binding primers and those that bind to the cassette combined 
with an external primer.  
 
 
 
 
 
 
 
Figure 8 PCR Verification of STM1808 mutant. PCR run as detailed in Methods with 
an annealing temperature of 50ºC and resulting products run on an electrophoresis 
gel. Lane 1: Hyperladder . Lanes 2-4: External STM1808 primers. Lane 2: WT, 
expected size 660; Lane 3:STM1808 Kan 1, expected size 2078; Lane 4:STM1808 
Kan 1, expected size 2078. Lanes 5-7: External STM1808 forward primer, internal 
pkD4 reverse primer. Lane 5: WT, expected no band; Lane 6: STM1808 Kan 1, 
expected size 789 Lane 7:STM1808 Kan 1, expected size 789.  
 
1    2    3    4      5   6   7  
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Figure 9 PCR Verification of yeaR mutant. PCR run as detailed in Methods with an 
annealing temperature of 50ºC and resulting products run on an electrophoresis gel.  
Lane 1: Hyperladder . Lanes 2-6: External yeaR primers. Lane 2: WT, expected size 
540; Lane 3: yeaR Kan 1, expected size 1817; Lane 4: yeaR Kan 3, expected size 
1817; Lane 5: yeaR Cm 2, expected size 1417; Lane 6: yeaR Cm 5, expected size 
1417. Lanes 7-9: External yeaR forward primer, internal pkD4 reverse primer. Lane 7: 
WT, expected no band; Lane 8: yeaR Kan 1, expected size 609; Lane 9: yeaR Kan 3, 
expected size 609; Lanes 10-12: External yeaR forward primer, internal pkD3 reverse 
primer. Lane 10: WT, expected no band; Lane  11: yeaR Cm 2, expected size 325; 
Lane 12: yeaR Cm 5, expected size 325. 
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Figure 10 PCR Verification of tehB mutant. PCR run as detailed in Methods with an 
annealing temperature of 50ºC and resulting products run on an electrophoresis gel. 
Lanes 1 and 8: Hyperladder . Lanes 2-6: External tehB primers. Lane 2: WT, expected 
size 800; Lane 3: tehB Kan 2, expected size 1903; Lane 4: tehB Kan 4, expected size 
1903; Lanes 5-7: External year forward primer, internal pkD4 reverse primer. Lane 5: 
WT, expected no band; Lane 6: tehB Kan 2, expected size 629; Lane 7: tehB Kan 4, 
expected size 629 
 
Figure 11: PCR Verification of yeaR tehB STM1808 triple mutant. PCR run as 
detailed in Methods with an annealing temperature of 50ºC and resulting products run 
on an electrophoresis gel. A: Lane 1: Hyperladder. Lanes 2-4: External yeaR primers. 
Lane 2: WT, expected size 540. Lane 3: yeaR tehB STM1808 1, expected size 177; 
Lane 4: yeaR tehB STM1808 6, expected size 177. Lanes 5-7: External tehB primers: 
Lane 5: WT, expected size 800. Lane 6: yeaR tehB STM1808 1, expected size 403; 
Lane 7: yeaR tehB STM1808 6, expected size 403. B: Lane 1: Hyperladder. Lanes 2-
4: External STM1808 primers. Lane 2: WT, expected size 720. Lane 3: yeaR tehB 
STM1808 1, expected size 1817; Lane 4: yeaR tehB STM1808 6, expected size 1817. 
1    2    3   4    5    6    7 1        2     3     4    
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3.2.3 There is no general growth defect for the TeR mutants cultured 
aerobically in LB  
 
To ascertain whether the mutations in yeaR, tehB, STM1808 had any impact on the 
ability of Salmonella to grow aerobically in rich media all mutants were grown in LB. 
Figure 12 shows that all strains grew like WT and therefore we were happy to continue 
with further phenotyping experiments.  
                                                                                                                                                                                                                                                                                                                                                                                                                           
 
Figure 12 The four single TeR mutants and triple TeR mutant have no general 
growth defect in LB aerobically. Strains were grown in 50ml at 200rpm.Samples 
taken every hour and optical density read at 600nm. 3 repeats were used and SE is 
shown.  
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3.2.4 TehB, STM1808 and TehB all contribute to tellurite resistance in 
Salmonella  
 
Although referred to as putative tellurite resistance proteins on the basis of their 
genome annotation (and contain a conserved domain, DUF1971, linked with tellurite 
resistance) (NCBI.com, 2017) there is currently no experimental evidence, confirming 
STM1808 and TehB as tellurite resistance proteins in Salmonella Typhimurium, 
indeed it has been proposed that there is no role of these proteins in tellurite resistance 
(Karlinsey et al. 2012). To determine whether they have any role in tellurite resistance 
in Salmonella Typhimurium, ΔyeaR, ΔSTM1808, ΔtehB and ΔtehB ΔSTM1808 ΔyeaR 
were tested for their ability to grow, aerobically and anaerobically, in the presence of 
5 μM potassium tellurite (Figure 13).   
This concentration was chosen due to the fact that the minimum inhibitory 
concentration (MIC) of tellurite for E. coli is between 3.94-7.88 μM (Taylor 1999). In 
both conditions the addition of tellurite had a clear toxic effect on WT Salmonella, with 
a ~70% reduction in OD at 24 hours aerobically, and ~50% reduction under anaerobic 
conditions. We, however, focused on how the mutant strains grew in comparison to 
the WT with the addition of tellurite. Aerobically there is a clear lag in growth for both 
ΔSTM1808 and ΔyeaR, which is less pronounced anaerobically, especially for ΔyeaR. 
The growth defect seen for ΔtehB both aerobically and anaerobically is much more 
pronounced (with a similar growth pattern seen for ΔtehB ΔSTM1808 ΔyeaR) with 
almost no growth observed. The data demonstrates an important role for TehB in 
protecting Salmonella against tellurite, with STM1808 and TehB also providing a 
degree of tellurite resistance (TeR). 
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Figure 13 In Salmonella resistance against potassium tellurite requires TehB, 
STM1808 and YeaR, both aerobically and anaerobically. Strains were grown 
aerobically in 50ml LB (A) or anaerobically in 1ml LB (B) with the addition of 5 μM 
potassium tellurite 
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3.2.5 Functional overlap between genes required for tellurite resistance in 
anaerobic protection against nitric oxide 
 
Since expression of the three TeR genes was induced in the presence of NO the 
mutant strains were then grown both aerobically and anaerobically in LB in the 
presence of deta NONOate, an NO donor (Figure 14).   
The addition of 5mM deta NONOate to LB has been shown to result in a maximum of 
8 μM of NO being released, reducing to 4 μM after 24 hours, we can therefore estimate 
that the addition of 10mM deta NONOate would result in a maximum of ≈16 μM of NO 
(Henard and Vázquez-Torres 2012). We used ΔhmpA as a negative control and ΔnsrR 
as a positive control. Consistent with previous studies (Gilberthorpe et al. 2007) there 
is a growth defect for ΔhmpA both aerobically and anaerobically when exposed to an 
NO donor and an increased rate of growth for ΔnsrR aerobically. The increase in 
growth rate for ΔnsrR is depressed anaerobically, presumably due to the anaerobic 
importance of NrfA and NorV which are controlled by additional regulators. Aerobically, 
in the presence of NO, there is no growth defect for the single mutants, ΔyeaR, ΔtehB, 
ΔSTM1808, mutants nor for the triple TeR mutant strain ΔtehB ΔSTM1808 ΔyeaR. 
Anaerobically there is no difference in growth between the WT and the single TeR 
mutants in the presence of the NO donor, however, in the triple mutant strain ΔtehB 
ΔSTM1808 ΔyeaR, a clear reduction in growth rate and final OD can be seen.  
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3.2.6 TehB H32 and H82 are not important for tellurite protection but are 
important for nitric oxide protection  
 
It has been previously shown in Salmonella that two histidine residues which are 
conserved in the DUF1971 domain are important for the nitric oxide resistance of 
STM1808 (Karlinsey et al. 2012). Numerous histidine residues were individually 
mutated to alanines and both single mutants behaved as the total STM1808 knockout 
strain. Further work then concluded that H82 is an important residue for zinc binding 
(Karlinsey et al. 2012).  
Since YeaR also possesses the DUF1971 domain with these same two conserved 
histidine residues we hypothesized that these would be equally as important for nitric 
oxide resistance, and possibly tellurite resistance, as in STM1808 (Figure 15). This 
conserved domain is not seen in TehB (Figure 16). While both the Karlinsey study and 
this work saw no growth phenotype for ΔyeaR in the presence of nitric oxide, we do 
see a growth defect in the presence of tellurite. Additionally, the ΔtehB ΔSTM1808 
ΔyeaR triple mutant strain does have a growth defect in the presence of nitric oxide 
where a complementation effect might be able to be seen.  
Six strains were constructed, the ΔtehB ΔSTM1808 ΔyeaR triple mutant was 
complemented with either WT yeaR, yeaR with H32 and H82 mutated to alanines, or 
the empty plasmid, from here referred to as ΔtehB ΔSTM1808 ΔyeaR PyeaR, ΔtehB 
ΔSTM1808 ΔyeaR PyeaRH32AH82A or, ΔtehB ΔSTM1808 ΔyeaR Pempty, 
respectively. The same plasmids were also transformed into the WT strain, with the 
resulting strains being WT PyeaR, WT PyeaRH32AH82A and, WT Pempty. 
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Figure 15 Alignment of STM1808 and yeaR. Performed using Clustal W alignment. 
H32 and H82 are highlighted in red. 
Figure 16 Alignment of tehB, STM1808 and yeaR. Performed using Clustal W 
alignment. H32 and H82 are highlighted in red. 
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All six strains were grown aerobically and anaerobically in LB to confirm no general 
growth defect or advantages were present (Figure 17). The six strains were then 
tested for their ability to grow aerobically in LB in the presence of 5 µM potassium 
tellurite. This was not carried out anaerobically as no growth defect is seen for ΔyeaR 
anaerobically (Figure 13).   
The TehB complemented strain, as ΔtehB ΔSTM1808 ΔyeaR PyeaR, showed a mild 
restoration in growth in comparison to the control strain, ΔtehB ΔSTM1808 ΔyeaR 
Pempty (Figure 18). Both ΔtehB ΔSTM1808 ΔyeaR PyeaR and the histidine altered 
complementation strain, ΔtehB ΔSTM1808 ΔyeaR PyeaRH32AH82A showed very 
similar levels of growth; therefore suggesting H32 and H82 do not play an important 
role in the tellurite resistance functions of TehB.  
When grown in the presence of deta NONOate, ΔtehB ΔSTM1808 ΔyeaR PyeaR 
shows a clear growth restoration in comparison to the control strain, ΔtehB ΔSTM1808 
ΔyeaR Pempty (Figure 19). However, ΔtehB ΔSTM1808 ΔyeaR PyeaRH32AH82A 
grows comparably to the triple mutant with the empty plasmid, therefore suggesting 
that these two histidine residues are important for anaerobic protection against nitric 
oxide.  
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3.2.7 Nitric oxide accumulates during nitrate respiration in ΔtehB ΔSTM1808 
ΔyeaR triple mutant  
 
In order to ascertain if the TeR proteins have a direct role in detoxifying NO we grew 
the strains anaerobically with nitrate as the alternative electron acceptor and 
measured production of endogenous NO. Firstly the WT strain was grown and 3 ml 
samples of headspace gas taken at 4 timepoints over 48 hours (Figure 20). NO levels 
increased until 40 hours and then were reduced at 48 hours. We therefore determined 
to efficiently compare levels of NO between the mutant strains measurements should 
be taken at 40 hours. In order to obtain more accurate NO levels the entire headspace 
(≈ 50 ml) was used for future results, the experiment was therefore sacrificed at this 
timepoint. 
Under these conditions (M9 minimal media, anaerobic, 20 mM nitrate) all the strains 
grew comparably to WT. To establish the validity of our experimental set up, NO 
released by ΔhmpA and ΔnsrR was measured and had higher and lower levels of 
headspace NO respectively, with 1.59 ±0.16 μM and 0.31 ±0.15 μM NO compared to 
0.72 ±0.14 μM from the WT Salmonella strain. We observed no significant (p < 0.05) 
difference in levels of NO released from any of the single TeR mutants, although a 
slight increase can be seen for ΔtehB (1.07 ±0.04 μM NO). However, the triple TeR 
mutant strain, ΔtehB ΔSTM1808 ΔyeaR, releases significantly (p < 0.05) higher levels 
of NO than the WT, with 1.33 ±0.11 μM NO detected, further supporting the functional 
redundancy between the TeR proteins in directly detoxifying NO (Figure 21).  
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Figure 21 Relative levels of nitric oxide produced by Salmonella mutants. Cultures were grown 
anaerobically in M9 minimal media with 20 mM nitrate and 5 mM glycerol with the headspace NO 
concentration measured after 40 hours of growth. All strains have 3 repeats, and standard error is 
shown. 
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3.2.8 Proteins involved in protection against reactive nitrogen species also 
protect against potassium tellurite  
 
Having demonstrated a role for the TeR proteins in both NO and tellurite resistance we 
sought to ascertain whether there is a correlation between tellurite and nitric oxide 
resistance. To do this four strains, each carrying a mutation in a system implicated in 
NO protection were exposed to tellurite (Figure 22). Aerobically there was no growth 
defect for the ΔytfE, ΔnrfA or ΔnorV mutants in the presence of tellurite. However, 
there was a distinct growth defect in the absence of the key NO detoxification protein 
HmpA. Anaerobically there is a clearer correlation between NO and tellurite resistance 
with YtfE, NrfA and NorV all exhibiting a degree of protection against tellurite toxicity. 
HmpA, however, does not appear to have a role in anaerobic tellurite protection. As 
NsrR is the master regulator of NO detoxification in Salmonella the most significant 
case for support of a correlation between NO and tellurite resistance can be seen with 
the phenotype of the NsrR mutant. Aerobically the disruption of NsrR, allowing for the 
up-regulation of the entire NsrR regulon, has a clear benefit to growth in the presence 
of tellurite in comparison to the WT. After 8 hours the OD600 for the ΔnsrR mutant had 
reached ≈0.50 as opposed to ≈0.08 for WT. This enhanced growth phenotype is not 
apparent in the absence of oxygen, with similar maximal growth for WT and ΔnsrR. 
However, the lag phase is shorter for the ΔnsrR mutant (at ~9 hrs) as opposed to ~14 
hours for the WT. Additionally, this correlates with a two-fold increase in the aerobic 
MIC of tellurite for the ΔnsrR mutant, 10 μM compared to 5 μM for the WT.  
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3.2.9 MIC of tellurite, selenite and hydrogen peroxide for WT and ΔtehB 
ΔSTM1808 ΔyeaR 
 
The toxicity of tellurite is frequently attributed to the production of ROS (Pérez et al. 
2007, Borsetti et al. 2005) and it is also known that at comparable levels selenite 
produces 4 fold higher levels of ROS than tellurite (Vrionis et al. 2015). One would 
therefore assume that if the toxicity of tellurite was attributable to the release of ROS 
that the MIC of selenite would be approximately 4 times lower than that of tellurite.  
However, we have shown that the MIC of selenite in Salmonella is ≈1000 times higher 
than tellurite (>4.9 mM vs 5.0 μM) suggesting that the toxicity observed with tellurite is 
not due to production of ROS (Table 7). Importantly, the MICs of H2O2 and selenite for 
the WT and the tellurite hypersensitive strain, ΔtehB ΔSTM1808 ΔyeaR are identical 
at 1.25 μM and >4.87 mM respectively. This suggests that the hypersensitivity to 
tellurite observed in ΔtehB ΔSTM1808 ΔyeaR is therefore not solely due to ROS.  
 
 
 
Table 7 MIC assay. WT and ΔtehB ΔSTM1808 ΔyeaR grown aerobically in 100uL LB 
to calculate MIC of potassium tellurite (K2O3Te), potassium selenite (K2O3Se) and 
hydrogen peroxide (H2O2). 
 
 Strain 
Compound WT ΔtehB ΔSTM1808 
ΔyeaR 
Tellurite 5.00 μM 2.50 μM 
Selenite > 4.87 mM > 4.87 mM 
Hydrogen Peroxide 1.25 μM 1.25 μM 
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3.2.10 The ΔtehB ΔSTM1808 ΔyeaR triple mutant is severely attenuated in IFN-
γ activated macrophages  
 
One of the key host defense mechanisms that challenges Salmonella survival in host 
macrophages is the production of NO via iNOS. In macrophages, NO levels can be 
stimulated by interferon gamma (IFN-γ) or inhibited by addition of NG-nitro-L-arginine 
methyl ester (L-NAME) upon hydrolysis to NG-nitro-L-arginine (L-NOARG) (Pfeiffer et 
al. 1996). When L-NAME treated macrophages were infected with either WT or ΔtehB 
ΔSTM1808 ΔyeaR there was no significant difference between the two strains in fold 
change in bacterial numbers between 2 and 24 hours post infection (pre and post the 
NO burst). When IFN-γ activated macrophages were infected with either WT or ΔtehB 
ΔSTM1808 ΔyeaR there was significantly (p< 0.01) lower survival of ΔtehB 
ΔSTM1808 ΔyeaR in comparison to WT with a 40.8 ±3.87 fold reduction for the triple 
TeR strain compared to 10.8 ±3.93 fold for WT (Figure 23).   
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Figure 23 The ΔtehB ΔSTM1808 ΔyeaR triple mutant is severely attenuated in IFN-γ 
activated macrophages. Fold change in cfu/ml between 2 and 24 hours post infection is 
shown for L-NAME treated (filled) and IFN-y activated (shaded) RAW 264.7 macrophages. 
6 repeats were used and SE is shown. A student’s t-test was used.  
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3.3 Discussion: 
 
In this chapter we set out to identify any uncharacterized genes involved in anaerobic 
NO detoxification by Salmonella Typhimurium and in doing so highlighted a connection 
between NO and tellurite detoxification. We have shown that TehB, YeaR and 
STM1808 are all involved in tellurite resistance in Salmonella, particularly aerobically; 
and that they provide resistance against NO, which our data suggests they play a role 
in detoxifying. A ΔtehB ΔSTM1808 ΔyeaR triple mutant has also been shown to be 
severely attenuated in activated macrophages.  
Of the three TeR proteins in this study, TehB has been the best characterised in E. coli 
studies. It has, however, been reported that TehB in Salmonella, which is homologous 
to TehB from Haemophilus influenzae, does not have homology in the domain that 
functions as an S-adenosyl-L-methionine (SAM)-dependent methyltransferase that is 
considered to be required for tellurite resistance (Karlinsey et al. 2012). We however 
found TehB to be the most important of the three proteins for TeR in Salmonella both 
aerobically and anaerobically (Figure 14). We have also shown a distinct phenotype 
for both ΔyeaR and ΔSTM1808 when grown aerobically in the presence of 5 μM 
potassium tellurite. Anaerobically this phenotype is reduced but is still visible, certainly 
at least for ΔSTM1808. This is in contrast to the suggestion that the methyltransferase 
domain that is lacking from TehB in Salmonella is vital for its role in protecting against 
tellurite (Karlinsey et al. 2012); and confirms the putative function of all three proteins.  
Although we have confirmed here the role of all three proteins, TehB, STM1808 and 
TehB in TeR, it remains the case that tellurite is probably not physiologically relevant, 
at least not at this stage of Salmonella’s evolution. Therefore, the fact that Salmonella 
has retained three independent systems for this function does imply that they have 
another important function and, from the results shown here, we propose this is in NO 
detoxification. Aerobically there is no growth defect for the mutant strains, including 
the triple mutant strain in the presence of 10 mM deta NONOate; but anaerobically 
there is a clear phenotype when all three systems are missing. Previous studies have 
shown a low level of protection provided by STM1808 against NO added to aerobic 
cultures, but not a requirement for TehB (Karlinsey et al. 2012). Therefore, we 
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conclude that there is functional overlap between the three systems for anaerobic NO 
protection.  
In order to ascertain whether this protection is as a direct result of NO detoxification 
as opposed to responding to the large amount of damage caused by NO in the cell, 
we grew the mutant strains under denitrifying conditions and measured the levels of 
NO released (Figure 21). While ΔtehB and ΔyeaR both accumulated higher levels of 
NO than the WT this was not significant, however, the triple TeR showed significantly 
higher levels of NO release. This confirmed the functional overlap between the three 
TeR genes and gives strong indication that they are directly involved in NO 
detoxification/reduction. It is not clear at this stage the mechanism by which this 
detoxification occurs and the protein biochemistry of this enzymatic activity warrants 
further work.  
It was noted by Karlinsey et al., (2012) that two histidine residues, H32 and H82, in 
STM1808 are important for the nitric oxide protection exhibited by the protein. These 
residues are part of the DUF1971 which is conserved within proteins thought to be 
involved in tellurite resistance. It was highlighted that a mutation of either of these 
histidine residues in STM1808 was equivalent to knocking out the entire gene when 
the strain was challenged with nitric oxide. Since STM1808 and YeaR are highly 
homologous, as shown in Figure 15, with H32 and H82 being conserved, we 
hypothesized that similarly to in STM1808 these residues would be vital for the role 
YeaR plays in nitric oxide detoxification. The residues are not conserved within TehB 
(Figure 16). Since, due to the functional redundancy of TehB, STM1808 and YeaR, 
we only see a mild phenotype for the single YeaR knockout mutant we therefore 
complemented the triple TeR mutant with either wildtype YeaR or YeaR with H32 and 
H82 mutated to alanines.  
These complementation strains were first tested for their ability to grow in the presence 
of 5 µM potassium tellurite (Figure 18) where there was a 1.5 fold increase in final OD 
for ΔtehB ΔSTM1808 ΔyeaR PyeaR compared to ΔtehB ΔSTM1808 ΔyeaR Pempty 
(0.043 v. 0.029) taking it from 32% of the final OD for WT Pempty to 47%. However, 
the ΔtehB ΔSTM1808 ΔyeaR PyeaRH32AH82A strain grew comparably, with a similar 
final OD of 0.04. In combination these results show that while TehB does play a role 
in the protection against tellurite in Salmonella, these two histidine residues are not 
important for this function. The role of the histidine residues in tellurite resistance by 
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STM1808 has not been looked at previously or in this study; this could be something 
of interest (Karlinsey et al. 2012).  
In contrast, there is a role for H32 and H82 in TehB-mediated nitric oxide protection 
(Figure 19). Complementation of the triple TeR mutant strain with WT TehB resulted in 
a restoration of growth, with the final OD reaching 0.390 in comparison to 0.201 for 
the control strain ΔtehB ΔSTM1808 ΔyeaR Pempty in the presence of deta NONOate 
and 0.497 in plain LB. Under these conditions however the same was not seen for 
ΔtehB ΔSTM1808 ΔyeaR PyeaRH32AH82A with the final OD only slightly higher than 
the control strain at 0.241. We therefore conclude that H32 and H82 of YeaR are 
important for nitric oxide, but not tellurite, protection in Salmonella. This result has two-
fold implications, the first being that there is a clear similarity between the functionality 
of STM1808 and YeaR in nitric oxide detoxification. In STM1808 these residues have 
been shown to be important for zinc binding – this could be looked at in YeaR. 
Secondly, the fact that the two histidine residues are important for one function of 
YeaR, nitric oxide protection, but not another, tellurite resistance, suggests that the 
protein is not working in precisely the same way for these two separate functions.  
Due to the role of the TeR proteins in NO detoxification we then tested whether the 
converse is true, that in Salmonella any strain that is sensitive to NO is also sensitive 
to tellurite; this could give an indication of the cause of toxicity. We demonstrated that 
the well characterised NO oxygenase/reductase, HmpA, is very important for tellurite 
resistance aerobically, but not anaerobically. When the NO sensitive repressor, NsrR, 
is deleted the entire NsrR regulon (consisting of hcp-hcr, ytfE, ygbA, hmp, yeaR-yoaG 
and STM1808) is upregulated (Karlinsey et al. 2012).  In the presence of tellurite ΔnsrR 
grows much better than WT aerobically and, although the phenotype is less 
pronounced anaerobically, there is still a clear role for the NsrR regulon in tellurite 
resistance; suggesting that the genes regulated by NsrR play a key role in tellurite 
resistance as well as in NO resistance. We also tested three further proteins that have 
been implicated in NO resistance, for their involvement in tellurite resistance. One of 
these, YtfE (Gilberthorpe et al. 2007) is NsrR regulated, but the other two, NrfA and 
NorV (Mills et al. 2005) are not. NorV and NrfA are known to be involved in NO 
resistance anaerobically and we have shown involvement in resistance against 
tellurite anaerobically. From our data, we conclude that there is a clear correlation 
between tellurite resistance and NO resistance in Salmonella. There is the possibility 
87 
 
that in LB, TeO3-2 leads to the release of NO and therefore the tellurite phenotype, and 
hence the correlation we are seeing is actually due to NO release post tellurite 
addition. The mechanism by which this may occur is unknown however there would 
be a varied mix of nitrogen and oxygen containing molecules present so it is feasible. 
We however do not believe this to be the case – the phenotypes we see for tellurite 
and NO are not directly comparable; and moreover we attempted to measure the NO 
levels from aerobic and anaerobic LB media containing different combinations of 
bacteria and tellurite and saw no NO release (data not shown). The results from our 
study on the importance of two histidine residues in YeaR also would not correlate 
with this hypothesis; the two residues are only seen to be important for protection 
against NO, if tellurite was simply triggering the release of NO then the residues would 
be important under both nitric oxide and tellurite stress.  
There are indications that tellurite toxicity is as a result, at least in part, of reactive 
oxygen species (ROS), which are released, when TeO32- is reduced to Te. Superoxide 
dismutase was upregulated in E. coli and Rhodobacter capsulatus in response to 
tellurite and, ROS protection mutant strains had increased tellurite sensitivities (Pérez 
et al. 2007, Borsetti et al. 2005). However, it has been shown that treatment of E. coli 
with selenite results in at least four times as much ROS than tellurite (Vrionis et al. 
2015). In our study the MIC of selenite (>4.875 mM) is much higher than that of tellurite 
(5 μM) (Table 1). This suggests that it is not solely the induction of ROS production 
that causes the toxic effects of tellurite. We also exposed the tellurite hypersensitive 
ΔtehB ΔSTM1808 ΔyeaR to H2O2 and selenite and saw no difference in sensitivity 
than the WT – indicating that the tellurite sensitivity of this strain is not due to ROS. It 
may be worth testing the sensitivity of the triple mutant to other sources of ROS, such 
as paraquat, as there is the potential that different results would be seen.  
STM1808 has previously been shown to be important for virulence in the murine 
model, with the authors suggesting a role in protection against nitrosative stress in 
macrophages (Karlinsey et al. 2012). In this study, we showed the tellurite 
hypersensitive ΔtehB ΔSTM1808 ΔyeaR strain to be attenuated in IFN-γ activated 
macrophages. The fact that we see this attenuation only in IFN-γ activated 
macrophages and not in L-NAME treated macrophages, which will fail to produce the 
nitrosative burst, further implicates these proteins in NO defense. It would be of merit 
to repeat these experiments treating the macrophages both with IFN-γ and L-NAME 
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in order to confirm the differences we see between the IFN-γ and L-NAME samples 
are solely due to NO release and not other defensive mechanisms controlled by       
IFN-γ.  
This work has raised a new area of research for the enigma of tellurite toxicity – the 
link between tellurite sensitivity and NO sensitivity; and here there are still many 
unanswered questions.  Originally, was the primary role of these three TeR  proteins in 
protection against tellurite, but when over time the environmental conditions 
Salmonella encounters changed, these proteins were retained due to their secondary 
role in NO resistance?  Or conversely are these proteins simply involved in NO 
detoxification and by chance have the ability to protect Salmonella against tellurite? If 
the latter is the case we perhaps would expect other tellurite resistance systems, 
(KlaABC, TerZABCDEF, Tmp, TrgAB and CysK) to contribute to NO detoxification 
and/or tellurite resistant bacteria such as Corynebacterium diphtheriae, Streptococcus 
faecalis, and some drug resistant Staphylococcus aureus strains (Summers and Silver 
1978) to have increased resistance to NO.  
There is one previous study linking nitrogen metabolism to tellurite, this links NarG, 
the nitrate reductase, to tellurite detoxification (Avazéri et al. 1997). They also 
identified an additional, unidentified, soluble protein which showed tellurite reductase 
activity. There was no tellurite sensitivity of the NarG mutant under anaerobic 
conditions, and the authors suggest this is due to the additional protein they identified; 
there is the potential that this is one of the proteins studied in this chapter. Avazéri et 
al., did not indentify the mechanism of tellurite reduction by NarG and could not 
conclude whether this single protein is responsible for the total reduction of Te4 to 
elemental tellurium, Te0. The pathways of tellurite and nitrate reduction are somewhat 
similar and as such we propose the potential model shown in Figure 24.  
This model suggests that Salmonella treats tellurite very similarly to nitrate, reducing 
it via the same pathway.  
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While this chapter has raised numerous further questions it has also achieved the 
original intention of this work, which was to characterize novel anaerobic nitric oxide 
detoxifiers. It is well known that the ability of Salmonella to survive within macrophages 
is vital to the progression of Typhoid fever (Page 25) and therefore that a strain which 
is unable to survive within this environment will not be able to progress into the 
systemic, fatal, stage of the disease. While STM1808 and TehB have been studied 
before in relation to nitric oxide detoxification (Karlinsey et al. 2012), their full effect, 
and therefore potential importance in this area, was not seen due to the functional 
overlap exhibited between these two proteins and TehB.  
 
3.3.1 Future Work 
The first thing that must now be done is protein biochemistry to confirm the role of 
YeaR, TehB and STM1808 in direct nitric oxide detoxification. This could be in the 
form of protein film voltammetry, a technique that has previously been used to quantify 
the NO reductase activity of NrfA from E. coli (van Wonderen et al. 2008). This 
technique works by immobilizing the enzyme onto an electrode, placing this in the 
potential substrate and monitoring any charge produced due to the flow of electrons 
(Angove et al. 2002).  
Further work should be done to assess the potential for these three proteins in 
combination with others as a potential vaccine strain. The first steps would be to 
combine these three mutations with other proteins such as HmpA, NrfA and NorV and 
assess the strain’s survival in macrophages. We would expect such a strain to have a 
very severe attenuation.  
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4. The role of CstA, Hcr and STM1273 in nitric oxide and 
tellurite resistance  
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4.1 Introduction:  
 
Chapter 3 looked at the proteins transcribed by three genes which were upregulated 
in response to NO and importantly all had the same annotated function in tellurite 
resistance. This chapter looks at three further genes which were upregulated under 
the same conditions but at the time had not been confirmed to have a role in nitric 
oxide protection or detoxification. Background information on these three proteins, 
CstA, Hcr and STM1273 is given below.  
Two microarray analyses by Arkenberg et al., (personal communication) revealed 
upregulation of these three genes both when subjected to an exogenous bolus of nitric 
oxide (40 μM) or grown under denitrifying conditions which will cause Salmonella to 
release both NO and N2O. cstA exhibited similar levels of upregulation in both of these 
analyses with a 4 fold increase from exogenous exposure and 7 fold during 
endogenous production. hcr was very highly upregulated under denitrifying conditions 
with a 77 fold increase in expression, but was also 7 fold upregulated by an exogenous 
NO bolus. STM1273 was upregulated 2.4 fold post exogenous NO exposure and not 
significantly changed when respiring on nitrate.   
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4.1.1 CstA   
CstA has been described as a peptide transporter, contains eighteen 
transmembrane domains and is annotated as a carbon starvation protein, being 
cAMP-CRP (cyclic adenosine monophosphate-catabolite regulation protein) 
dependent in E. coli; that is when carbon levels drop cAMP levels rise and activate 
expression of the gene (Blum et al. 1990, Garai et al. 2015). Glucose starvation of 
E.coli results in a 6 fold increase in expression levels (Blum et al. 1990). CstA acts 
as a virulence factor in Salmonella; as a cstA mutant had a 67% reduction in C. 
elegans killing compared to WT. A cstA mutant was also 39% reduced in its ability to 
initiate polymorphonuclear leukocytes migration and 54% reduced in epithelial cell 
invasion (Tenor et al. 2004). There has been no study looking at this virulence 
further, for example in the mouse model. Most studies on cstA have looked at its 
regulation. CsrA, a global regulator, has been shown to translationally regulate CstA 
in E. coli, the main targets of CsrA regulation are proteins involved in central carbon 
metabolism, motility, and biofilm development (Dubey et al. 2003).  
Another regulator is YjiY, in both S. Typhi and S. Typhimurium cstA has been shown 
to be the predominant gene regulated by this protein. In E. coli YjiY is regulated by the 
two-component system YehUT, which is conserved throughout the majority of enteric 
bacteria. Similarly, to YjiY transcriptome analysis identified cstA as the predominantly 
yehUT regulated gene in both S. Typhi and S. Typhimurium (Wong et al. 2013). The 
YehUT operon of S. Typhi has been found to contain a higher than average level of 
mutations, suggesting adaptive evolution is occurring; potentially indicating an 
importance for this operon (Wong et al. 2013). 
 
4.1.2 Hcr 
Hcr is transcribed in an operon with Hcp, a hybrid cluster protein. Hcr catalyses the 
reduction of the Hcp with NADH as the electron donor. In E. coli the two proteins are 
only produced when the bacteria is grown in the presence of nitrate and nitrite – 
suggesting a role in nitrogen metabolism (van den Berg, Hagen and van Dongen 2000, 
Overton et al. 2006). There has been suggestion that hcr functions as a hydoxylamine 
reductase and has peroxidase activity (Almeida et al. 2006, Wolfe et al. 2002).  
 
94 
 
A 2007 study tested the importance of Hcr for aerobic survival in LB in the presence 
of 3 mM GSNO (a NO donor) and saw no growth defect for a S. Typhimurium hcr 
mutant (Gilberthorpe et al. 2007).  However, a role for Hcr in protection against NO-
mediated respiration inhibition has been shown in Salmonella. Since HmpA is said to 
be the most important protein for NO detoxification, Karlinsey et al., constructed their 
mutants in a ΔhmpA background to avoid this masking any functions, additionally a 
nsrR deletion was used to avoid any interactions of NsrR related genes.  The growth 
profile of this ΔnsrR ΔhmpA Δhcr strain was monitored in LB containing 3mM 
Spermine-NONOate and a growth defect was seen (Karlinsey et al. 2012). In E. coli, 
Hcr has been confirmed to be a high affinity NO reductase during anaerobic growth 
(Wang et al. 2016).  
NsrR has been confirmed to regulate hcp-hcr in both E. coli and Salmonella (Karlinsey 
et al. 2012, Filenko et al. 2007). In E. coli, hcp-hcr, hmpA, and ytfE are the three 
transcripts most tightly regulated by NsrR (Filenko et al. 2007).  
The hcp-hcr operon is induced in activated RAW 264.7 macrophages but not by 
untreated macrophages or those where iNOS activity has been inhibited. (Kim, 
Monack and Falkow 2003). Infection studies using C57BL/6J mice surprisingly 
revealed increased killing of the mice for low doses of the hcp and hcr mutants (termed 
nipA and nipB respectively) (Kim et al. 2003). It was then noted by Karlinsey et al., 
that C57Bl/6J mice lack a functional Nramp1 locus and as such have reduced NO 
production, and so a study was conducted with C3H/HeN mice which do not lack this 
locus. This study inoculated mice with a 1:1 ratio of WT and the mutant and examined 
surviving bacteria in numerous organs. However, hcp mutants outcompeted the WT 
strain indicating the lack of hcp results in increased survival of Salmonella and 
corroborating the results of Kim et al. (Karlinsey et al. 2012).    
 
4.1.3 STM1273  
STM1273 lies 410bp downstream of yeaR, the role of which in nitric oxide and tellurite 
resistance was confirmed in Chapter 3. There is very little in the literature about this 
protein, however it was originally annotated as a putative nitric oxide reductase 
(McClelland et al. 2001). The RyhB sRNA have mainly been shown to affect translation 
of proteins requiring iron in response to low iron availability. One of the RhyB 
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homologs, ryhB-2 overlaps with STM1273, leading to the suggestion that STM1273 
may be a target of RyhB regulation (Kim and Kwon 2013a, Kim and Kwon 2013b, Kim 
2016). Previous work from the Rowley lab found no role for STM1273 anaerobically in 
the presence of 40 μM aqueous NO. NO sensitivity had not been looked at during 
aerobic growth. The fact that STM1273 is only upregulated after a NO bolus and not 
during nitrate respiration suggests that it may be more important for exogenous rather 
than endogenous NO detoxification.  
 
 
 
4.2 Aims 
 
Based on the results of the previous chapter, which found a link between NO and 
tellurite protection both aerobically and anaerobically in Salmonella, this chapter will 
further assess the importance of three proteins in both NO and tellurite resistance.  
 
• Determine the role of CstA, Hcr and STM1273 in NO protection, aerobically and 
anaerobically.  
• Assess the importance of CstA, Hcr and STM1273 in macrophage survival 
• Challenge ΔcstA, Δhcr and ΔSTM1273 with potassium tellurite to assess if they 
play a role in protection  
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4.3 Results 
4.3.1 Δhcr ΔSTM1273 and ΔcstA grow comparably to WT in LB both aerobically 
and anaerobically   
Deletion mutants (Arkenberg, personal communication) were first tested for any 
general growth defects on LB both aerobically and anaerobically. All three mutant 
strains grew comparably to WT (Figure 25).  
 
  
Figure 25 The three mutant strains, Δhcr, ΔSTM1273 and ΔcstA grow comparably 
to WT in LB. Conducted both aerobically (A) and anaerobically (B). Strains were grown 
for 24 hours in 1 ml LB in a SpectraMax plate reader. Data shows 3 repeats.  
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4.3.2 STM1273, CstA and Hcr are important for nitric oxide protection both 
aerobically and anaerobically  
In order to determine the contribution of STM1273, CstA and HmpA to the survival of 
Salmonella when challenged with NO, deletion mutants of STM1273, cstA and hcr 
were grown in the presence of 5 mM Deta NONOate both aerobically and 
anaerobically (Figure 26). Aerobically the three strains, ΔSTM1273, ΔcstA and Δhcr 
showed similar levels of growth, with the final ODs being 67%, 61% and 66% of WT’s, 
respectively.  Anaerobically, again, the three strains ΔSTM1273, ΔcstA and Δhcr 
showed similar levels of growth to each other, with the final ODs being 72%, 71% and 
69% of WT’s.  This therefore confirms the role of all three proteins in both aerobic and 
anaerobic exogenous nitric oxide protection.  
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Figure 26 STM1273, CstA and Hcr are important for nitric oxide protection both 
aerobically and anaerobically. Strains were grown both aerobically (A) and 
anaerobically (B) in 1ml LB in a SpectraMax plate reader for 24 hours, with the addition 
of 5 mM Deta NONOate. Solid black circles indicate the WT and white circles the 
indicated mutant strain. All strains have a minimum of 3 repeats and SE is shown.  
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4.3.3 Nitric oxide accumulates in Δhcr in comparison to WT when grown under 
denitrifying conditions  
When grown in minimal media with the addition of nitrate and glycerol, Salmonella will 
use the provided nitrate as a terminal electron acceptor and undergo denitrification. 
Nitric oxide is produced as an intermediate of denitrification. We would therefore 
expect a strain lacking a gene which is important in the reduction of nitric oxide to 
accumulate greater levels than WT. When cultured anaerobically on M9 with 20 mM 
nitrate, both ΔcstA and ΔSTM1273 produced slightly lower levels of NO than WT at 
40 hours, suggesting they play no direct role in NO detoxification (Figure 27). There 
was however a near 2-fold significant increase in the level of NO which accumulated 
in the Δhcr mutant suggesting that this protein plays a direct role in the reduction of 
NO (Figure 27). 
  
Figure 27 Nitric oxide accumulates in Δhcr in comparison to WT when grown under 
denitrifying conditions. Strains were grown in M9 minimal media with the addition of 20mM 
NaO3 and 10mM glycerol. Nitric oxide from the headspace was measured at 40 hours. All strains 
have a minimum of 3 repeats, SE is shown and a student’s T Test was used.  
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4.3.4 Δhcr and ΔcstA are significantly attenuated in activated macrophages  
Macrophages release NO as an integral part of the host response via iNOS, the 
inducible nitric oxide synthase. iNOS can be upregulated by interferon gamma (IFN-
γ) or inhibited by addition of NG-nitro-L-arginine methyl ester (L-NAME) (Pfeiffer et al. 
1996). Therefore, IFN-γ-activated macrophages release higher, more physiologically 
relevant, levels of NO and L-NAME-treated macrophages will release low or no NO. 
Bacterial counts were taken 2 and 24 hours post macrophage infection and the fold 
reduction in numbers is shown (Figure 28). As would be expected, all strains had 
increased survival when the macrophages were treated with L-NAME in comparison 
to IFN-γ. There is a significantly greater reduction in bacterial numbers for ΔcstA in 
comparison to WT, this would suggest that this protein plays a role in survival inside 
macrophages which is not based on NO detoxification. All three strains, Δhcr, ΔcstA 
and ΔSTM1273 show a virulence defect in IFN-γ treated macrophages. The WT strain 
has a 13.8 fold reduction in cfu/ml of Salmonella between 2 and 24 hours, this 
increases to 22.2 fold for ΔcstA, 22.3 fold for ΔSTM1273 and 26.8 fold for Δhcr.  
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Figure 28 Hcr and CstA are important for survival within activated macrophages. Fold 
change in cfu/ml between 2 and 24 hours post infection is shown for L-NAME treated (filled) and 
IFN-y activated (shaded) RAW 264.7 macrophages. 4 repeats were used and SE is shown. A 
student’s t-test was used. 
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4.3.5 STM1273, Hcr and CstA all offer Salmonella protection against potassium 
tellurite in the presence and absence of oxygen.  
 
Following on from Chapter 3, once Hcr, CstA and STM1273 had been shown to be 
important for nitric oxide protection we wanted to see if like other known nitric oxide 
detoxification systems, YtfE, NorV, NrfA, HmpA, there was a role for these proteins in 
potassium tellurite protection. All three mutants exhibited a slight growth defect both 
aerobically and anaerobically in the presence of potassium tellurite (Figure 29). It 
should be noted in contrast that YtfE, NorV and NrfA only appear to play a role in TeR 
anaerobically, and HmpA only aerobically (Figure 22).  
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4.4 Discussion  
 
The importance for Salmonella to efficiently detoxify nitric oxide and the systems in 
place to do this has been discussed in detail in the introduction (Page 33) and 
expanded upon in Chapter 3.  
Of the three proteins studied in this chapter, Hcr has been the most well characterised, 
especially in regards to NO protection. It is known to be NsrR regulated in Salmonella 
which infers a strong likelihood to being involved in NO protection. Additionally, Hcr 
has been shown to play a role in NO-mediated respiration inhibition (Karlinsey et al. 
2012) but not in direct NO protection aerobically (Gilberthorpe et al. 2007). In E. coli, 
Hcr has been shown to encode a NADH oxidoreductase, and be transcribed in an 
operon with Hcp, the hybrid cluster protein; additionally it was seen that both proteins 
are needed in combination order to reduce NO in anaerobic conditions (Wang et al. 
2016, van den Berg et al. 2000, Filenko et al. 2007). 
In this chapter, we have shown a role for Hcr in both aerobic and anaerobic growth – 
with growth defects compared to WT in both conditions in the presence of 5mM deta 
NONOate. Additionally, an experiment looking at the levels of NO in the headspace of 
an hcr mutant growing under denitrifying conditions showed a near 2-fold increase in 
comparison to WT. This indicates a direct role of Hcr in nitric oxide detoxification. 
Finally, Δhcr was significantly attenuated in activated macrophages, with a 26.8 fold 
reduction in bacterial numbers during infection compared to 13.8 fold for the WT strain. 
It has been previously shown that hcr is upregulated in RAW 264.7 macrophages and 
hence it would be expected the protein would play a role in survival (Kim et al. 2003).  
As noted in the introduction of this chapter very little is known about the STM1273 
protein, but one thing of note is that is it situated just downstream of YeaR, separated 
only by one gene, YoaG. As shown in Chapter 3, YeaR is important both for nitric 
oxide and tellurite protection, and while being closely situated on the genome is not 
evidence alone that two proteins would have similar function, it is often common. It is 
clear from Figure 26 that STM1273 plays a role in protection against NO both 
aerobically and anaerobically in Salmonella. In contrast to Hcr however this did not 
correlate to an increase in the NO that accumulated under denitrifying conditions 
(Figure 27), which would indicate that the role STM1273 plays in protection against 
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NO is not in directly detoxifying it. It could however be the case that the loss of 
STM1273 results in the upregulation of one or more other NO detoxification systems 
and hence causes a decrease in NO emissions; therefore, this result should not be 
used to totally disregard the putative function of STM1273 as a nitric oxide reductase. 
While the STM1273 mutant did not fare significantly worse than WT in activated 
macrophages, it did show an increase in bacterial death. It is therefore possible that 
STM1273 plays a minor role in the survival of Salmonella inside macrophages, which 
could be further highlighted in combination mutant strains. 
CstA, annotated as a carbon starvation protein, also appears to play a role in NO 
protection, both aerobically and anaerobically (Figure 26). The ΔcstA strain 
accumulated similar levels of NO in comparison to WT when grown in minimal media 
supplemented with nitrate, as with STM1273, this does not necessarily mean that CstA 
does not directly detoxify NO, however it may also be the case that the protein is 
instead involved in protecting Salmonella from some of the toxic effects of NO.  
The results from the macrophage infection experiment have two implications for CstA. 
Firstly, the strain has significantly reduced survival in activated macrophages in 
comparison to the WT strain, suggesting that the protein is important for the survival 
in normal, activated macrophages. Secondly, in L-NAME treated macrophages, where 
iNOS is inhibited and hence NO is not produced, the cstA mutant also had significantly 
reduced survival. This suggests that CstA is important for survival in macrophages not 
solely because of its ability to provide protection against NO.  
The most likely reason for this is the general stress response function of CstA. The 
stress response sigma factor, σS, is thought to upregulate CstA (Dubey et al. 2003). 
There are five alternative sigma factors in Salmonella, σS is primarily stimulated by 
nutrient starvation or by the bacteria entering stationary phase (Hengge-Aronis 2002). 
As a general stress response regulator σS is known to be important for numerous 
stresses, including a number which would be present while Salmonella resides within 
macrophages and indeed has been shown to be important for survival within the 
environment of the macrophage. Specifically, σS is important for starvation, including 
nitrogen and carbon limitation (McCann, Kidwell and Matin 1991, Mulvey et al. 1990, 
Spector and Cubitt 1992, Spector 1998), oxidative stress (Lange and Hengge-Aronis 
1991) and osmotic shock (McMeechan et al. 2007). Carbon starvation proteins have 
been shown to be induced during macrophage growth (Abshire and Neidhardt 1993) 
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and it is known that Glucose and Glycolysis are necessary for a successful 
macrophage (and mouse) infection by Salmonella (Bowden et al. 2009, Bowden et al. 
2010). In addition, σS, has specifically been shown to be important for the survival of 
Salmonella within the macrophage (Fang et al. 1992).  
Lastly, we tested the three mutants, Δhcr ΔcstA and ΔSTM1273, for their survival in 
the presence of potassium tellurite both aerobically and anaerobically. All three strains 
showed a mild growth defect in comparison to WT under both conditions. This 
strengthens the argument made in Chapter 3 that there is a correlation between 
tellurite resistance and NO resistance in Salmonella; however, it does not bring any 
new information as to why or how this is the case.  
In summary, this chapter has confirmed the role of the three proteins, CstA, Hcr and 
STM1273 in nitric oxide protection of Salmonella both aerobically and anerobically. 
The role of Hcr seems the most clear, with a distinct increase in the amount of NO 
which accumulates, and reduced survival in activated macrophages. While the role 
that STM1273 and CstA play is slightly less concrete, there is good evidence that the 
proteins are involved in the NO response and additionally with macrophage survival. 
As with the proteins in Chapter 3, protein biochemistry, including protein film 
voltammetry could be used to ascertain whether these proteins directly reduce NO.  
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5 Contribution of Vitamin B12 dependent and independent 
methionine synthases to anaerobic nitrate respiration  
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5.1 Introduction 
 
This chapter examines a potential link between the production of two compounds 
produced by Salmonella, vitamin B12 and nitrous oxide – both of which should 
seemingly come at a cost to the bacteria. 
The overarching aim of this chapter will be to determine if nitrous oxide production by 
Salmonella contributes to pathogenesis and is based on two major observations. The 
first is a result of a combination of studies by Rowley et al, 2012, Streminska et al, 
2012 and Runkel et al (in prep) who identified that nitrous oxide production by 
Salmonella Typhimurium cultured in nitrate sufficient/glycerol limited chemostats is an 
order of magnitude higher than that produced by related non-pathogenic E. coli strains 
(Figure 3). The second being the observation by Sullivan et al, that N2O accumulation 
in Paracoccus denitrificans nosZ mutants (N2O genic) induces a switch from vitamin 
B12-dependent to vitamin B12-independent biosynthetic pathways (Sullivan et al. 
2013). Nitrate respiration and therefore possibly N2O emissions, are particularly 
relevant to two infection scenarios; the first in the inflamed intestine where nitrate is 
produced as part of the host inflammatory response (Winter et al, 2010), and, the 
second in the intracellular environment of the macrophage.  
As described in more detail in the introduction (1.8 Denitrification in Salmonella, Page 
30), as a facultative anaerobe Salmonella has the ability to respire on nitrate, and in 
doing so releases nitrous oxide as an end product. When grown under denitrifying 
conditions in a chemostat Salmonella has been shown to produce N2O at measurable 
amounts of ≈1600 µM, in comparison to E. coli which releases > 100 µM (Figure 3). 
This is a surprising phenotype as due to its interaction with vitamin B12, nitrous oxide 
is deemed toxic.   
The synthesis and requirements of vitamin B12 in Salmonella, primarily in methionine 
synthesis, are described in the introduction (Page 39). This chapter will look at the 
interactions between vitamin B12 and nitrous oxide and additionally the regulation of 
vitamin B12 and methionine synthesis.  
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The 17 kb cob operon from which vitamin B12 is synthesised is grouped into three 
clusters: cobI, cobIII, cobII (Rondon and Escalante-Semerena 1996, Chen et al. 
1995b). The cob operon is located adjacent to the pdu operon (Figure 30) which codes 
for propanediol dehydratase both of which are induced by propanediol. Furthermore 
propanediol induces transcription of pocR, a gene encoding the positive regulator of 
the cob operon, PocR (Rondon and Escalante-Semerena 1996). The expression of 
pocR is under the control of two regulators, Crp and ArcA,  both classed as global 
regulators of genes in Salmonella (Ailion, Bobik and Roth 1993). 
Crp is the receptor protein for cyclic AMP (cAMP) and is the global regulator for genes 
involved in carbon source utilisation in the absence of glucose. With over 200 targets 
in E. coli Crp is thought to regulate a wide range of proteins involved in transport of 
carbon sources as well as their utilisation (Shimada et al. 2011). Since it is known that 
PocR is important for the regulation of the pdu operon required for the use of the 
carbon source propandediol, it is logical that this operon is under the control of this 
regulator. ArcA, Aerobic Respiratory Control, is important for sensing oxygen levels 
within the cell. The regulon of ArcA in E. coli is well characterised but fewer studies 
have been conducted in Salmonella (Salmon et al. 2005, Liu and De Wulf 2004). In 
Salmonella ArcA either directly or indirectly targets nearly 400 genes, including those 
required for propanediol utilisation and ethanolamine utilisation; which is not the case 
in E. coli (Evans et al. 2011).  
 
 
Figure 30 The organisation of the cob operon of vitamin B12 synthesis with 
respect to the pocR gene and pdu operon. The cob (vitamin B12 synthesis) and 
pdu (propanediol dehydratase) operons are both induced by PocR, the product of 
the pocR gene. (Diagram not to scale). 
 
Despite studies demonstrating that deletion of pocR results in a downregulation of the 
cob and pdu operons (Bobik, Ailion and Roth 1992), the precise regulatory 
mechanisms of the cob operon and the importance of PocR remain unclear.  
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It is known that the presence of oxygen (as little as 2kPa) is enough to inhibit the cob 
genes but the exact mechanism is unclear. Additionally, it has been shown that 
anaerobic respiration as opposed to anaerobic glucose fermentation results in higher 
transcription of the operon; this is partially due to cAMP levels. The production of B12 
however is not dependent on cAMP and the compound is possibly more important in 
establishing anaerobic conditions than in direct regulation (Escalante-Semerena and 
Roth 1987).  
 
 
5.2 Aims:  
This chapter aims to assess the impact of both exogenous and endogenous N2O on 
Salmonella growth, with specific attention to the activity of methionine synthesis. In 
doing so we aim to provide an explanation for the synthesis of both N2O and vitamin 
B12 in Salmonella. 
Specifically, this will be achieved by: 
• Creation of mutants in MetE, MetH, MetR.  
• Monitoring survival of mutants under denitrifying conditions and in the presence 
of exogenous N2O. 
• Determining the importance of PocR for vitamin B12 synthesis.  
• Investigating the importance of these proteins for Salmonella survival in 
macrophages. 
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5.3 Results 
 
5.3.1 Construction of metE and metR truncated mutants.  
 
 
Figure 31 Position of metE and metR on the Salmonella SL1344 genome 
 
The vitamin B12 independent methionine synthase, MetE, and MetR, the activator for 
both metE and metH, lie next to each other on the genome, with 1202bp separating 
them (Figure 31). They are transcribed in opposite directions and therefore it is 
possible that their promoter sites are contained within each other. If this were the case 
it would mean that a complete deletion of metE might effectively result in a metE metR 
double mutant, and therefore MetH (reliant on the activator MetR unless exogenous 
B12 is present) would also not be functioning. Although promoter mapping in E. coli 
suggests this is not likely to be the case (Figure 32), to be sure that both the metE and 
metR mutants are true single mutants, truncated mutants of both genes have been 
produced where approximately 500bp at the 5’ prime region of each gene have been 
left unaltered (Figure 33,  
Figure 34). 
 
 
Figure 32 MetE and MetR promoter site mapping in E. coli (taken from 
biocyc.org) 
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Figure 33 PCR Verification of truncated metE and metR mutants. A: Lane 1: 
Hyperladder. Lanes 2-6: External metE primers. Lane 2: WT, expected size 1500; 
Lane 3: metE Kan 2, expected size 2130; Lane 4: metE Kan 6, expected size 2130; 
Lane 5: metE Cm 2, expected size 1730; Lane 6: metE Cm 8, expected size 1730. 
Lanes 7-11: External metR primers. Lane 7: WT, expected size 795; Lane 8: metR 
Kan 1, expected size 2040; Lane 9: metR Kan 5, expected size 2040; Lane 10: metR 
Cm 2, expected size 1640; Lane 11: metR Cm 4, expected size 1640.  B: Lane 1: 
Hyperladder. Lanes 2-4: External metE forward primer, internal pkD4 reverse primer. 
Lane 2: WT, expected no band; Lane 3: metE Kan 2, expected size 748; Lane 4: metE 
Kan 6, expected size 748. Lanes 5-7 External metE forward primer, internal pkD3 
reverse primer. Lane 5: WT, expected no band. Lane 6: metE Cm 2, expected size 
464; Lane 7: metE Cm 8, expected size 464. Lanes 8-10: External metR forward 
primer, internal pkD4 reverse primer. Lane 8: WT, expected size, no band; Lane 9: 
metR Kan 1, expected size 748; Lane 10: metR Kan 5, expected size 748; Lanes 11-
13: External metR forward primer, internal pkD3 reverse primer. Lane 11: WT, 
expected size, no band; Lane 12: metR Cm 2, expected size 464; Lane 13: metR Cm 
4, expected size 464.   
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Figure 34 Confirmation of mutant construction. PCR confirmation of single mutants 
as follows: Lane 1:MetH (Cm), metH External, pkD3 Internal, 753; Lane 2: MetH(Kan), 
metH External, pkD4 Internal,1037bp; Lane 3: WT, metH External, metH Internal, 
1070bp 
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5.3.2 All mutants grow like WT in LB aerobically 
The methionine related mutants were grown alongside WT SL1344, aerobically, in rich 
LB media, to confirm the absence of any general growth defect (Figure 35). The 
concentration of methionine in LB broth has been shown to be between 2 and 6 mM 
(0.3-0.9 mg/ml)  (Sezonov, Joseleau-Petit and D'Ari 2007), at least two fold higher 
than the amount required for supplementation of a known methionine autotroph, 150 
µg/ml (Urbanowski et al. 1987). 
 
 
Figure 35  All mutant strains grow at similar rates to WT aerobically in LB broth. 
Strains were cultured in 50ml LB. Results are shown as means ± standard error of the 
mean from two separate experiments performed in duplicate. 
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5.3.3 ΔmetE and ΔmetR are attenuated in aerobic minimal media without the 
addition of vitamin B12 or methionine  
 
Salmonella is only able to synthesis vitamin B12 anaerobically, therefore in aerobic 
conditions where exogenous methionine is lacking, the vitamin B12 independent 
methionine synthase, MetE, is required for survival (Figure 36). Three of the mutants, 
ΔmetE, ΔmetE ΔmetH, and ΔmetR are therefore completely attenuated when grown 
in M9 minimal media aerobically (Figure 36). When supplemented with either vitamin 
B12 (100 µg/ml) or methionine (30 µg/ml) this growth defect is fully restored to WT 
levels. The addition of methionine results in a growth benefit to all strains (in 
comparison to the addition of B12 and for WT and ΔmetH which do not possess growth 
defects under any conditions). This suggests there is a noticeable metabolic expense 
of the synthesis of methionine by MetE.  
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5.3.4 Vitamin B12 is toxic to Salmonella, but not due to cobalt toxicity  
 
In order to chemically complement the B12 auxotrophic strain ΔmetE, an appropriate 
concentration of vitamin B12 needed to be determined. Vitamin B12 was initially added 
to anaerobic M9 cultures at 1 mg/ml as per (Sullivan et al. 2013) and while this resulted 
in restoration of growth of ΔmetE it inhibited growth of the SL1344 WT strain (data not 
shown). A range of concentrations of vitamin B12 were tested in order to determine a 
concentration where the WT strain and ΔmetE mutant grew comparably, this was 
found to be 0.05 mg/ml, 20 fold less than was used for the Paracoccus experiments 
(Figure 37).  
Since Vitamin B12 has a cobalt ion at its centre we thought the Vitamin B12 toxicity being 
seen may be due to a cobalt toxicity. A previous study has put the MIC of cobalt at 18 
µg/ml for S. enterica LT2 (Thorgersen and Downs 2009). Since cobalt makes up 4.3% 
of vitamin B12 when B12 is added at 1 mg/ml this equates to 0.043 mg/ml cobalt – 
however this is of course protected within the molecule. Salmonella was grown in the 
presence of a range of concentrations of cobalt from 0.043 mg/ml up to 1 mg/ml (far 
in exceeding that added with 1 mg/ml vitamin B12) with no defect seen (Figure 38). We 
therefore conclude that the toxicity seen when Salmonella SL1344 WT is grown in the 
presence of vitamin B12 is not due to cobalt toxicity.  
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Figure 37 Vitamin B12 exhibits a toxic effect on WT Salmonella. Strains were grown in 
nitrate-sufficient, glycerol-limited M9 minimal media supplemented with vitamin B12 as 
indicated for 48 hours. 
Figure 38 Cobalt is not toxic for WT Salmonella. Strains were grown in nitrate-sufficient, 
glycerol-limited M9 minimal media supplemented with cobalt chloride as indicated for 48 
hours. 
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5.3.5 MetE is important for the survival of denitrifying Salmonella  
 
Salmonella has the ability to respire on nitrate when oxygen is unavailable, as 
described in the introduction (Page 30) this results in the net production of N2O. To 
create denitrifying conditions Salmonella was grown in anaerobic conditions, in M9 
minimal media with the addition of 20mM nitrate.  
The growth of WT Salmonella was compared to ΔmetE, ΔmetH, ΔmetE ΔmetH and 
ΔmetR when grown in denitrifying conditions and with the addition of vitamin B12 or 
methionine (Figure 39). WT Salmonella exhibits similar growth in the absence or 
presence of methionine, with maximum growth of ≈0.2 OD600 reached by 24 hours. 
The addition of vitamin B12 reduces the maximum growth to ≈0.15 OD600 which also 
occurs by 24 hours.  
In all three tested conditions the ΔmetH mutant grows as per WT. The ΔmetE mutant 
exhibits very little growth until 40 hours at which point a maximum OD of ≈0.15 is 
reached. If supplemented with either vitamin B12 or methionine the growth is 
comparable to WT.  
A double ΔmetE ΔmetH mutant has normal growth with the addition of methionine but 
the addition of vitamin B12 does not allow for growth and very little growth is seen for 
this, and the unsupplemented conditions over 48 hours. There is some growth seen 
which in both cases may be as a result of cell death and methionine turnover.  
When grown with no additional supplements ΔmetR exhibits a similar growth pattern 
to ΔmetE, that is minimal growth seen until 40 hours at which point a maximum OD of 
≈0.15 is reached. Supplementation with either Vitamin B12 or methionine results in a 
restoration of this growth defect.  
The same growth conditions were then carried out but with the additional step of the 
bottles being saturated with N2O pre-inoculation. The addition of N2O to WT 
Salmonella did not result in a growth defect except in the B12 supplemented bottles 
where it further increased the mild growth defect seen. This resulted in a maximum 
growth of 0.07 OD600 by 17 hours which didn’t increase by 48 hours. Without the 
addition of N2O (but with vitamin B12) the WT strain exhibits similar growth until 17 
hours but by 24 hours reaches maximum OD of ≈0.15.  
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For the ΔmetE mutant similar growth is seen to WT with the addition of methionine 
either with or without exogenous N2O (Figure 40Error! Reference source not f
ound.). While in standard anaerobic conditions the addition of vitamin B12 provides a 
partial restoration of the growth defect when exogenous N2O is added this affect is 
greatly reduced and very little growth is seen. In the un-supplemented cultures ΔmetE 
is able to reach an OD comparable to WT growth with methionine by 40 hours. When 
exogenous N2O is added however this phenotype is lost and the strain exhibits almost 
no growth until 48 hours.  
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Figure 40 MetE is important for the survival of Salmonella grown with 
exogenous N2O. Strains were grown anaerobically in nitrate-sufficient, glycerol-
limited M9 minimal media which had been saturated with N2O. Where indicated 
vitamin B12 (0.05 µg/ml) or methionine (30 µg/ml) were added. All strains have 3 
repeats and SE is shown 
 
Time (Hours)  
0
0.05
0.1
0.15
0.2
0.25
0.3
0 5 10 15 20 25 30 35 40 45 50
WT
WT
B12
WT
Meth
WT
WT B
WT
M
0
0.05
0.1
0.15
0.2
0.25
0.3
0 5 10 15 20 25 30 35 40 45 50
met
E
met
E
B12
met
E
Met
h
A
b
s
o
rb
a
n
c
e
 (
O
D
6
0
0
) 
 
WT N2 
WT N2 + B12 
WT N2 + Methionine 
WT N2O 
WT N2O + B12 
WT N2O + Methionine 
 
ΔmetE N2 
ΔmetE N2 + B12 
ΔmetE N2 + Methionine 
ΔmetE N2O 
ΔmetE N2O + B12 
ΔmetE N2O + Methionine 
 
123 
 
5.3.6 Construction of a PocR mutant 
A ΔpocR deletion mutant, alongside a ΔmetE ΔpocR double mutant were created, 
and correct construction was confirmed by PCR (Figure 41).  
 
 
 
  
A 
B 
Figure 41 Confirmation of correct mutant construction of ΔpocR and ΔmetEΔpocR . 
Products were run on 1% (w/v) agarose gel against hyperladder II (Bioline). (A) Verification of 
pocR mutants. Lanes 1-4: WT (860 bp), ΔpocR Cmr (1395 bp), ΔpocR Kanr (1795 bp), 
ΔmetEΔpocR (1795 bp) respectively with pocR_Ex_F and pocR_Ex_R. Lane 5:  WT (no 
product) with pocR_Ex_F and pKD4_R. Lane 6: ΔpocR Cmr (305 bp) with pocR_Ex_F and 
pKD3_R. Lane 7: ΔpocR Kanr (589 bp) with pocR_Ex_F and pKD4_R. Lane 8: ΔmetEΔpocR 
(589 bp with pocR_Ex_F and pKD4_R). (B) Verification of metE mutants. Lanes 1-3: WT 
(3054 bp), ΔmetE (2885 bp), ΔmetEΔpocR (1654 bp) respectively with metE_Ex_F and 
metE_Ex_R. Lane 4-5: WT (no product) and ΔmetE (1683 bp) respectively with metE_Ex_F 
and pKD4_R. Lane 6: ΔmetEΔpocR (370 bp) with metE_Ex_F and pKD3_R. 
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5.3.7 PocR is not required for growth in LB or M9 aerobically  
Both in LB, and M9 supplemented with glucose, ΔpocR exhibits comparable growth to 
WT. In LB, the double mutant ΔmetEΔpocR also grows as WT, but in M9 
supplemented with glucose, ΔmetEΔpocR grows in the same fashion as ΔmetE 
exhibiting no growth over 24 hours (Figure 42).   
 
 
 
Figure 42 PocR is not required for growth in LB or M9 aerobically. Strains were 
grown in 50ml LB (A), or 50ml M9 + glucose (B).  
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5.3.8 PocR is not essential for the regulation of metE  
 
When growing anaerobically under denitrifying conditions ΔmetE struggles to grow but 
eventually reaches a maximum OD equivalent to WT Salmonella. The growth of 
ΔmetE ΔpocR was analysed under these conditions and exhibited a slight restoration 
in the growth defect in comparison to the single ΔmetE strain. That is, the absence of 
PocR mildly restores the growth defect seen for ΔmetE. A single ΔpocR mutant has 
no growth defect under these conditions (Figure 43).    
 
Figure 43  The growth of ΔmetE and ΔmetEΔpocR are comparable when growing 
under denitrifying conditions.  Strains were grown anaerobically in nitrate-sufficient, 
glycerol-limited M9 minimal media. All strains have 3 repeats, and standard error is 
shown. 
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5.3.9 The ΔmetE mutant does not produce the MetE protein 
 
Since a low level of growth is seen for ΔmetEΔmetH under anaerobic conditions, 
without the addition of vitamin B12 or methionine, a western blot was performed using 
an anti-MetE antibody (Mogk et al. 1999, Mordukhova and Pan 2013) to confirm that 
the protein is not being produced (potentially by a secondary copy of the gene). 
Samples were taken from anaerobic cultures at various timepoints and at 48hrs for 
aerobically growing WT. While protein can be seen on the coomassie stain for all 
samples except ΔmetE at 17 hours (when no bacterial growth is seen), MetE is only 
detectable in the WT sample growing aerobically (Figure 44). Thus, we confirm that 
no MetE protein is being produced by the ΔmetE strain or subsequent double mutants.  
 
  
Figure 44 The MetE protein is not produced by ΔmetE or ΔmetEΔpocR during 
anaerobic growth. Gel and blot lanes: 1) WT 17h. 2) ΔmetE 17h. 3) ΔmetE 48h. 4) 
ΔmetEΔpocR 17h. 5) ΔmetEΔpocR 48h. 6) WT 48h aerobic positive control. (A) 
Whole cell lysates were run on 12% (v/v) SDS-PAGE. (B) Presence of MetE 
detected with an anti-MetE rabbit polyclonal antibody. 
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5.3.10 A ΔmetEΔcobS mutant is unable to grow in M9 media in anaerobic 
conditions 
To confirm whether the ΔmetE mutant grows anaerobically due to the eventual 
production of vitamin B12 and thus use of MetH, a further double mutant deficient in 
metE and cobS, the final gene in the cob operon was generated.  
It was found that after 48h, ΔmetEΔcobS grew significantly less than the WT. These 
results suggest that this inability to grow is due to the inability to produce vitamin B12 
(Figure 45).  
 
 
  
Figure 45 The deletion of cobS and metE results in an inability of S. 
Typhimurium to grow. ΔmetEΔcobS growth was significantly lower than the WT. 
Bacteria were grown anaerobically for 48h in M9 minimal medium and OD600 
measured to determine growth. Data plotted as mean values from one experiment 
performed in duplicate and error bars representative of SE. 
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5.3.11 MetE is important for survival of Salmonella in macrophages  
 
In order to assess the importance of MetE for the survival of Salmonella in 
macrophages, a gentamycin protection assay was used. This was carried out both in 
normal DMEM and in DMEM which lacks both methionine and vitamin B12. In normal 
DMEM media there is no difference between the survival of the three strains tested, 
WT, ΔmetE and ΔmetH. However, in the absence of methionine and vitamin B12 the 
ΔmetE mutant is significantly (P > 0.05) attenuated (Figure 46). 
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Figure 46 MetE is required for intracellular survival in murine macrophages in 
the absence of methionine or vitamin B12. Salmonella uptake into IFN-γ activated 
macrophages was conducted for 2 hours and 24 hours before gentamicin treatment 
killed all extracellular bacteria in normal tissue culture media in both the presence 
and absence of methionine. Internalised bacteria were recovered by lysing the 
macrophage and the numbers of bacteria enumerated by viable counts. (a) with 
methionine (b) without methionine/B12. Data shown is an average of three 
experiments. *Denotes significant difference P < 0.05 (independent t-test, n=3). 
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5.4 Discussion 
 
At the beginning of this PhD there was a clear research gap consisting of two 
phenomena in Salmonella. The first being the inexplicable production of high levels of 
toxic nitrous oxide, and the second being the highly metabolically expensive synthesis 
of the seemingly unnecessary compound, vitamin B12. This chapter has made the first 
steps in explaining these two questions by showing a link between them, and in doing 
so highlights a potential novel virulence strategy.  
The synthesis of methionine by Salmonella is essential for growth unless the amino 
acid is exogenously supplemented. Therefore, a MetH deletion mutant is fully reliant 
on MetE for this process and a MetE deletion mutant is reliant on MetH. Since MetH 
requires vitamin B12 to produce a functional holoenzyme, a MetE mutant is therefore 
dependent on the endogenous production of vitamin B12 in order to grow. We can 
conclude that when growth is seen for the MetE mutant strain, or any strains including 
this deletion in combination with additional mutataions, that conditions are present 
whereby Salmonella is able to synthesise vitamin B12 and produce a functioning MetH 
protein.  
The main growth phenotypes of the mutants described in this chapter are summarised 
in (Table 8). The key mutant is ΔmetE, since this strain gives us the most information 
about the requirements for vitamin B12.    
 
5.4.1 Importance of MetE for denitrifying Salmonella 
Growth in M9 minimal media with and without the addition of vitamin B12 and 
methionine was used to assess the survival of Salmonella‘s requirements and 
synthesis of vitamin B12 aerobically.  WT Salmonella, as well as ΔmetH are able to use 
the functional vitamin B12 independent MetE protein in order to synthesise methionine 
and therefore exhibit the same levels of growth in the presence and absence of vitamin 
B12 or methionine.  The ΔmetE mutant is unable to grow in these conditions without 
the addition of B12 or methionine – this confirms that Salmonella is unable to 
aerobically synthesise vitamin B12.   The same phenotype is also seen for ΔmetR, as 
a positive regulator of both MetE and MetH this shows that aerobically 
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Table 8: Summary of growth abilities of Salmonella mutants. A tick (✔) indicated the strain grew as WT, a cross (✖) indicates 
no growth was seen, both (✖/✔) indicates growth lower than that seen for WT.  
 
  
 LB M9 aerobic M9 anaerobic 
   + B12 + Methionine  + B12 + Methionine 
WT ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
ΔmetE ✔ ✖ ✔ ✔ ✖/✔ ✔ ✔ 
ΔmetH ✔ ✔ ✔ ✔ ✔ ✔ ✔ 
ΔmetE 
ΔmetH 
✔ ✖ ✖ ✔ ✖ ✖/✔ ✔ 
ΔmetR ✔ ✖ ✔ ✔ ✖/✔ ✔ ✔ 
ΔpocR ✔ ✔   ✖/✔   
ΔmetE 
ΔpocR 
✔ ✖   ✖/✔   
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Salmonella is reliant on MetR in order to activate either the MetE or MetH protein. This 
phenotype can also be recovered by the addition of vitamin B12, therefore the 
conclusion can be drawn that vitamin B12 itself is able to regulate either the MetE or 
MetH protein (most logically MetH).  When both MetE and MetH are absent, 
Salmonella is only able to grow aerobically on M9 with the addition of methionine.       
Conditions where Salmonella will be required to use nitrate or nitrate for the terminal 
electron acceptor in respiration can occur outside the host but also in the mammalian 
intestine, as part of the host-generated inflammatory response (Lopez et al, 2012). 
Growth of the various mutants was therefore analysed on M9 minimal media 
anaerobically with nitrate present to assess the importance of these genes while 
undergoing denitrification, which can occur when Salmonella is residing in the 
intestine. WT Salmonella grows the same with and without the addition of methionine, 
so while it only is able to reach a maximum OD600 of ≈0.2, this is probably due to the 
minimal media and anaerobic conditions in general and not to do with vitamin B12-
/methionine metabolism. Similarly to aerobic growth on M9, ΔmetH is able to grow like 
WT in all conditions, this confirms that the MetE protein is produced and functional, to 
provide the bacteria with enough methionine for growth. While for the first 24 hours of 
growth ΔmetE shows very little growth, by 40 hours the strain is able to reach an OD 
comparable to WT. Since the ΔmetE strain relies on MetH for its methionine synthesis, 
and MetH is dependent on vitamin B12, in these conditions, for this strain to grow, 
Salmonella needs to be synthesising enough vitamin B12 in order for growth to be 
seen. It therefore is likely to be the case that during the first 24 hours of growth the 
bacteria is slowly attempting to build up a vitamin B12 pool, however since growth is 
also reliant on denitrification there will be a net release of nitrous oxide which will be 
interacting with the vitamin. Therefore, in order for visible growth to be seen for ΔmetE 
a point must be reached where more vitamin B12 is being produced than is being 
targeted by nitrous oxide. 
A similar growth pattern is seen for ΔmetR as for ΔmetE;growth is slow until 40 hours 
when growth can be seen, and the growth defect can be restored by the addition of 
either vitamin B12 or methionine. The ΔmetR mutant has a functional MetH and MetE 
– and while MetH will rely on vitamin B12, MetE should be able to produce methionine 
from the beginning of growth such as occurs for ΔmetH. This phenotype therefore 
133 
 
suggests that the activation of MetE is dependent on either MetR or on vitamin B12, 
since at later time points the vitamin B12 pool should have been established.  
This hypothesis for the phenotype of ΔmetE and ΔmetR is corroborated by the growth 
phenotype of ΔmetE ΔcobS under the same conditions. CobS is one of the final genes 
in the cob operon and is its deletion is known to stop the synthesis of vitamin B12 in 
Salmonella. This strain shows nearly no growth over 48 hours.  
From the previous results it would be expected that a ΔmetE ΔmetH double mutant 
would be unable to grow without the addition of methionine. However, growth, albeit 
very low, is seen for both the unsupplemented culture and that supplemented with 
vitamin B12. There are two potential explanations for this observation, the first being 
that after 24 hours there is a low level of methionine turnover resulting from cell death 
from the initial inoculation. The second possibility is that by 40/48 hours there is 
contamination in the cultures, as described (Page 49), each timepoint requires four 
needles, two one-use needles for liquid sampling, and two multi use needles for gas 
sampling to be inserted through the silicon lid. While precautions were taken such as 
cleaning the outside of the silicon lid with ethanol, and cleaning the reusable Hamilton 
gas syringe between sampling, this is not a totally sterile process. Samples could be 
taken throughout to determine if contamination is present.  
 
5.4.2 Vitamin B12 toxicity  
Vitamin B12 was initially added to aerobic M9 cultures at 100 µg/ml as per (Sullivan et 
al. 2013) where it only had a slight negative effect on the growth of WT Salmonella.  
However, when this same concentration was added to M9 anaerobically, a significant 
growth defect was seen, reducing the OD of the WT to that similar to non-
supplemented Salmonella. A concentration of vitamin B12 was determined where 
ΔmetE and WT Salmonella grew comparably, this was 0.05 µg/ml.   
There is no information in the literature about a toxic effect of vitamin B12 on 
Salmonella, or in fact for any bacteria. In humans no toxicity has been observed for 
vitamin B12 and no safe upper limits have been defined (Flynn et al. 2003, Burgess, 
Smid and van Sinderen 2009). There is a small body of work looking at the toxicity of 
vitamin B12 on mammalian cells due to catalysing the oxidation of sulfhydryl groups in 
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sulfhydryl-dependent cells (Toohey 1975); this however should not have an effect on 
Salmonella in anaerobic conditions, so is unlikely to be the explanation.  
It was however considered that the toxicity could be due to the cobalt contained within 
the compound. However even at levels far exceeding those which result in a toxic 
effect from vitamin B12, no toxicity was seen and hence it is concluded that the toxicity 
seen when Salmonella SL1344 WT is grown in the presence of vitamin B12 is not due 
to cobalt toxicity. 
Another possibility is that vitamin B12 has a regulatory effect on Salmonella. MetE is 
known to be down-regulated by MetJ as well as the MetH-B12 holoenzyme (Wu, 
Urbanowski and Stauffer 1992). Therefore, in conditions with high levels of vitamin B12 
it could be expected that MetE is downregulated. However, this would be reliant on 
the MetH-B12 holoenzyme and so growth should not be affected.  
It should be noted that high levels of vitamin B12 are unlikely to occur in natural 
conditions, since the synthesis of the vitamin is so metabolically expensive it is highly 
improbable that any bacteria, even on lysis, would be releasing the compound in any 
significant concentrations. The recommended daily intake for humans varies for 
different age groups but is ≈2 µg, it can be assumed therefore that concentrations 
would never reach 100 µg/ml in the intestines or anywhere that Salmonella might 
reside. The toxic effect could therefore be simply a result of such an unusually high 
level of a very large molecule. 
The possibly was considered that even though a metE knockout was constructed the 
bacteria was still producing the MetE protein via a potential secondary copy of the 
gene, and this was allowing for the eventual growth of a ΔmetE ΔmetH mutant, or 
indeed the single ΔmetE strain. To confirm this was not the case a western blot was 
carried out using an anti-MetE antibody  
A further interesting observation was made during the Western blot analysis. No MetE 
protein was detected from the WT strain at the 17h time-point, suggesting it is only 
relying on MetH for methionine synthesis. Potentially, the MetE protein is used at later 
stages of growth, when N2O levels have begun to accumulate and inactivate vitamin 
B12. However, this hypothesis highlights a difference in comparison to the anaerobic 
growth curve data and does not explain why the growth of ΔmetE was reduced in 
comparison to the WT at the 17h time-point if both strains are using the same enzyme 
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for synthesis of methionine, not that WT is using MetE as suspected. Potentially, MetE 
may be present in the WT sample but at a lower concentration than the aerobic 
sample. Exposure time may need to be increased during blot visualisation in order to 
detect low levels of the protein. Further investigation should be undertaken in which 
later time-points are sampled to quantify MetE production by the anaerobic WT strain. 
 
5.4.3 Regulation of the cob operon by PocR  
 
A PocR mutant, and subsequent ΔmetEΔpocR strain were constructed to determine 
the importance of this gene for Salmonella, specifically in the regulation of the cob 
operon. Since the cob operon is so large and the synthesis of vitamin B12 so 
metabolically expensive it is logical to assume there is efficient regulation.  
The cob operon is transcribed adjacently to the pdu operon, which encodes genes 
required for the vitamin B12 dependent utilisation of propanediol as an energy source; 
both operons are under the transcriptional control of PocR, encoded by pocR which is 
situated between the two operons (Ailion et al. 1993). Aerobically it is known that 
Crp/cAMP are important for induction of PocR and therefore the two operons, and 
anaerobically ArcA/ArcB are also required. The importance of Crp suggests that 
carbon utilisation is a primarly function of vitamin B12. Additionally it has been shown 
that 1,2-propanediol enhances the binding of PocR and as such increases the 
activation of the cob operon – presumably to provide the vitamin B12 required for the 
utilisation of this energy source (Rondon and Escalante-Semerena 1996). A study has 
also shown that PocR is induced by glycerol – the carbon source used for anaerobic 
growth in this study (Bobik et al. 1992). However there lies a paradox in this co-
regulation. Aerobically Salmonella is unable to produce vitamin B12 (even if the cob 
operon is fully transcribed) and therefore propanediol cannot be utilised. 
Anaerobically, whilst the pdu operon is induced, oxygen is required for the utilisation 
of the carbon source, alternative electron acceptors cannot be used and propanediol 
cannot be fermented. Therefore, while it has been hypothesised in the literature that 
the fact that PocR is the major regulator of the cob operon suggests propanediol 
respiration is the primary use of vitamin B12 in Salmonella, this seems unlikely to be 
the case (Bobik et al. 1992).  
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Another candidate regulator of the cob operon, CsrA (carbon storage regulator A), has 
been proposed. First identified in E. coli, CsrA is classed as a global regulator, and 
until recently in Salmonella was known only to upregulate genes of the pathogenicity 
island SPI-1, necessary for intracellular invasion (Lawhon et al. 2003, Altier, Suyemoto 
and Lawhon 2000). However, Lawhon et al. (2003) identified that genes of the cob 
operon were significantly downregulated in a ΔcsrA mutant in comparison to the WT. 
Furthermore a downregulation of genes located in the eut and pdu operons, both of 
which are dependent on the presence of B12, were also observed, signifying that CsrA 
has multiple roles aside from SPI-1 regulation (Lawhon et al. 2003). 
There are many possibilities for future investigations into the regulation of vitamin B12 
synthesis by Salmonella. Primarily it would be interesting to investigate the anaerobic 
growth of a triple deletion mutant in metE, pocR and csrA. If this mutant was unable 
to grow anaerobically, it would indicate that either pocR or csrA are essential to B12 
synthesis and exhibit functional overlap. However, if growth was still observed, it would 
show that there are other, unknown regulators yet to be identified. 
One study looking at the transcription levels of the cob operon under different 
conditions highlights the 40 fold increase in transcript levels between the anaerobic 
fermentation of glucose and under conditions of anaerobic respiration. It is stated that 
they believe there to be unidentified functions which exist that require B12 under 
conditions of anaerobic respiration but that since cob mutants are able to grow 
normally on glycerol fumarate they believe them to be inessential (Escalante-
Semerena and Roth 1987). In the context of this study it is not surprising that cob 
mutants struggled to grow on glycerol fumarate – and it is more likely that the operon 
is being upregulated in anaerobic conditions for growth of Salmonella on nitrate.  
The results in this study suggest that the absence of PocR partially restores the growth 
phenotype of ΔmetE when growing anaerobically on nitrate. This therefore indicates 
that there is an alternative regulatory mechanism inducing the expression of the cob 
operon for B12 production, enabling Salmonella to continue to use MetH to produce 
methionine.  
One potential explanation for this phenotype is that there are multiple regulators 
inducing expression of the cob operon in the absence of PocR, resulting in a greater 
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level of transcription of cob genes. This would account for the increased growth rate 
of ΔmetEΔpocR compared to ΔmetE. 
Figure 47 outlines a possible model to explain the results observed in this study. The 
binding of PocR to its recognition site potentially could block the binding sites of other, 
currently unknown transcription factors of the cob operon. Whereas, in the absence of 
PocR these sites would be available. 
 
 
 
 
 
 
 
 
 
 
 
Figure 47 Working model – regulation of the cob operon (A) Proposed model for 
induction of the cob operon by PocR. When transcribed, PocR binds to its binding 
site (dark purple box) and induces cob expression. Access to other transcription factor 
binding sites (grey boxes) is blocked by the presence of PocR. (B) The proposed 
mechanism for the positive regulation of the cob operon in the absence of PocR. 
Binding sites for other transcription factors are accessible and interaction may induce 
expression of the cob operon. 
  
A 
B 
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5.4.4 The pathogenic effect of the production of nitrous oxide by Salmonella in 
the intestine 
 
Based on the results presented in this chapter the hypothesis was drawn that there is 
a distinct link between the two phenomena highlighted in the introduction to this 
chapter – the production and release of large quantities of nitrous oxide and the 
synthesis of the metabolically expensive vitamin B12.  
This study has shown that Salmonella is afforded a growth benefit by MetE when 
growing anaerobically on nitrate, that is, that the absence of this gene results in a 
distinct growth defect.  
Nitrate is present in the human intestine from two primary routes, the first being dietry 
products and the second endogenous synthesis. Different diets result in differing 
amounts of nitrate in the gut, with highest concentrations coming from nitrate-rich 
vegetables, particularly leafy greens (Lidder and Webb 2013). Vegetarians therefore 
on average have higher daily intakes of nitrate, at ∼4.3 mM nitrate/day compared to 
∼1.2 mM nitrate for a standard western diet, the Acceptable Daily Intake has been set 
at 5 mM nitrate/day since 1962 (Katan 2009).  
While most early studies looking at nitrate in the gastrointestinal tract are focused on 
this from a human cell perspective, specifically in relation to cancer, these studies give 
some insights into the nitrate environment of the gut.  
A study looking at the nitrate and nitrite concentrations in human fecal and ileostomy 
(a method of sampling directly from the end of the small intestine) samples concluded 
that the lower gastrointestinal tract favours denitrification over nitritrication. Fecal 
nitrate levels ranged from 0 to 14 µmol/kg (0 to 0.9 ppm) and ileostomy samples from 
0 to 7 µmol/kg (0 to 0.4 ppm). Experiments were also carried out that showed that the 
addition of 500 µmol/kg nitrate to a fecal sample resulted in this nitrate being reduced 
10 fold within 15 minutes and fully depleted within 2 hours; thus there must be high 
levels of denitryfing microorganisms present in faeces and additionally suggesting the 
high turnover of nitrate in the gut may result in false underreporting of nitrate 
concentrations from sampling (Saul et al. 1981).  
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It has been known that there is endogenous production of nitrate in the human 
intestine since at least 1978 (Tannenbaum et al. 1978) but more modern studies have 
looked at this from the perspective of gut bacteria.  
Pathogenic bacteria, including Salmonella, can induce an inflammatory response in 
the intestine. Whilst this was traditionally thought to be detrimental to the pathogen, 
since it is part of the host inflammatory response, more recently this has be shown to 
in fact be beneficial to pathogens, and that triggering the host immune’s defence can 
disrupt the gut environment beneficially for pathogenic bacteria (Stecher et al. 2007).  
This can result in the release of nitrate into the gut lumen, and additionally in the 
decrease in the representation of obligate anaerobes and an increase in facultative 
anaerobic members of the Enterobacteriaceae family (Winter et al. 2013, Lupp et al. 
2007). In fact, it has been shown that in order to outcompete the microbiota and cause 
an infection, Salmonella is reliant on its ability to trigger inflammation. The T3SS-1 
effector protein, SopE, enhances intestinal inflammation during Salmonella infection, 
via the activation of caspase 1 and the subsequent cleavage of interleukins into active 
cytokines (Hoffmann et al. 2010, Lopez et al. 2012). These cytokines, IL-1β and IL-18 
contribute to the production of IFN-γ which stimulates iNOS to produce NO. Nitric 
oxide can then react with ROS and produce peroxynitrite, ONOO-, which isomerises to 
nitrate, NO3 (Szabó, Ischiropoulos and Radi 2007). This means that SopE-dependent 
iNOS expression generates host-derived nitrate and this nitrate has been shown to 
increase the growth of Salmonella (Lopez et al. 2012). Interestingly, nitrate is shown 
to be a negative regulator of tetrathionate respiration. Potentially this shows that nitrate 
respiration is preferred to tetrathionate respiration in the intestine (Lopez et al. 2012).   
Similarly to the pathogen mediated host release production of nitrate, Salmonella also 
triggers the host to produce tetrathionate, which can then be used as an alternative 
electron acceptor (Hensel et al. 1999). This occurs via the reaction of ROS generated 
by inflammation with endogenous luminal thiosulfate. Indeed, data shows that the 
ability to respire tetrathionate provides Salmonella a distinct advantage when growing 
in the inflamed gut (Winter et al. 2010, Winter and Bäumler 2011). This therefore is a 
secondary example of Salmonella exploiting the host immune response to provide an 
altered ecological niche beneficial for its growth. Most interestingly however is the 
carbon sources which are required to allow for tetrathionate respiration, either 
ethanolamine or propanediol, both of which require vitamin B12. It is noted by the 
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authors that tetrathionate respiration using ethanolamine or propanediol are the only 
conditions they know under which wild-type Salmonella requires B12 for growth (Price-
Carter et al. 2001).  
Stecher et al., propose a working model for the three-way microbiota-pathogen-host 
interaction during murine Salmonella colitis, which suggests that Salmonella infection 
involves both triggering inflammation and secondarily surviving and thriving from the 
change in the ecological niche.  
 The results of this chapter contribute additional knowledge to this story, by showing 
that not only does the ability to respire on nitrate mean that Salmonella can survive 
within the inflamed intestine but that in doing so will release toxic nitrous oxide to 
further target the microbiota and potentially the host itself.  
The importance of the gut microbiota is becoming ever more diverse, but one of the 
well known functions of these bacteria is in colonisation resistance, via the barrier 
effect. This happens in three main ways, the first being the commensal bacteria 
providing a physical barrier to the pathogen, which aim to target attachment and 
subsequent invasion into epithelial cells, the second involves a symbiotic relationship 
with the host to control nutrient availability and the third in activity producing 
antimicrobial compounds (Guarner and Malagelada 2003, Buffie and Pamer 2013). 
It is therefore of interest to consider the impact of nitrous oxide on the commensals. 
The four dominant phyla in the human gut are Firmicutes, Bacteroidetes, 
Actinobacteria, and Proteobacteria, while each individual’s gut microbiota is different 
there are some species which are common to most. These include, Bacteroides 
fragilis, Bacteroides melaninogenicus, Bacteroides oralis, Bifidobacterium bifidum 
Enterococcus faecalis, Escherichia coli, Enterobacter sp., Klebsiella sp. and 
Lactobacillus. There are three processes to assess here, the vitamin B12 independent 
synthesis of methionine, demonstrated by the presence of MetE, the ability to 
synthesise vitamin B12 de novo and the ability to reduce nitrous oxide to N2 via the 
enzyme NosZ (Table 9). Of all the commensal bacteria analysed, none have the ability 
to reduce N2O – and therefore the presence of this gas in high volumes in the intestine 
will impact on the vitamin B12 pool and any vitamin B12 they are able to synthesise. 
Only one species however, Lactobacillus, is able to synthesise vitamin B12 de novo 
and we can therefore conclude all other rely on vitamin B12 uptake from the 
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environment – of course as the vitamin B12 pool is depleted this will become a limited 
resource. Lastly, the presence of the vitamin B12 independent methionine synthase 
was determined, any bacteria lacking this strain will rely on the vitamin B12 dependent 
MetH in order to synthesise methionine, only some members of the Klebsiella species 
and some strains of Escherichia coli have metE.  
 
Table 9 Presence of metE, nosZ and ability to synthesise B12 of eight common 
commensal bacteria and human epithelial cells  
 metE B12 synthesis nosZ 
Bacteroides fragilis ✖ ✖ ✖ 
Bacteroides melaninogenicus ✖ ✖ ✖ 
Bacteroides oralis ✖ ✖ ✖ 
Bifidobacterium bifidum ✖ ✖ ✖ 
Enterococcus faecalis ✖ ✖ ✖ 
Escherichia coli ✔ ✖ ✖ 
Klebsiella sp ✔ ✖ ✖ 
Lactobacillus sp ✖ ✔ ✖ 
Human epithelial cells  ✖ ✖ ✖ 
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Therefore, the overriding model drawn from this data is that when residing in the 
intestine Salmonella triggers the release of nitrate into the gut lumen and uses this for 
denitrification. This then results in previously inexplicably high levels of nitrous oxide. 
The nitrous oxide released will target the vitamin B12 pool and as such the commensals 
which rely on this cofactor for multiple processes, including methionine synthesis, will 
not be able to survive. Additionally, Salmonella may be able to ‘anaesthetise’ the host 
epithelium as similarly to the majority of commensal bacteria these cells are reliant on 
vitamin B12 and lack the ability to produce it. The working model produced by Stecher 
et al., has been adapted to include this hypothesis (Figure 48) (Stecher et al. 2007).  
 
The ability of Salmonella to survival and reproduce inside macrophages is of key 
importance to its pathogenesis in causing systemic infections. The importance of MetE 
in macrophage survival was shown when media was lacking in methionine. This 
therefore suggests that methionine is not present in macrophages, but additionally that 
nitric oxide, which is produced by macrophages, is also involved in the targeting of the 
vitamin B12 pool. As discussed at more length in Chapter 3, genes which are important 
for intracellular survival of Salmonella inside macrophages have the potential to be 
further studied in relation to making a new vaccine strain.  
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Figure 48 Working model A) Working model adapted from (Stecher et al. 2007) showing 
the three way interactions between the host, microbiota and Salmonella in normal 
conditions and in enterocolitis. B) Altered model of Salmonella enterocolitis with the 
addition of N2O release by Salmonella targeting the vitamin B12 pool and thus the inhibition 
of the microbiota by the pathogen.  
A 
B 
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5.4.5 Future work 
 
Further work should now be done to show the importance of this system in competition 
with the gut microbiota and in the survival and pathogenesis of Salmonella in vivo. 
Initially simple cultured competition experiments could be conducted, mimicking the 
previous experiments under denitrifying conditions, but with the addition of one or 
multiple commensal bacteria. To create a more realistic environment, a microfluidic 
gut model could be used. Microfluidic model organs are increasingly being used for 
many different functions as they enable a much higher level of control over conditions 
than in animal models (Esch, Bahinski and Huh 2015, Bhatia and Ingber 2014, Huh, 
Hamilton and Ingber 2011). While new in the gut microbiota field there are a number 
of systems being used, these allow a defined ‘microbiota’ to be stabilised before the 
addition of the pathogen (Shah et al. 2016, Kim and Ingber 2013, Kim et al. 2016b). 
Various mammalian cells can also be cultured in the system and so one could quantify 
the ability of Salmonella to cross over the epithelium, and potentially invade 
macrophages.  
If these experiments, potentially in combination with mouse model studies, confirm the 
importance of nitrous oxide production, vitamin B12 synthesis and the ability to produce 
methionine independently of vitamin B12 for Salmonella in outcoming the gut 
commensals, this is an exciting new window of research.  
The most logical reaction would be to either attempt to reduce the nitrous oxide 
produced by Salmonella, or reduce its detrimental effects on the gut commensals. This 
could be done by introducing bacteria capable of complete denitrification to the gut. 
Another option would be in the creation of ‘Smart’ probiotics, that is, genetically 
modified probiotic bacteria. If our hypothesis is correct, Salmonella is able to exploit 
the fact that the common gut microbiota are both unable to reduce nitrous oxide and 
unable to synthesise essential methionine in its presence. Therefore, if these bacteria 
were altered to either produce NosZ to reduce N2O or MetE, to enable them to 
synthesise methionine independently of vitamin B12 this might lose Salmonella one of 
its pieces of pathogenic machinery.  
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6 A correlation between nitrous oxide emissions and vitamin 
B12 synthesis in Salmonella serovars 
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6.1 Introduction 
 
Different Salmonella serovars are distinguished by the somatic (O), flagellar (H) and 
capsular (Vi) antigens on the outer membrane (Shi et al. 2015). As introduced 
previously (Page 18) different serovars infect different hosts and cause different 
disease types, so naturally, in order to do so, there are differences in the genes they 
have retained and in their nutritional requirements. One difference we have noticed is 
the lack of conservation in the cob operon between different serovars, resulting in 
differences in their ability to synthesise vitamin B12. As described in the introduction 
(Page 38), the synthesis of vitamin B12 is split into three sections. Mutations, or loss of 
function, can therefore occur in different parts of the operon resulting in different 
effects, for example, a strain lacking a complete Part I can synthesise cobalamin if 
provided with cobinamide and Part II of the cob operon is still able to synthesise 
vitamin B12 if supplied with dimethylbenzimidazole (DMB) (Roth et al. 1993). 
  
6.1.1 Salmonella Typhimurium SL1344/474  
S. enterica serovar Typhimurium strains are split into sequence types (STs), both 4/74 
and SL1344 belong to ST19 (Kingsley et al. 2009).  Salmonella Typhimurium 4/74 was 
orginally isolated from a calf exhibiting salmonellosis, and is the parent strain of 
Salmonella Typhimurium SL1344 which is the WT strain which is used throughout this 
thesis (Jones, Collins and Aitken 1988, Rankin and Taylor 1966, Hoiseth and Stocker 
1981).  S. enterica serovar Typhimurium strains are the most commonly used strain 
for Typhoid fever research due to the fact that while it causes a gasteroenteric infection 
in humans it causes typhoid like symptoms in mice.  
 
6.1.2 Salmonella Enteriditis  
S. Enteritidis is responsible for approximately 14% of all Salmonella gasteroenteritis 
infections in the United States and is thought to be either the first or second most 
common Salmonella serovar in most countries (Braden 2006). Infection from 
Salmonella Enteritidis is highly associated with contamination from eggs, or more 
specifically, the eggshell.  
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6.1.3 Salmonella Dublin 
S. Dublin is most commonly associated with infection in cattle but can also less 
commonly infect pigs and also humans. In cattle it causes an enteric fever and also 
commonly induces abortion (Coburn et al. 2007). Cattle frequently enter a chronic 
carrier stage, equivalent to that seen in humans post infection with S. Typhi, whereby 
they can shed the bacteria in large numbers and spread the infection quickly within a 
herd. The bacteria can also be passed through the milk and hence to calves or, if from 
dairy farms, to humans (Nielsen et al. 2004).  
 
6.1.4 Salmonella Choleraesuis 
S. Choleraesuis is a host adapted serovar which causes a systemic infection in swine. 
As well as the loss of life this disease causes, there is a large economic burden to the 
meat industry. In 1958 Choleraesuis was responsible for 90% of isolated causes of 
Salmonella in pigs, however by 1997 this had dropped to a single isolated case in the 
UK (Sojka et al. 1977). 
 
6.1.5 Salmonella Gallinarum and Pullorum 
Salmonella Gallinarum and Pullorum were originally thought to be two separate 
serovars but now are regarded as two biovars of the same serovar – that is they are 
indistinguishable by standard serotyping. However, they differ physiologically and 
biochemically (Barrow and Freitas Neto 2011).   
S.  Gallinarum causes typhoid in fowl, and can also rarely causes an infection in mice 
and humans. The disease is acute or chronic septicemia which generally affects adult 
birds. Interestingly the eradication of S. Gallinarum allowed for the increase of S. 
Enteritidis, and subsequent increase in human infections, as this strain could then fill 
the vacated ecological niche (Rabsch et al. 2000).  
S. Pullorum is the causative agent of pullorum disease and contrary to Gallinarum 
causes a systemic disease more commonly seen in young birds.  
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6.1.6 Citrobacter rodentium  
In addition to studying a number of Salmonella serovars we also look at Citrobacter 
rodentium. Since the Salmonella sytemic serovars Typhi and Paratyphi are Hazard 
Group 3 human pathogens these were inpractical for use in this study. Citrobacter 
rodentium provided us with a safe model of another systemic strain, as it a model for 
the emerging pathogen enterohemorrhagic Escherichia coli (EHEC) (Mundy et al. 
2005). It is worth noting that previous work in the Rowley lab (Figure 3) has shown a 
signifciant difference between the amount of N2O released by Salmonella and a K12 
E. coli strain, what is not clear from that work is whether the reduced N2O release from 
E. coli is indicative of the entire species or due to the fact that this is a commensal 
strain. This strain releases a toxin similar to the Shiga toxin produced by Shigella 
dysenteriae (O'Brien and LaVeck 1983).  EHEC causes severe and bloody diarrhoea, 
haemorrhagic colitis (HC) and, haemorrhagic uraemic syndrome (HUS); the latter of 
which causes acute renal failure,thrombocytopenia, and microangiopathic haemolytic 
anaemia. The mortality from HUS is quite high at up to 17%, with a further 30% 
suffering from permanaent disabilites (Carter et al. 1987, Griffin and Tauxe 1991, 
Messens et al. 2015, Karmali 1989, Karmali, Gannon and Sargeant 2010, Welinder-
Olsson and Kaijser 2005).  
 
6.1.7 Differences in vitamin B12 synthesis between Salmonella serovars  
S. Gallinarum and S. Pullorum are two host-restricted strains which cause a systemic 
infection in fowl. It has been noted that both serovars have developed pseudogenes 
which result in the loss of ability to synthesise Vitamin B12, and hence this is a potential 
marker of a switch from an enteric to a systemic disease (Langridge et al. 2015). One 
of the functions vitamin B12 plays in Salmonella is in the degradation of 1,2-
propandediol required for the use of tetrathionate as an electron acceptor. It is known 
that the ability to reduce tetrathionate was lost pre-divergence and the loss of B12 
synthetic ability was lost at a later point (Langridge et al. 2015). We therefore believe 
it may be the case that systemic strains have lost the ability to synthesise vitamin B12 
due to the fact that they have moved out of the intestine where vitamin B12 dependent 
tetrathionate respiration is of benefit (Nuccio and Bäumler 2014). This chapter aims to 
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build on this hypothesis and combine it with the possibility that the levels of N2O 
produced by these strains may vary, due to its toxic effects on vitamin B12 (Page 36).  
The vitamin B12 transporter, BtuB is present in EHEC and is a known virulence factor 
in this strain, highlighting an importance of acquisition of vitamin B12 from the external 
environment (Hochhut, Dobrindt and Hacker 2005), and there is evidence that EHEC 
cannot synthesise B12 de novo (Cordonnier et al. 2016). Vitamin B12 is important 
however for the induction of EutR which contributes to metabolism and virulence in 
EHEC (Luzader et al. 2013).  
Nuccio and Bäumler’s analysis revealed mutations in genes required for ethanolamine 
degradation, propanediol utilisation and vitamin B12 synthesis and regulation, in the 
systemic-disease causing strains: S. Choleraesuis, S. Gallinarum, S. Paratyphi A & C 
and S. Typhi, whereas the strains which cause an enteric infection, S. Agona, S. 
Enteritidis, S. Heideberg, S. Newport and S. Typhimurium, did not have mutations in 
these locations (Nuccio and Bäumler 2014). In this chapter we aim to measure the 
differing levels of vitamin B12 produced by different Salmonella serovars.  
In Chapter 5 it was highlighted that since nitrate is present in the inflammed intestine, 
Salmonella will be able to use this to respire and in turn release high levels of nitrous 
oxide. As previously discussed it has been noted that Salmonella Typhimurium 
produces an order of magnitude more nitrous oxide then the close relative E. coli. We 
hypothesise that Salmonella produces this high level of nitrous oxide in order to 
compete with other gut bacteria by targetting the vitamin B12 pool. The question is 
therefore raised whether Salmonella serovars which cause systemic infections and 
therefore do not remain in the microxic environment of the inflammed intestine where 
nitrate is available, will produce similar levels of nitrous oxide.  
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6.1.8 Measurement of vitamin B12  
The most common reason for wanting to quantify the level of B12 in a sample is for 
medical purposes from a human blood. Here, two different measurements can be 
taken, total cobalamin in the blood, or cobalamin bound to the transport protein 
transcobalamin (termed holoTC). HoloTC is also referred to as active vitamin B12 as it 
is only in this form that it can be taken up by the human cells for use (Nexo and 
Hoffmann-Lücke 2011). The former is more common however the latter is more likely 
to give relevant information for medical purposes such as the diagnosis of Vitamin B12 
deficiency (Nexo et al. 2002, Refsum et al. 2006).  
High throughput medical labs use immunoassay based techniques for the 
quantitfication of Vitamin B12, there are several commercially available kits. Examples 
include an electrochemiluminiscence immunoassay (ECLIA) measured on a Roche 
Elecsys 2010 (Roche Diagnostics, Basel, Switzerland), Vitamin B12 AccuBind ELISA 
Kits (Monobind, California, USA), Vitamin B12 ELISA (Eagle Biosciences, New 
Hampshire, USA). These assays are based on the instrinsic factor, which is the 
enzyme important for uptake of Vitamin B12 in humans. The main drawback of these 
assays for use in this study is price, with most costing many hundreds of pounds; it is 
also unclear whether these assays would be suitable for measuring the endogenously 
produced vitamin B12 by Salmonella; that is there is no mention of this in the literature.  
Microbiological assays have also been used to measure vitamin B12. One study used 
the protozoan Ochromonas mahamensis which requires B12 for growth and responds 
linearly to the vitamin B12 (FORD 1953). Mutant strains of E. coli  have also been used 
(BURKHOLDER 1951). In general, these microbiological assays are not as accurate 
and take longer than immunoassays.  
The measurement of vitamin B12 levels from bacterial cultures has not previously been 
performed in our lab group. This chapter includes the optimisation of a vitamin B12  
quantification assay for measurements of vitamin B12 synthesised by Salmonella, 
based on a previously published protocol (Lawrence and Roth 1996). This assay is a 
disc diffusion assay based on the B12 dependency of a Salmonella metE mutant.  
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6.2 Aims 
Building on the results from Chapter 5 this chapter aims to uncover if the hypothesis 
that Salmonella produces high levels of N2O and vitamin B12 in order to outcompete 
the gut microbiota therefore means that systemic strains will not produce these 
compounds to the same extent. Specifically we will: 
• Bioinformatically analyse the cob operon across multiple Salmonella serovars. 
• Measure the levels of vitamin B12 and N2O produced by a range of Salmonella 
serovars.  
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6.3 Results:  
6.3.1 Systemic Salmonella serovars have mutations in the cob operon  
An alignment of the cob operon between the 8 Salmonella strains studied in this 
chapter and also two further systemic strains, Salmonella Paratyphi A and Salmonella 
Typhi, was constructed to visualise differences between the operon in these strains 
(Figure 49). The percentage identities of each gene in comparison to SL1344 are 
shown in Table 10.  In addition to the core cob operon (cbiA – cobT), two upstream 
genes, pocR and pduF, and one downstream, erfK, were included in the alignment.  
RNA-seq analysis of the cob operon has revealed that a single transcript runs from 
the beginning of the operon and finishes after the erfK gene (Jay Hinton, personal 
communication), it is for this reason erfK was included in the alignment. In contrast, in 
E. coli it is most likely the transcript is halted before erfK  (Lawrence and Roth 1995). 
There is very little in the literature about ErfK, except for the possible involvement of 
the protein in protection against bile (Hernández et al. 2012). The gene product of 
PocR is a positive transcriptional regulator of the cob operon, although is not essential 
for its transcription. PocR also regulates the pdu operon, responsible for vitamin B12 
dependent propanediol utilisation (Rondon and Escalante-Semerena 1992, Bobik et 
al. 1999, Chen et al. 1995a, Escalante-Semerena and Roth 1987). 
The entire cob operon was present in all the enteric strains, S. Typhimurium SL1344, 
S. Typhimurium 4/74, S. Dublin and, S. Enteritidis, with 98% or higher consensus for 
all genes. A complete cob operon is also present in the systemic swine strain, S. 
Choleraesuis, with 97% or higher consensus for all genes. The closely related strains 
S. Gallinarum and Pullorum both contain missing genes, the regulator pocR is absent 
in Gallinarum, and the first gene of the operon cbiA is absent in Pullorum. The two 
strains which cause systemic infections in humans, S. Typhi and Paratyphi both have 
numerous mutated genes; in S. Typhi cbiB and cbiK, and in S. Paratyphi cbiA and 
pduF (Figure 49, Table 10). In all the cases of ‘missing’ or ‘mutated’ genes there are 
a large number of stop codons inserted into the DNA sequence, which has resulted in 
the gene being visible in some cases on the alignment (Figure 49), such as in the case 
of S. Typhi. However, it is very clear from viewing the DNA sequence that a functional 
mRNA would not be transcribed and therefore no protein would be produced.  
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Table 10 Genetic consensus of the cob operon across Salmonella serovars Percentage identities (DNA) are 
shown. Genes with 0% identity are highlighted. Constructed via MultiGeneBlast. 
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erfK  100 100 100 100 99 99 99 99 99 
cobT  100 100 100 100 99 99 98 98 98 
cobS  100 100 100 100 99 99 97 97 98 
cobU  100 100 99 99 100 99 99 99 99 
cbiP  100 100 98 98 99 98 99 99 99 
cbiO  100 100 98 98 98 98 98 98 98 
cboQ  100 100 98 98 98 98 99 99 99 
cbiN  100 100 100 100 98 98 98 98 98 
cbiM  100 100 100 100 99 100 100 100 92 
cbiL  100 100 98 98 97 98 99 99 99 
cbiK  100 100 99 98 100 98 98 98 0 
cbiJ  100 100 99 99 98 99 98 98 92 
cbiH  100 100 98 98 99 98 99 99 99 
cbiG  100 100 99 98 99 98 99 99 99 
cbiF  100 100 99 99 99 99 99 99 100 
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cbiT  100 100 100 100 100 99 100 100 99 
cbiE  100 100 98 98 98 97 100 100 100 
cbiD  100 99 99 99 99 99 98 98 98 
cbiC  100 100 100 100 99 99 98 98 98 
cibB  100 100 98 99 98 98 97 97 0 
cbiA  100 100 99 98 98 98 0 0 99 
pocR  100 100 100 100 99 0 99 99 99 
pduF  100 100 100 100 100 99 99 0 99 
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6.3.2 Development and optimisation of a Vitamin B12 quantification assay  
 
As discussed in the Introduction to this chapter, the measurement of levels of vitamin 
B12 produced by bacteria has not been done previously in our lab, and while there are 
commercially available kits these come at a high cost. We therefore worked to develop 
the protocol for a microbiological assay for B12 measurement which would be able to 
measure the B12 produced by Salmonella, based on a previously published protocol 
(Lawrence and Roth 1996). The assay is based on the vitamin B12 dependency of a 
Salmonella Typhimurium SL1344 metE mutant. This strain is spread on a minimal 
media plate which lacks vitamin B12 and a sample from the test strain placed on a filter 
disc. The growth of the metE strain can then be measured which correlates with the 
amount of vitamin B12 in the sample. The growth diameter of a range of standard 
vitamin B12 concentrations (A) and the resulting standard curve (B) are shown in Figure 
50.  
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Figure 50 Vitamin B12 bioassay. A SL1344 ΔmetE mutant was spread on an M9 
minimal media plate. A disc is placed in the middle with a specific concentration 
of vitamin B12 and the resulting growth measured. Diameter of growth is shown 
in (A) and (B) for the construction of a calibration curve, error bars show SE.  
Vitamin B12 concentration (µg/ml) 
Vitamin B12 concentration (µg/ml) 
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6.3.4 Levels of Vitamin B12 produced by Salmonella serovars and Citrobacter 
rodentium 
 
In order to comparatively measure the amount of vitamin B12 produced by the various 
strains, growth conditions had to be used under which all strains grew equally. There 
was no external methionine or vitamin B12 and, components for the synthesis of 
vitamin B12 were not limited (cobalt, 1,2-propanediol). M9 minimal medium was used, 
supplemented with an amino acid mix containing all 19 amino acids except 
methionine.  
Under these conditions all strains grew comparably, that is there was no lag for any of 
the serovars which had been seen previously for S. Pullorum and S. Gallinarum in the 
absence of additional amino acids. All strains reached maximum OD by 24 hours so 
the assay was conducted at this timepoint.  
While this assay cannot give a clear or accurate measure of the exact amount or rate 
of synthesis of vitamin B12 by each strain it is possible to compare relative levels 
between the strains and to calculate the concentration of vitamin B12 in the 10 μl 
sample using the calibration curve constructed (Figure 50). 
The two S. Typhimurium strains, SL1344 and 4/74 produced the highest levels of B12, 
at 0.1 µg/ml and 0.14 µg/ml respectively. This was then followed by the four further 
‘enteric’ strains, S. Dublin (0.070 µg/ml), S. Enteritidis (0.045 µg/ml) and S. 
Choleraesuis (0.025 µg/ml). Of the two ‘systemic’ strains, only S. Gallinarum showed 
any level of B12 production (0.013 µg/ml), no production was seen for S. Pullorum. 
Cirtrobacter rodentium produced the lowest measured level of B12 (0.011 µg/ml).  
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Figure 51 Vitamin B12 bioassay. A SL1344 ΔmetE mutant was spread on an M9 minimal media plate. 
A disc is placed in the middle with a sample of lysed cells from the relevant strain. Protocol described 
in detail in Materials and Methods (Page 54). The diameter of the growth is shown in (A), and the 
concentration of the 10µl spot in (B), calculated using the calibration curve (Figure 50B). Data is 
representative of 3 repeats and SE is shown. 
A 
B 
S
. 
T
y
p
h
im
u
ri
u
m
 
S
L
1
3
4
4
 
 
S
. 
T
y
p
h
im
u
ri
u
m
 4
/7
4
  
S
. 
E
n
te
ri
ti
d
is
  
S
. 
D
u
b
lin
  
S
. 
G
a
lli
n
a
ru
m
  
S
. 
P
u
llo
ru
m
  
S
. 
C
h
o
le
ra
e
s
u
is
  
C
. 
ro
d
e
n
ti
u
m
    
S
. 
T
y
p
h
im
u
ri
u
m
 
S
L
1
3
4
4
 
 
S
. 
T
y
p
h
im
u
ri
u
m
 4
/7
4
  
S
. 
E
n
te
ri
ti
d
is
  
S
. 
D
u
b
lin
  
S
. 
G
a
lli
n
a
ru
m
  
S
. 
P
u
llo
ru
m
  
S
. 
C
h
o
le
ra
e
s
u
is
  
C
. 
ro
d
e
n
ti
u
m
    
160 
 
6.3.5 Comparison of NO and N2O released by different Salmonella 
serovars during anaerobic nitrate growth  
 
Salmonella serovars and Citrobacter rodentium were grown under denitrifying 
conditions to compare the levels of NO and N2O released by each strain. Strains were 
grown in M9 minimal media supplemented with casamino acids to ensure comparable 
growth of all strains irrespective of amino acid requirements, 20 mM nitrate and 10 
mM glycerol. We attempted to conduct this experiment without the addition of 
casamino acids to be more in line with other experiments conducted throughout this 
thesis however the growth rate of the different serovars was highly variable and 
therefore any attempt to draw comparisons would have been futile. With the addition 
of casamino acids growth was comparable between all strains (Figure 52).   
Nitric oxide and nitrous oxide measurements were taken at 17, 24, 40 and 48 hours of 
growth, concentrations for each timepoint are shown as well as total NO/N2O for the 
entire 48 hours (Figure 53 & Figure 54).  
In general, a similar pattern is seen for the differences in NO and N2O released by 
each strain, that is, the strains that release the most/least NO also release the 
most/least N2O (Figure 53 & Figure 54). Additionally, all strains release greater levels 
of N2O than NO, with an average difference of 7.7 fold. This pattern does not always 
hold true however; the WT strain used throughout this thesis, S. Typhimurium SL1344, 
produced the second highest level of N2O but the least amount of NO, a 13 fold 
difference between the two gases. This suggests that there is, in comparison to the 
other strains, a higher rate of conversion of NO to N2O. Surprisingly however, the 
opposite is seen for the parent strain S. Typhimurium 4/74 with the lowest levels of 
N2O but the second highest level of NO, a 3.7 fold difference (Figure 53 & Figure 54). 
Salmonella Pullorum exhibited the highest levels of both NO and N2O release, totaling 
108.7 µM and 1.0 mM respectively. The closely related strain, Salmonella Gallinarum 
which also causes systemic fowl infections, showed much lower levels, 67.3 µM NO 
and 0.47 mM N2O. Citrobacter rodentium released NO and N2O levels higher than all 
but 2 of the Salmonella serovars, 83.2 µM and 0.67 mM respectively  (Figure 53 & 
Figure 54).  
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Figure 52 All tested Salmonella serovars and Citrobacter rodentium grow comparably. 
Strains were grown in nitrate-sufficient, glycerol-limited M9 minimal media supplemented with 
casamino acids. 3 repeats were used and SE is shown.  
S. Typhimurium SL1344 
 
S. Dublin 
 
S. Enteritidis 
 
S. Pullorum 
 
S. Gallinarum 
 
S. Typhimurium 4/74 
  
S. Choleraesuis 
 
C. rodentium 
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6.4 Discussion 
 
This chapter asked the whether there is a link between vitamin B12 production and the 
level of nitrous oxide released between different strains. This was partially based on 
the hypothesis raised in Chapter 5 that Salmonella produces this high level of nitrous 
oxide in order to compete with other gut bacteria by targetting the vitamin B12 pool. 
The potential is therefore raised whether systemic pathogens, including some 
Salmonella serovars which do not remain in the microxic environment of the inflammed 
intestine where nitrate is available, will produce similar levels of nitrous oxide to those 
that do not, and whether this is linked to their ability to produce vitamin B12.  
The vitamin B12 sythesis ability of different Salmonella serovars was discussed in the 
introduction of this chapter and built upon in the results. An alignment of the cob 
operon (Figure 49, Table 10) confirmed that pseudogenes have formed and genes 
been lost in 4 of the 5 systemic strains analysed, Salmonella Gallinarum, Pullorum, 
Typhi and Paratyphi, but not in Salmonella Choleraesuis. There are however a large 
number of mutations in the B12-dependent systems required for propanediol utilisation 
and ethanolamine degradation in S. Choleraesuis (Nuccio and Bäumler 2014). It was 
interesting that especially in Salmonella Typhi the genes were not completely missing 
but instead have aquired large numbers of stop codons throughout the DNA sequence. 
All the mutated systemic strains had a mutation in either cbiA or cbiB, the first two 
genes of the operon, or in pocR, the positive regulator of the operon. A mutation at the 
beginning of the cob operon would result in the synthesis of the vitamin being halted 
in the very early stages, this would therefore stop the metabolically expensive process 
before it progressed very far. A further mutation further down the operon would have 
very little phenotypic effect at that point as the proteins work sequentially in respect to 
the order of genes in the operon.   
The mutation of pocR in Salmonella Pullorum is interesting, this strain contained a 
complete cob operon except for this, and was not analysed in the Nuccio study. While 
it is known that pocR is a positive regulator of the cob operon it is not clear from the 
literature whether the translation of the operon is dependent on pocR or not (Rondon 
and Escalante-Semerena 1992, Chen et al. 1995a). This study assessed the 
importance of PocR for the synthesis of vitamin B12 in S. Typhimurium SL1344 and 
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concluded since the vitamin B12 addicted mutant ΔmetE when combined with a ΔpocR 
mutation was still able to grow in anaerobic minimal media conditons under which a 
ΔmetE ΔcobS mutant is not, that PocR is not an essential regulator of the operon and 
that there are other unknown regulators. In the case of Salmonella Pullorum it 
therefore may be the case that this mutation does not result in the total lack of ability 
to trancribe the cob operon and produce vitamin B12, however we have not yet looked 
into what an alternative regulator might be and whether this holds true across multiple 
Salmonella serovars.  
We then developed a bioassay which would enable us to compare vitamin B12 
production between different Salmonella serovars (Figure 50) This assay, which is 
based on a previously described protocol (Lawrence and Roth 1996), uses the vitamin 
B12-dependency of a S. Typhimurium ΔmetE strain in order to assay the presence of 
the vitamin in a sample. The main issue faced however was in growing the strains 
equally and ensuring conditions where the production of vitamin B12 was required and 
thereore should occur, and that all components of the synthesis (such a cobalt which 
is required as a cofactor) were not limited. The major drawback however of this assay 
is that it does no provide an exact amount of B12 produced by the strains or a 
production rate. This is due to the fact that cells from 200 ml of culture must be lysed 
to release the endogenously produced vitamin and this process involves boiling which 
may damage a percentage of the vitamin – all strains were treated equally however 
and so comparisions are warranted. From the final results of this (Figure 51) we can 
conclude a few things. Our WT strain, S. Typhimurium SL1344 and the parent strain, 
4/74 produced the highest levels of B12, this was followed by the other enteric strains, 
S. Dublin and Enteriitdis, and then S. Choleraesuis. S. Gallinarum produced a very 
low level of B12 and S. Pullorum showed no growth around the disc and so we conclude 
no measurable B12 was released. Citrobacter rodentium, a model strain for the 
systemic causing EHEC, produced the lowest measurable level of vitamin B12. There 
is therefore a clear trend, that enteric strains which will spend long periods of time in 
the intestine, produce high levels of vitamin B12 and systemic strains, which will quickly 
disseminate into other parts of the body, produce much lower concentrations of B12.  
The next stage of this study was to compare the levels of nitrous oxide produced by 
the different strains while undergoing denitrification. The hypotheis was that since we 
believe Salmonella Typhimurium releases such high levels of N2O in order to compete 
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with the gut microbiota by targetting the vitamin B12 pool of these B12-auxotrophs, that 
non-enteric strains which do not remain in the intestine will not benefit from this survival 
advantage of high N2O emmisons and hence will release lower N2O.  
In general this hypothesis held true with the systemic strains producing less total N2O 
than the enteric strains (Figure 53), however not in all cases. Our WT strain S. 
Typhimurium SL1344, produced the second highest level of N2O whereas the parent 
strain S. Typhimurium 4/74 released the lowest levels of N2O. The latter of this is quite 
surprising and further study should be done to confirm the result. The two further 
enteric strains, S. Dublin and S. Enteritidis then produced the next highest levels of 
N2O, distinctly higher than S. Choleraesuis and S. Gallinarum, two systemic strains. 
However, two systemic strains, S. Pullorum and Citrobacter rodentium released two 
of the highest levels of N2O. This study needs to be repeated to draw any strong 
conclusions, steady state culturing may also provide more useful insight into any 
differences between the strains.  
Taken in combination the results of this chapter potentially provide insight into a link 
between vitamin B12 production and N2O release throughout systemic and enteric 
strains. It is clear from previous studies, our alignment and the bioassay conducted 
that enteric strains are capable of producing B12 and at higher levels than the systemic 
strains. We cannot conclude from this data whether the reason for this phenomenon 
is correlated to a change in the production of N2O by the strains or not. However, it 
seems clear that since the systemic strains have lost the ability to synthesise vitamin 
B12 this must not be of importance to their survival and pathogenesis.  
Assessing the survival of the different strains when challenged with N2O could reveal 
further insights in to their interactions with this gas, and moreover competition studies 
with commensal gut bacteria would be of interest. Do the enteric strains outcompete 
the gut microbiota, whereas the systemic strains do not – and would this difference 
disappear in the absence of available nitrate?  
A further question arises whether this link between N2O production and B12 synthesis 
is present throughout a wider range of pathogenic bacteria, particularly enteric 
pathogens. Most Campylobacter species are disease-causing, including C. jejuni, one 
of the primary causes of foodborne disease in humans and C. coli which also causes 
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an enteric infection in humans (Skirrow 1977). Campylobacter species are unable to 
produce both N2O and vitamin B12 (Payne et al. 1982, Rodionov et al. 2003).  
The enteric pathogen Clostridium difficile causes similar symptoms including watery 
diarrhea, fever and abdominal pain; it makes up about 20% of cases of antibiotic-
associated diarrhea (Kelly, Pothoulakis and LaMont 1994, Vogel 1995). C. difficile can 
synthesise vitamin B12, however analysis of its genome shows that both NarG and 
NapA are absent and it is therefore unlikely this strain can produce N2O (Rodionov et 
al. 2003) 
The enteric pathogen Vibrio cholera is the causative agent of cholera, which causes 
vomiting and diarrhea, and has a fatality ratio of approximately 4% (WHO). V. cholera 
can produce B12 (Rodionov et al. 2003) but only contains the periplasmic nitrate 
reductase (Nap) enzyme (Braun and Thöny-Meyer 2005) and so, it could be expected 
to produce lower levels of N2O. V. cholera can however produce NO and is able to 
reduce N2O and use it as an electron acceptor  (Janoff et al. 1997, Kaspar and Tiedje 
1981, Yoshinari 1980).   
From the three common enteric pathogens mentioned here it would appear that this 
phenomenon does not translate to other strains. Another member of the 
Enterobacteriaceae family, to which Salmonella and E. coli belong, Klebsiella 
pneumonia, does produce both N2O and B12. When undergoing denitrification 
Klebsiella converts ≈5% of the nitrate to N2O, a similar level to measured for 
Salmonella in this study (Satoh, Hom and Shanmugam 1983). K. pneumonia is found 
in our normal microbiota, in the mouth, skin and gut; however if inhaled it can result in 
pneumonia which carries a fatality rate of abput 50% (Meatherall et al. 2009). 
Klebsiella can also cause urinary tract infections, particularly in diabetics, and can lead 
to bladder or kidney stones (Ronald 2003). This strain is therefore not an enteric 
pathogen but contains the characteristics we see from enteric Salmonella strains.  
There are many non-enteric, or systemic, pathogens which are unable to produce B12 
including pathogenic Neisseria, Hemophilus influenza and Helicobacter pylori and 
Bordetella pertussis. The latter three of these are unable to produce N2O, Neisseria 
can reduce NO to N2O but cannot reduce nitrate, potentially resulting in low N2O 
emissions (Rodionov et al. 2003, Stewart 2003, Barth, Isabella and Clark 2009, Marais 
et al. 1999). In contrast, the non-enteric bacteria Pseudomonas aeruginosa, which 
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causes numerous infections in the urinary tract, skin wounds, blood and, airways, 
particularly of cystic fibrosis patients, produces both B12 and N2O (Bodey et al. 1983, 
Zumft 1997).  
It therefore seems that while in Salmonella there is a link between B12 and N2O 
production and being the causative agent of an enteric infection, throughout all 
bacteria this may be a more general link to pathogenicity.  
In Salmonella, vitamin B12 is required for the degradation of 1,2-propandediol required 
for the use of tetrathionate as an electron acceptor, which is present in the inflamed 
intestine. The loss of ability to reduce tetrathionate came at an earlier stage than the 
loss of B12 synthetic ability (Langridge et al. 2015). With the conclusions drawn from 
this chapter we therefore believe it may be the case that systemic strains have lost the 
ability to synthesise vitamin B12 due to the fact that they have moved out of the intestine 
where as well as vitamin B12 dependent tetrathionate respiration providing a growth 
advantage, N2O is released targeting any exogenous B12 (Nuccio and Bäumler 2014). 
If this is the case it could then be that enteric Salmonella strains which already require 
B12 provide themselves with a pathogenic advantage by producing high levels of N2O 
– something that provides no advantage, but a clear detriment to non-B12 producing, 
systemic strains.  
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7 General Discussion  
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As each chapter has already been individually discussed this general discussion will 
summarise the major results of the study, contextualise the results in the wider body 
of Salmonella research, and provide suggestions for future studies.  
 
7.1 Context 
Salmonella is a global pathogen which causes a range of diseases in humans and 
animals. In humans, there are two major disease types, gastroenteritis and an 
systemic infection known as Typhoid fever. Enteric infections are generally self-
limiting, and apart from infections of the immunocompromised, elderly or young, do 
not require any treatment. Typhoid fever however is a much more serious infection 
which without treatment usually results in death, and as such there are ≈200,000 
global deaths annually.  
The development of antibiotic resistant strains is an increasingly severe problem 
across a large number of pathogenic bacteria, primarily due to increased use and 
misuse of antibiotics. 
There are also multi-drug resistant strains of Salmonella which are resistant to the so 
called ‘last resort’ antibiotics and therefore are untreatable. Current vaccines against 
Typhoid fever have numerous drawbacks, including not providing life-long resistance 
and hence being of limited use to those living in the endemic regions.  
It is therefore of key global interest to better our understanding of how Salmonella 
causes infection in order to develop new treatments, including, but not limited to 
antibiotics, and vaccines.  
 
7.2 Nitric oxide  
Nitric oxide (NO) is a free radical which has both cytostatic and cytotoxic activities and 
causes widespread damage to numerous cellular targets including DNA and proteins 
(Fang 2004). Salmonella is exposed to NO both endogenously and exogenously 
throughout its lifecycle. As a facultative anaerobe, Salmonella has the ability to use 
alternative electron acceptors for respiration when oxygen is unavailable, one of these 
is nitrate. The respiration of nitrate in Salmonella, referred to as truncated 
denitrification, involves the sequential reduction of nitrate via nitrite and nitric oxide to 
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nitrous oxide. Hence the endogenous reduction of NO is required whenever 
Salmonella is respiring using nitrate. Additionally, the release of NO is an essential 
part of the host immune system particularly by macrophages. Salmonella have the 
ability to reside, survive and replicate within host macrophages, and rely on this ability 
in order to cause a systemic disease. NO release by macrophages is via the inducible 
NO synthase, iNOS. iNOS has been shown to be of particular importance to the host 
immune defence system in mice, with mice deficient in iNOS being significantly more 
susceptible to Salmonella infection (Alam et al. 2002, Mastroeni et al. 2000). 
There are three well characterised enzymes for NO detoxification in Salmonella, 
HmpA, NorV and NrfA, the triple deletion of which does not render Salmonella 
completely unable to withstand NO stress (Mills et al. 2008). This therefore suggests 
there are further systems at play to enable Salmonella to detoxify NO.   
Since NO detoxification is an essential step during Salmonella pathogenesis a better 
understanding of this process could allow the development of antibacterial drugs or 
vaccines that can target the enzymes involved in NO defense. 
 
7.3 Nitrous oxide  
Nitrous oxide is produced by Salmonella by the reduction of nitric oxide, primarily 
carried out by Hmp and NorVW. In Salmonella, due to the lack of a nitrous oxide 
reductase, denitrification is truncated and hence nitrous oxide is the end product. 
Similarly to Salmonella, E. coli also lacks a nitrous oxide reductase and hence has a 
net release of N2O; however a combination of studies by (Rowley et al. 2012) 
(Stremińska et al. 2012) and Runkel et al (personal communication) has identified that 
nitrous oxide production by Salmonella Typhimurium cultured in nitrate 
sufficient/glycerol limited chemostats is an order of magnitude higher than that 
produced by related non-pathogenic E. coli strains (Figure 3).  
In fact it has been observed that Salmonella also produces high levels of NO, and has 
been hypothesised that this is in order to enable the bacteria to produce such high 
levels of nitrous oxide and if so, for what purpose (Maia and Moura 2014). 
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7.4 Vitamin B12 
Salmonella is one of a reasonably small number of bacteria that is able to synthesise 
vitamin B12 de novo. B12 synthesis is a highly metabolically expensive process, the 
vitamin itself is very large, with a molecular weight of 1355.37 g/mol, and the process 
involves 30 different genes, which together make up over 1% of the Salmonella 
genome. Curiously however the requirements for vitamin B12 in Salmonella are very 
low. There are only four B12 dependent processes - vitamin B12-dependent methionine 
synthase, MetH, ethanolamine ammonia lyase, which degrades ethanolamine (Roof 
and Roth 1989), propanediol dehydratase which allows Salmonella to use propanediol 
as a carbon source, and queuosine synthase, which produces queuosine, a 
nucleoside found in four tRNAs which is not essential for growth under laboratory 
conditions (Frey et al. 1988).  
It was not until 2001 that a deleterious effect of losing any of these processes was first 
noted and therefore the beginning of an explanation as to why Salmonella produces 
vitamin B12. Tetrathionate is an alternative electron acceptor which is produced in the 
inflamed intestine, the ability of Salmonella to respire using tetrathionate is dependent 
on either ethanolamine or propanediol the utilisation of which are both vitamin B12 
dependent processes (Price-Carter et al. 2001, Thiennimitr et al. 2011).  
However, the ability to respire on tetrathionate alone does not seem sufficient to 
warrant the synthesis of vitamin B12. An observation was made in Paracoccus 
denitrificans that N2O accumulation induces a switch from vitamin B12-dependent to 
vitamin B12-independent biosynthetic methionine pathways (Sullivan et al. 2013); this 
therefore suggested a possibility for a similar phenomenon in Salmonella, and a link 
between nitrous oxide, vitamin B12 and methionine requirements.  
 
7.5 Characterisation of NO detoxification enzymes 
The basis of this work was a prior study done in the Rowley group where a microarray 
was conducted in order to identify novel genes involved in the anaerobic protection 
against nitric oxide. Six genes highlighted from this analysis were further investigated 
during this study, cstA, hcr, STM1273, yeaR, tehB and STM1808, the latter three of 
which have the same annotated function as tellurite resistance genes.  
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This study created knockout mutants of each of these six genes and a ΔtehB 
ΔSTM1808 ΔyeaR triple mutant strain. Aerobically no growth defect was observed 
when Salmonella was challenged with NO in the absence of these three genes, even 
in combination. However, anaerobically, there is a clear defect for a triple ΔtehB 
ΔSTM1808 ΔyeaR mutant growing in the presence of 10 mM of the NO donor deta 
NONOate. Since there is no phenotype visible for the single mutants we conclude that 
there is functional overlap between TehB, STM1808 and YeaR in anaerobic nitric 
oxide protection. Further experiments then measured the amount of NO released by 
the different strains when growing under denitrifying conditions and once more the 
triple mutant strain showed significantly higher levels of release than the WT.  
Three further genes which were upregulated by either exogenous or endogenous NO 
were then investigated. We confirmed a mild role for all three, cstA, hcr and STM1273, 
in both aerobic and anaerobic NO protection. The knockouts were only assessed as 
single mutants, as opposed to in combination with either other well-known NO 
detoxification systems or those identified in this study. It could therefore be the case 
that more pronounced phenotypes would become visible when combining some of 
these mutations, as seen for the TeR strains.  
The clearest role for any of these three proteins in direct NO reduction was for Hcr. 
When grown under denitrifying conditions the Δhcr mutant releases significantly higher 
levels of NO than the WT strain, thus suggesting that Hcr directly detoxifies NO and 
hence this strain has an impaired ability to do so. It is interesting that both the CstA 
and STM1273 knockout strains in fact release slightly lower levels of NO than the WT, 
indicating that these two proteins do not directly reduce endogenous NO.  
STM1273 was only upregulated in the microarray conducted after exogenous NO 
exposure, not during endogenous exposure during denitrification. If STM1273 is 
present in the periplasm as opposed to cytoplasmic membrane this would further 
strengthen this hypothesis, and the cellular localization of this protein needs to be 
determined.  
It is worth considering how the various NO protection systems across all bacteria 
function. The most common proteins are globins, heme-containing globular proteins 
which are important for transporting oxygen. The most well characterised and often 
said to be key NO reduction enzyme in Salmonella is Hmp, a flavohaemoglobin. 
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Additional globin proteins with roles in NO tolerance include HbN from Mycobacterium 
bovis and Vgb from Vitreoscilla sp (Ouellet et al. 2002) which similarly to Hmp convert 
NO into nitrate (Frey et al. 2002). However, additionally there are globin proteins which 
function in other ways such as Myoglobin and haemoglobin in animals which is thought 
to have a role in NO scavenging (Brunori 2001) and, Cgb in Camplylobacter jejuni, 
which confers resistance through an unknown mechanism (Elvers et al. 2004). A 
second group of NO protection enzymes are the reductases, this include NorV and 
NrfA from Salmonella and are capable of directly reducing the compound either to 
nitrous oxide or ammonia.  
The next step is to determine the exact mechanism of how the six proteins included in 
this study provide Salmonella with protection against NO. Protein film voltammetry can 
be used in order to determine and quantify the NO reductase activity, as has previously 
been done for NrfA from E. coli (van Wonderen et al. 2008). This technique works by 
immobilizing the enzyme onto an electrode, placing this in the potential substrate (NO) 
and monitoring any charge produced due to the flow of electrons and thus the redox 
potential (Angove et al. 2002). In addition, the effect of changing conditions such as 
pH or other inhibitors can be assessed. Understanding the mechanism by which these 
proteins provide protection against NO is important for building a complete picture of 
NO resistance in Salmonella – especially if these different systems are acting in 
different ways at different parts of the cell. It would be the case if designing vaccines 
or drug targets based on any of these systems that one must be aware of how the 
numerous proteins interact, especially if they are able to compensate for the loss of 
others.  
 
7.6 A link between nitric oxide and tellurite resistance in Salmonella 
Three of the proteins shown in this study to be involved in NO protection are annotated 
as tellurite resistance proteins. We therefore also assessed the impact a loss of these 
proteins has on Salmonella growing in the presence of potassium tellurite. The results 
of this study show a clear link between tellurite and nitric oxide resistance in 
Salmonella.  
We initially became interested in tellurite due to the fact that three of the proteins 
upregulated in response to NO, and discussed above, are annotated as tellurite 
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resistance genes. Tellurite is highly toxic to a wide range of bacteria; the causation of 
the toxicity is not currently clear but there are multiple resistance systems across the 
bacterial kingdom. The results presented here confirm TehB, STM1808 and YeaR to 
be important for tellurite protection in Salmonella, both aerobically and anaerobically. 
Previous work has suggested that the version of TehB in Salmonella, as opposed to 
the E. coli homologue, may not have the ability to protect against tellurite due to 
differences in the SAM-methyltransferase domain (Karlinsey et al. 2012). Conversely, 
we found TehB to afford Salmonella with the highest level of protection against 
tellurite.  
We then hypothesised that since tellurite resistance proteins also afford Salmonella 
an advantage in the protection against NO that the reverse may also be true, that 
proteins known to play a role in NO protection may also provide tellurite resistance. 
The most striking result here was that of ΔnsrR. NsrR is the master negative regulator 
of NO detoxification in Salmonella and is responsible for regulating hcp-hcr, 
ytfE, ygbA, hmp, yeaR-yoaG and STM1808 (Karlinsey et al. 2012). When challenged 
with tellurite ΔnsrR grows considerably better than WT. This therefore shows that the 
upregulation of these genes results in Salmonella being able to survive in the presence 
of this toxin. This was further investigated using numerous knockout strains which 
showed that YtfE, NrfA and NorV all exhibit a small but measureable degree of 
protection against tellurite anaerobically. The three proteins whose role in NO 
protection was confirmed in this study, CstA, Hcr and STM1273, also were shown to 
provide tellurite resistance.  
 
7.7 Nitrous oxide  
The second aspect of this thesis was looking at the role of nitrous oxide production in 
Salmonella. Previous studies have highlighted that Salmonella produces and releases 
nitrous oxide at high levels – but have been unable to provide an explanation as to 
why this might be. From the results presented here we hypothesise that when residing 
in the inflamed intestine, Salmonella releases N2O in order to outcompete the resident 
gut microbiota.  
The key protein linking nitrous oxide, vitamin B12 and the intestine together is MetE. 
Since nitrous oxide binds to and inactivates vitamin B12, MetH, the vitamin B12 
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dependent methionine synthase is unable to function adequately in its presence, 
however since Salmonella possesses a vitamin B12 independent methionine synthase, 
MetE, this protein is able to perform this vital function. A key finding of this work was 
the importance of MetE for denitrifying Salmonella, where a clear growth defect for 
ΔmetE was seen, a defect which was further amplified by saturating the growth media 
with N2O.  
The regulation of vitamin B12 synthesis was also investigated. Previous studies have 
highlighted PocR as being the primary regulator of the cob operon and hence of 
vitamin B12 synthesis. However, results from this study suggest that there are 
alternative regulators due to the fact that the absence of PocR is not detrimental for 
the vitamin B12 addicted strain, ΔmetE, and in fact provides a slight restoration of the 
growth defect. We provide a potential explanation that when PocR is present it binds 
in such a location that it blocks the binding sites for other unknown regulatory 
elements. The full understanding of the regulation of the cob operon may then provide 
insights into when and why this operon is active.   
Based on the hypothesis drawn we then queried whether the production of vitamin B12 
and N2O is similar throughout a range of Salmonella serovars, in particular if systemic 
strains produce these two compounds at the same rate as enteric strains. Systemic 
strains of Salmonella, such as Salmonella Typhi the causative agent of Typhoid fever, 
do not remain in the inflamed intestine where nitrate is available for extended periods 
of time, and instead reside in areas of the body where oxygen is likely to be more 
abundant.  
By looking both bioinformatically and by the development of a vitamin B12 bioassay we 
concluded that there is a general trend for enteric Salmonella serovars to produce 
higher levels of vitamin B12 than the systemic strains. Both S. Typhi and S. Paratyphi 
could not be assessed in our hands but bioinformatic analysis would suggest that they 
are unable to produce any vitamin B12. There was a less strong correlation for the 
amount of N2O produced by the different strains although a general trend could be 
seen with the enteric strains releasing higher levels of N2O than the WT strain. What 
is of most interest here is that the systemic strains must not require vitamin B12 and 
hence have acquired pseudogenes or lost genes in the cob operon, this further 
indicates the important of vitamin B12 for Salmonella residing in the intestine.  
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Initial future experiments should be based on competing Salmonella against members 
of the gut microbiota under denitrifying conditions as would be found in the inflamed 
intestine. Bioinformatic analysis of common gut microbiota revealed that almost no 
members of the microbiota have the vitamin B12 independent enzyme, MetE (Table 9). 
In addition, none of the microbiota we analysed possess NosZ, the enzyme required 
for the reduction of nitrous oxide. It therefore is highly likely that when growing on 
nitrate Salmonella will be able to outcompete the gut microbiota. Since it would be very 
complex to assess this interaction in vivo an in vitro approach would be required. A 
simple co-culture experiment could be used, whereby the same experimental setup 
used in this study is used but with commensal gut bacteria and Salmonella cultured in 
the same vessel. This would require thorough experimental design to ensure 
conditions which allowed for both bacteria to grow, that is that when cultured 
separately the commensal bacteria exhibits normal growth. One drawback of this set 
up is that it does not closely mimic the natural conditions of the gut, where a complex 
community of gut commensal bacteria are situated with a small number of Salmonella 
infecting. A preferential system would be a model where a defined microbiota could 
be allowed to become established and then a later inoculation of Salmonella be made, 
and the effect of the pathogen on the microbiota numbers monitored. One system 
which could allow for this would be a microfluidics gut model, where media is 
constantly being pumped through the system and thus bacteria can survive for 
extended periods of time. This is a new and rapidly developing field but a number of 
groups are having successes with similar studies (Shah et al. 2016, Kim and Ingber 
2013, Kim et al. 2016a).  
Based on the general hypothesis drawn and also the significant reduction in survival 
seen for a ΔmetE mutant in macrophages it would also be of interest to monitor this 
strain in the mouse model. In particular this could be used not just to monitor the 
survival of the mice, but to track the ability of the bacteria to disseminate from the 
intestine. Analysis of the mouse stools to measure bacterial diversity and quantity 
could also be used to give some information on how this strain, in comparison to the 
WT, impacts on the mouse microbiota.  
There are three potential ways to try and target Salmonella using this information. One, 
by increasing the levels of vitamin B12 available, two, by removing the N2O from the 
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intestine or three, by providing the commensal bacteria with a way by to survive even 
with high levels of N2O and low levels of vitamin B12.  
Since we have shown that in vitro the effect of N2O can be overcome with the addition 
of vitamin B12 there is the potential that this could be the case in the intestine. Vitamin 
B12 could be delivered to the intestine in high levels, either orally in a prebiotic fashion, 
or in combination with antibiotics, and this may be able to negate the advantage 
Salmonella has over the non-vitamin B12 producing commensal bacteria.  
Another possibility is reducing the amount of N2O present. There is a wide range of 
work looking at the production and release of N2O into the atmosphere from 
agricultural soils due to its function as a greenhouse gas; and therefore, research into 
possible mitigation strategies (Ravishankara et al. 2009). The most feasible strategies 
are those which rely on the natural bacteria N2O reductase system, NosZ, and 
increasing the expression and function of this enzyme. It may be possible to engineer 
a member of the gut microbiota to express nosZ. This would allow the gut bacteria to 
reduce N2O to N2. This could then be used as a probiotic strain which would be able 
to remove the N2O which Salmonella emits from the intestine and negate the impact 
this has on the wider vitamin B12 pool.  
Additionally, providing important members of the gut microbiota with MetE, the vitamin 
B12 independent methionine synthase would allow them to survive even in the 
presence of N2O. The creation of genetically modified, so called ‘smart’ probiotic 
strains is controversial and not yet well studied; any work in this field would need to do 
thorough testing to ensure that the modification to the bacteria does not result in a 
conversion to a pathogenic phenotype, nor that the gene introduced cannot be 
transferred to other bacteria. There are however increasing numbers of studies looking 
to modify probiotic bacterial strains   (Kullen and Klaenhammer 2000, Steidler and 
Rottiers 2006, Durrer, Allen and Hunt von Herbing 2017, Hwang et al. 2017) 
 
7.8 Survival within macrophages 
Numerous strains constructed throughout this study were tested for their ability to 
survive within murine macrophages. The ability for Salmonella to survive within the 
host environment of the macrophage is essential to its virulence (Fields et al. 1986) 
and therefore this is a key feature in the pathogenicity of the pathogen and potential 
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source of a vaccine stain. The most severely attenuated strain is the ΔtehB ΔSTM1808 
ΔyeaR triple tellurite mutant with a four-fold reduction in bacterial survival compared 
to the WT strain. Approximately a two-fold reduction was seen both for Δhcr and for 
ΔmetE when methionine was lacking from the cell culture medium. These phenotypes 
are all of worth pursuing to assess if the phenotypes translate to a reduced survival of 
these strains in a mouse model. The combination of some of these mutations, or the 
addition of knockout mutation of proteins such as HmpA may also further amplify the 
phenotypes seen.  
 
7.9 Final conclusions 
 
In conclusion, this study highlights two aspects of denitrification in Salmonella which 
may contribute to pathogenesis. We have characterised novel nitric oxide 
detoxification proteins and shown a clear link between nitric oxide and tellurite 
protection in Salmonella. We have also provided an explanation for two phenomena, 
the production of vitamin B12 and the production of high levels of N2O. We hypothesise 
that these two compounds afford Salmonella an advantage when residing in the 
inflamed intestine.   
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